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The work described in this dissertation is divided into three chapters each discussing 
independent projects where either gas-liquid flow technology or microwave reactor 
technology was applied to organic synthesis.  
The first chapter describes the flow hydroxy-carbonylation of ortho-substituted iodo 
arenes. It was found that through the use of a “tube-in-tube” reactor to introduce the 
carbon monoxide gas to the reaction mixture, a number of ortho-substituted carboxylic 
acids could be prepared. The second part of this chapter deals with the synthesis of a 
herbicidal intermediate which was prepared through the carboxylation reaction with 
carbon dioxide (dry ice). A parallel flow process for the preparation of this herbicidal 
intermediate was also developed. This work was reported in one publication. 
In the second chapter another gas; oxygen, was used in continuous flow as an oxidant 
in the Chan-Lam reaction. The first part of this chapter demonstrates how a continuous 
process for the synthesis of a herbicidal intermediate was developed through an optimised 
catalytic Chan-Lam reaction which was also shown to consistently work at different 
scales. In the second part a more generalised catalytic Chan-Lam reaction was optimised 
and this lead to a small collection of C-N coupled products. This work was published in 
one publication. 
The use of 1,4-dithain-2,5-diol as a precursor for 2-mercaptoacetaldehyde was used as a 
building block for the synthesis of thiazoles in the third chapter. Using microwave 
reactor technology the optimised reaction conditions for this novel transformation was 
quickly achieved. A bifurcation pathway was discovered where either 2-aminothiophens 
or 2-substiuted thiazoles were prepared, which was demonstrated through the synthesis 
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1 Introduction  
 
“Enabling technologies”1 is a broad term used to refer to techniques that either increase 
the productivity of reactions through a more efficient process or offer an improved setup 
through the use of modern equipment. This includes intuitive programs such as Design 
of Experiment (DOE) programs and equipment that can be integrated with robotic 
modules such as microwave reactors, meso/micro-flow reactors and automated liquid 
handlers. These have all found a number of high-throughput applications, especially in 
library generation and fast optimisation of reaction conditions.  
The use of enabling techniques in contemporary laboratory setups allow for a more 
efficient workforce by improving the overall process at different levels. Although there 
has been an immense improvement in the general chemistry knowledge over the last 
decades, allowing today’s chemists to perform almost any transformation needed to build 
highly complex molecules, the techniques employed to build the structures did not change 
at the same rate. Due to the conservative nature of chemists, and the initial high costs 
associated with new techniques/equipment, the idea of substituting well known chemistry 
techniques with new and improved ones is still a challenge. Unlike in other sciences, 
chemists still use the same equipment associated with chemical synthesis (such as round 
bottom flasks, separator funnels and Schlenk lines) that were used over six decades ago. 
However, chemists have started to gain an appreciation that in order to overcome 
additional bottlenecks, there is a requirement to change of mind set and the application 
of novel enabling techniques.  
The use of microwave reactor technology is one such example which has been used  
extensively in high throughput experiments due to the potential for automation.2 Some 
researchers have reported the so called “microwave effect” which was used early on to 
explain the superior results obtained through microwave heating when compared to 
conventional heating. Loupy et al.3 have suggested that these differences may be due to 
a number of reasons such as the formation of “hot spots” in the microwave vial.  However, 
it is not easy to verify such proposals due to the difficulty to accurately measure the inside 
local temperatures without changing the environment of the reaction. Nevertheless, 
microwave reactors have found many uses in chemistry and are now found in most 
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modern research facilities. The holding capacity of most microwave vials is however a 
limiting factor when considering scaling up reactions.  
Design of Experiments (DOE) is a method by which a designed experiment is performed 
to aid in explaining the variation of information obtained under the conditions used. 
When just one factor influences the output, it is relatively easy to vary that factor and 
monitor the response. However, when more than one factor is affecting the response, as 
is the case, in most real-life situations, changing just one factor at a time is inefficient. 
The use of DOE allows for the investigation of how factors jointly affect the response. 
This is generally done through the use of dedicated software (such as JMP) to analyse 
data obtained and model the pattern of responses to identify active factors, which can 
then be used to predict trends. Although, such analysis can be used to achieve well 
optimised systems, it is generally accepted that this comes with a considerable 
expenditure of resources and time. For some industries such optimised conditions may 
offer a cheaper, more efficient way of producing a product/intermediate, which on large 
scales offer a significant savings. However, for chemists that do not need to scale up 
reactions, the effort required to optimise a reaction through DOE might not be sufficiently 
beneficial when considering the resources and time required.      
In this thesis, emphasis is given to gas-liquid chemistry, an area that still has several 
bottlenecks associated with both safe use and scale up. This thesis mainly aims to 
investigate classes of reactions that use toxic and/or dangerous gases to produce useful 
intermediates, using flow methodology to overcome the aforementioned bottlenecks. The 
next section will thus be dedicated to illustrating examples of gas-liquid flow chemistry 
from the literature, covering carbon monoxide, carbon dioxide and oxygen. There are 
other gases that are used in flow chemistry that will not be covered in this thesis, however, 




1.1 The Use of Flow Chemistry in Aiding Gas-Liquid Chemistry  
The use of toxic and dangerous gases is highly restricted and controlled in modern 
synthetic laboratories. Increased safety considerations, including precautionary 
limitations on their use at scale, are often mandated for gas processing operations. 
Understandably, for something as ethereal as a gas, which cannot be easily contained, 
leakages are very difficult to prevent when conventional synthetic equipment is used. 
Consequently, dedicated high pressure facility rooms are normally built specifically to 
enable access to gas based transformations. Pressurised gas reactions are normally 
continually monitored for leakage using specialised gas and/or pressure detectors, with 
personnel using such facilities having to undergo specialised training. Furthermore, 
restrictions on the scales of high pressure reactions are also put in place to mitigate risks, 
making the scale up of these reactions challenging. 
1.1.1 Alternative Approaches 
The use of gas surrogates has been developed to circumvent the direct use of certain 
gases, with the in situ liberation of the required gas being the most common method. 
Several carbon monoxide precursors exists such as those derived from aldehydes,5 formyl 




Similarly, the use of transfer hydrogenation is often applied as a substitute for gaseous 
hydrogen, which can be delivered through a donor such as formic acid via a metal 
complex (e.g. Ru),10 often in association with diamine or phosphine ligands. It is also 
possible to use metal free hydrogen gas substitutes such as Hantzsch esters often 
promoted by the addition of an auxiliary organocatalyst.11 Additional gas substitutes for 
less common species have also been developed such as Selectfluor® (which acts as a F 
donor)12 and DABSO as a gaseous sulfur dioxide substitute.13 Even though these gas 
substitutes are useful for small scale chemistry, they often tend to be either too toxic,14 
atom inefficient or too expensive to be used at larger scales. 
1.1.2 Application of Gases 
One of the main limiting factors when pursuing a transformation using a gaseous 
component is establishing the required stoichiometry by solubilising sufficient quantities 
of the gas into the reaction media. The low solubility of certain gases like carbon 
monoxide (Table 1),15 often deems that high pressures are required, with the 
concentration of the dissolved gas also showing a rapid decrease with an increase in 
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temperature, especially when the boiling point of the solvent is approached. Thus, 
following Henry’s law, when the reaction temperature is elevated, an increase in pressure 
is required to maintain the same concentration of dissolved gas. 
Table 1: Solubility of carbon monoxide in selected solvents at 25 °C.15 





n-Heptane 146.46 11.71 x 10-3 
Cyclohexane 108.75 9.12 x 10-3 
Methylcyclohexane 128.35 9.68 x 10-3 
Toluene 106.86 7.59 x 10-3 
Perfluoroheptane 227.33 17.11 x 10-3 
Perfluorobenzene 115.79 1.35 x 10-3 
Chloroform 80.94 7.94 x 10-3 
Acetone 74.01 10.44 x 10-3 
MeOH 40.73 9.24 x 10-3 
EtOH 58.68 8.26 x 10-3 
n-Propanolb 74.79 7.36 x 10-3 
i-Propanol 76.55 7.89 x 10-3 
i-butanol 92.88 7.03 x 10-3 
Dimethylformamideb 77.04 1.82 x 10-3 
Water 18.07 0.95 x 10-3 
a Concentration in moles per litre at 1 atm. partial pressure of carbon monoxide. 
b Measurements taken at 20 °C. 
 
Continuous flow technology can provide many advantages over traditional batch 
synthesis.16 Firstly, the high heat and mass transfer rates which are possible when using 
small channelled fluidic systems enable reactions to be performed under a wider range of 
conditions, many of which are not accessible within conventional batch reactors. In the 
case of gas-liquid reactions a high interfacial area (a) is essential for an efficient mass 
transfer rate. Batch reactions performed in a traditional round bottom flask have much 
lower interfacial areas and this decreases with an increase in the size of the flask, Figure 
1. Note: when the reaction is stirred, the vortex formed increases the interfacial area 
which also depends on the speed of mixing. Table 2 shows some published interfacial 
areas for different reactors, showing much larger values for certain reactor types 
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especially microchannel reactors (a = 3400-18000 m2m-3), with a maximum interfacial 
value of 18000 m2m-3 for a 300 µm x 100 µm microchannel.17 
 
Figure 1: Qualitative measure of interfacial area (a) for typical round bottom flasks when the 
liquid is static. 
Table 2: Published interfacial area for different gas liquid contactors.17 
Type of contactor a (m2m-3) 
Bubble columns 50-600 
Couette-Tylor flow reactor 200-1200 
Impinging jet absorbers 90-2050 
Packed columns, concurrent 10-1700 
Packed columns, counter current 10-350 
Spray column 75-170 
Static mixers 100-1000 
Stirred tank 100-2000 
Tube reactors, horizontal and coiled 50-700 
Tube reactors, vertical 100-2000 
Gas-liquid microchannel contactor 3400-18000 
 
A significant increase in the interfacial contact area can permit reactions that are not 
normally feasible under conventional batch synthesis conditions to be promoted in flow. 
In general, gases are easier to use in flow as their delivery can be regulated by dosing 
controlled flow volumes and using the higher internal pressures within the flow system 
to aid dissolution. Since flow technology also allows for coupling multiple connected 
6 
 
reactors, the storing of chemicals is reduced together with shipping costs as intermediates 
needed for the desired product can potentially be synthesised and used directly in the next 
step without the need of isolation. Also hazardous chemicals, such as pyrophoric or air 
sensitive chemicals are much easier to use without the need for complicated precautions. 
Scale-up to production levels is potentially easily achieved by replicating the same 
reactor used for pilot plant experiments via a numbering-up approach or through 
prolonged running of the same reactor in a continuous manufacture scenario without any 
redesign in the set-up. Both approaches drastically reduce the transition time moving to 
scale and are thus financially beneficial. 
1.1.3  Approaches Used in Micro and Meso Gas-Liquid Flow Reactions 
Microchannel reactors have been extensively used employing a biphasic flow regime 
most commonly segmented flow, where bubbles of a gas are separated by slugs of a liquid 
(Figure 2). The toroidal currents formed in both the liquid and gas segments enhance the 
mixing and increase mass transfer.18 Another approach, which also involves a gas and a 
liquid stream concurrently flowing together, is created by the introduction of a fast 
flowing gas stream injected at high pressures into a slower liquid flow (Figure 2). The 
velocity of the gas creates an annular flow (pipe flow) with the liquid being pushed 
against the boundary walls of the microchannels. The thin liquid layer again allows for a 
high interfacial contact area, with a decrease in the diffusion length.  
A further reactor design based upon this same principle is the falling film microreactor, 
in which the liquid phase flows through microchannels under gravity to form a thin liquid 









Figure 3: Falling film reactor with liquid flow falling downwards and gas flowing either upwards 
(left) or downwards (right) above the liquid flow. 
Mesh microreactors have also used for gas-liquid flow reactions. This design makes use 
of a fine metal or ceramic mesh separating the liquid flow in the microchannels. The gas 
component is passed into the reactor and flows through the mesh to enter the liquid 
stream.20 The fine openings in the mesh (average pore size of 76 µm) allows for an 
increase in the gas-liquid interfacial contact area and the small gap separating the mesh 
and the microchannel allows for a very short diffusion length. 
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A related approach involves the use of a gas-permeable membrane system which spatially 
separates the liquid and the gas flows by creating a mono-directional barrier. Several such 
systems have been constructed making use of this reactor format, employing gas porous 
interleafed sheets, wafers or tubing. As an example the conventional ‘tube-in-tube’ design 
reported by the Ley group21 makes use of an amorphous fluoropolymer Teflon AF-2400 
membrane which has high permeability for gases but not liquids.22 The design enables 
the formation of micro-bubbles around the outer walls of the membrane tubing which are 
quickly dissolved into the traversing liquid flow (Figure 4). As a consequence of the large 
surface area and small cross sectional diameter of the Teflon AF-2400 tubing, gas 
diffusion across the membrane and into the inertia flow stream is extremely rapid. The 
Jensen group studied the diffusion phenomenon of several different configurations of the 
‘tube-in-tube’ design involving the ‘conventional’ and reengineered ‘reverse’ designs 
(Figure 4).23 The reverse ‘tube-in-tube’ design, also known as the ‘on-demand’ design, is 
capable of being additionally heated to warm the liquid flow whilst also supplying the 
gas, whereas the conventional ‘tube-in-tube’ design can only be used to saturate the liquid 
flow with a gas at ambient temperature. Despite this limitation the simple assembly of 
the conventional ‘tube-in-tube’ design still make the set-up attractive. It can be easily 
constructed from commercially available amorphous fluoropolymer Teflon AF-2400 
membrane tubing simply inserted into a length of wider bore PTFE tube and connected 
by the appropriate Swagelock® unions. The corresponding reverse ‘tube-in-tube’ design 




Figure 4: ‘Tube-in-tube’ reactors. Conventional design with liquid flowing through the inner 
tube (Top). Reverse design with gas flowing through the inner tube (Bottom). 
1.1.4 Different Gases Used in Flow 
As a consequence of all the new techniques developed for the easier introduction of gases 
to flow systems the area of gas-liquid reactions has become an increasing popular 
research topic. Several groups have made substantial progress in overcoming problems 
normally encountered when gases are used in batch as will be illustrated in the next 
sections. Carbon monoxide, carbon dioxide and oxygen will be covered in detail, other 
gases are covered in the full review we authored about the use of gases in flow chemistry.4 
1.1.4.1 Carbon monoxide 
Carbon monoxide is a toxic (poisoning symptoms occur above 50 ppm concentration in 
air)14 and highly flammable gas that due to its limited solubility in most organic solvents 
(Table 1), reactions employing it are most commonly carried out at elevated pressure. 
This makes the use of carbon monoxide a risk, especially in standard labs or when large 
quantities are needed. However, because it is a synthetically versatile and low cost 
building block, chemists have continued using it despite its associated hazards.24 Indeed, 
carbon monoxide is perhaps one of the most used gases and as such it is used in several 
industrial process such as the Fischer-Tropsch process,25 and alcohol formation through 
hydroformylation.26 Carbon monoxide is also routinely used for the conversion of aryl 
halides and pseudo-halides to higher oxidation level groups such as amides, esters, 
aldehydes and carboxylic acids. 
The Long group reported one of the first flow-carbonylation in 2006 as a safe and scalable 
way to make simple amides from iodobenzene (1a), 4-iodoanisole (1b) and 2-
bromopyridine (1c) with benzyl amine as the substrate. A microfluidic reactor was used 
to combine the reactants and a base and the carbon monoxide were delivered in an annular 
flow regime.27 The reactions were compared with existing batch protocols and although 
the yields from the micro-flow system were only moderate (12-58% yields of amide 
formed), were an improvement on those obtained in batch (11-25% yields, Table 3). Of 
note was the α-ketoamide by-product, formed through over-carbonylation, which was 
















1a 3.75 min 31 18 49 
1a 7.5 min 37 17 54 
1a 15 min 46 9 55 
Batch - 25 0 25 
1b 3.75 min 10 20 30 
1b 7.5 min 10 19 29 
1b 15 min 12 28 40 
Batch - 11 0 11 
1c 3.75 min 46 0 46 
1c 7.5 min 51 0 51 
1c 15 min 58 0 58 
Batch - 18 0 18 
 
Ryu et. al. later published a flow carbonylation protocol for aryl iodides and 
phenylacetylene in ionic liquids such as [BMIm]PF6 which can function as a recyclable 
reaction media and catalyst support. The results were again compared to the analogous 
batch reactions, and demonstrated higher yields when performed in flow (Scheme 1).28 
Furthermore, the palladium-catalysed carbonylative Sonogashira coupling yielded only 
the acetylenic ketone when performed in micro-flow but also formed the Sonogashira 
coupled by-product when run under batch conditions. When diethylamine was used as 
the nucleophilic partner, the micro-flow procedure gave a mixture of the amide (14) and 
the α-ketoamide (15) the latter being the main product (95:6 – 87:13, 15:14). This was in 
drastic contrast to what was observed by the Long group who instead obtained the amide 
as the main product.27 This was probably due to the higher pressures used in the Ryu plug 
11 
 
flow system (15-20 atm) which allows for a greater concentration of dissolved carbon 
monoxide in the solvent giving a higher proportion of the double addition α-ketoamide 
product. 
 
Scheme 1: Palladium-catalysed carbonylative coupling of aryl iodides and phenylacetylene in 
flow. 
The specific conditions leading to the formation of the α-ketoamides was studied by the 
Buchwald group in an attempt to avoid its generation.29 As would be expected it was 
concluded that in a micro-flow reactor either elevating the temperature or decreasing the 
pressure increases the selectivity for the formation of the amide with carbon monoxide 
added in an annular flow manner. 
The Long group additionally reported on the use of flow carbonylation for the synthesis 
of amides comprising radiolabelled 11CO.30 In this reaction, a triphasic reaction system 
utilising a silica-supported palladium diphosphine catalyst was employed as a packed bed 
reactor, produced by loading the catalysts into a length of Teflon tubing. Very good yields 
were achieved for electron deficient bromo-arenes (99% yield, 3 examples) but much 
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lower yields were obtained for the more challenging electron rich systems (23-26%, 2 
examples). This would correlate well with the need for longer reaction times for electron 
rich systems which would be difficult to achieve in the low residence time reactor 
assembled for this study. 
Miller et al. showed that the use of a chip based microfluidic system with an annular CO 
flow profile could be used to rapidly screen for ligand activity in amino-carbonylations. 
A simple coupling between iodobenzene 1a and benzylamine 2 was used as a standard 
test reaction.31 A total of eight different catalysts were screened across a range of 
temperatures varying from 75 °C to 150 °C using very short residence times (2 min). 
Generally catalysts performed better as the temperature was increased, with PdCl2(dppf), 
PdCl2(dppp), PdCl2(Biphenphos), PdCl2(DPEphos), PdCl2(Synphos) and Pd(PPh3)4 
giving good GC yields (>75%) at 150 °C whereas PdCl2(BINAP) still only gave 45% GC 
yield even at the highest temperature of 150 °C. The best pre-catalyst was found to be 
PdCl2(Xantphos) which gave 94% GC yield at the higher temperature range and was 
found to give an 85% GC yield even at 75 °C. 
The Ryu group described their continuing studies of carbonylation chemistry expanding 
into radical carbonylation of aliphatic halides.32 They employed a microfluidic flow 
system with the carbon monoxide delivered through a simple T-piece connector (Table 
4). It was shown that using the radical initiator V-65 [(2,2′-azobis(2,4-
dimethylvaleronitrile), half-life time: 12 min at 80 °C] in the presence of 1-
bromododecane (16), tributyltin hydride and carbon monoxide at 80 °C, full conversion 
of the 1-bromododecane was achieved in 12 min, with a 77% isolated yield of tridecanal 
(17). The same continuous micro-flow system was also used with silicon-based hydride 
donors delivering various aldehydes, unsymmetrical ketones and a δ-lactam all in good 








Table 4: Radical carbonylation in micro-flow system. 
 





0.02 M in toluene, 
Bu3SnH (1.2 equiv.), 
V-65 (10 mol%), 





0.02 M in toluene, 
Bu3SnH (1.2 equiv.), 
V-65 (10 mol%), 





0.02 M in toluene, 
Bu3SnH (1.2 equiv.), 
V-65 (10 mol%), 





0.05 M in toluene, 
Bu3SnH (1.1 equiv.), 
V-65 (10 mol%), 




0.017 M in toluene, 
Bu3SnH (1.5 equiv.), 
H2C=CH-COCH3 (4 equiv.) 
V-65 (10 mol%), 





0.02 M in toluene, 
(TMS)3SiH (1.5 equiv.), 
H2C=CH-COCH3 (1.2 equiv.) 
V-65 (30 mol%), 





0.02 M in toluene, 
(TMS)3SiH (1.5 equiv.), 
H2C=CH-CN (1.2 equiv.) 
V-65 (30 mol%), 





The de Mello group and collaborators reported a comparison between the use of annular 
flow and plug flow for amino-carbonylation reactions (Scheme 2).33 Even though the 
annular flow method was shown to be efficient, it was limited to short residence times 
(2-5 min). The plug flow method could enable longer residence times and had a reduced 
tendency to block the reactor due to formation of Pd black particulates during 
carbonylation. It was reported that the use of the Pd dimer [Pd2(µ-I)2(P
tBu3)2] served as 
an excellent pre-catalyst for aminocarbonylation being far superior to many other 
previously reported catalysts. 
 
Scheme 2: Comparison between annular and segmented flow in amino-carbonylation system. 
The amino-carbonylation of halogenated aryl carboxylic acids with various amines has 
also been reported by Csajági et al. using a commercial pressurised continuous flow 
reactor (Scheme 3).34 The substrates were passed through a phosphine immobilised 
version of Pd(PPh3)4 to generate moderate to good yields of a variety of amide products 




Scheme 3: Amino-carbonylation of halogenated aryl carboxylic acids in flow using the X-
cubeTM. 
The use of a conventional ‘tube-in-tube’ configuration for carbonylation reactions was 
reported by the Ley group (Scheme 4).35 In this publication a selection of aryl iodides, 
bromides and vinyl iodides were tested, with most of the substrates giving good to 
excellent yields (62-93% yields, 14 examples). A solvent mixture of toluene, MeOH and 
dimethylformamide was used. The MeOH was utilised as the nucleophilic partner and 
the dimethylformamide was found to be beneficial for stabilising the palladium catalyst 
and thus preventing the formation of palladium black. An in-line scavenger cartridge 
packed with polymer-bound thiourea resin was used to remove the palladium from the 
reaction mixture making the purification of the crude material easier. Furthermore a 
ReactIR detector was deployed in-line to monitor the carbon monoxide concentration in 
the flow stream. This was used to find the optimum pressure to give the highest carbon 
monoxide concentration in the liquid stream. The use of a second ‘tube-in-tube’ system 
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under vacuum to remove the excess dissolved carbon monoxide as an in-line process was 
also described. The removal of residual carbon monoxide was also monitored using 
ReactIR. This is especially relevant for industrial processes that make use of 

















Scheme 4: A) Methoxy carbonylation in flow using the ‘tube-in-tube’ reactor design. B) Use of 
in-line IR monitoring to determine concentration of dissolved carbon monoxide in solvent. C) 




The use of a reverse ‘tube-in-tube’ configuration was exemplified by Leadbeater and co-
workers for the carbonylation of several aryl iodides to give the alkoxy carbonylative 
products in excellent conversions (91-99%, 8 examples) (Scheme 5).36 The same group 
also published a carbonylative system where a plug flow system was used, and although 
it showed superior yields to the batch systems, it was still not as efficient as the reverse 
‘tube-in-tube’ system.37 
 
Scheme 5: Alkoxycarbonylation of aryl iodides in flow using the reverse ‘tube-in-tube’ reactor. 
The Ryu group devised an innovative use of the ‘tube-in-tube’ system (Scheme 6).38 
Instead of directly dosing carbon monoxide to the inner gas-permeable tube, a mixture of 
concentrated sulfuric acid and formic acid was mixed to form carbon monoxide in situ 
(Morgan reaction), which was then shown to be available for Heck aminocarbonylation. 
Two flow streams were directed in a co-current flow configuration for the work 
described, however, no specific mention was made to acknowledge if the counter flow 
system was also trialled.  
The same group published a similar protocol for the carbonylation of alcohols through 
the Koch-Haaf reaction.39 Again, concentrated sulfuric acid and formic acid were directly 
mixed with the substrate in a Hastelloy-made micromixer. The acid mixture forms carbon 
monoxide in situ through the Morgan reaction which in turn reacts with the carbocation 
formed after the elimination of the hydroxyl group. The authors showed that there were 
selectivity limitations and the reaction in flow gave little improvement compared to batch 
protocols (Table 5). Additionally they also showed a multigram scale-up version for the 




Scheme 6: Aminocarbonylation of 40 in flow using the Morgan reaction in the reverse ‘tube-in-
tube’ reactor. 
Table 5: Comparison of Koch-Haaf reactions of adamantanols in microflow and batch.a  




Temperature: 20 °C 
Flow rate (42/HCO2H): 
0.30 mL/min 
Flow rate (H2SO4): 0.88 
mL/min 
Residence time: 2 minc 






Temperature: 15-20 °C 
Addition time: 5 min 





Temperature: 20 °C 
Flow rate (44/HCO2H): 
0.30 mL/min 
Flow rate (H2SO4): 0.88 
mL/min 
Residence time: 2 minc 






Temperature: 17-20 °C 
Addition time: 5 min 








Temperature: 20 °C 
Flow rate (46/HCO2H): 
0.01 mL/min 
Flow rate (H2SO4): 0.3 
mL/min 
Residence time: 20 minc 






Temperature: 17-20 °C 
Addition time: 3 min 
Reaction time: 10 min 
 
 




Scheme 7: Multigram scale flow synthesis of 1-adamantanecarboxylic acid (43). 
Recently, a conventional ‘tube-in-tube’ system was used to expand the scope of 
carbonylation reaction in flow such as aminocarbonylations (79-93%, 5 examples), 
alkoxycarbonylations (60-95%, 9 examples) and hydroxycarbonylations (58-100%, 5 
examples) including some intra-molecular examples to form two lactams and a lactone 
(95%, 3 examples).40 An interesting addition was the use of a gaseous amine (dimethyl 
amine) in the hydrazine-promoted amino-carbonylation process, achieved by coupling 
two conventional ‘tube-in-tube’ systems in series (Scheme 8). In the initial screening, a 
higher concentration of substrates was investigated but this gave low conversions, 
indicating that the reaction was limiting in at least one of the gases used. An alternative 
set-up, where the substrates were directly passed through the ‘tube-in-tube’ reactors to 
saturate the streams was also tested but this showed low conversions. Eventually the 
20 
 
system set-up shown in Scheme 8 was used. This required the use of several back-
pressure regulators positioned at different locations within the set-up to stabilise the flow 
and to maintain the required system pressure. Additionally, a small column packed with 
glass wool was employed after the reactor to filter off any precipitate formed during the 









Scheme 8: Aminocarbonylation in flow using two gases via conventional ‘tube-in-tube’ reactors. 
A near stoichiometric (1.2 equiv.) amount of carbon monoxide was shown to be effective 
for the continuous flow Heck-carbonylation of 1-bromo-3,5-bis(trifluoromethyl)benzene 
(53). The reaction was promoted by PdCl2(PPh3)2 as the catalyst with 1,4-
bis(diphenylphosphino)butane (dppb) as the supporting ligand.41 A kilogram-scale 
production of product 54 was successful when using a large tubular reactor ~900 mL 
(10.7 mm i.d.  x 10 m) at 0.65 M concentration to produce a throughput of 1.86 kg/day 
while still maintaining the 99% yield originally obtained for the smaller scale reaction 
(Scheme 9). In addition, the flow deprotonation of allylsilane (55) to form a 1-
silylallyllithium intermediate which was then carbonylated and quickly quenched with 
trimethylsilane chloride to furnish a dienol silyl ether 56 in excellent yield and E/Z ratio: 
(93%, 97:3) was reported.42 A comparison with the batch protocol indicated that the flow 
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process was more efficient and very straightforward to run (Scheme 10). The flow 
protocol was subsequently expanded to a wider selection of alkylsilanes and electrophiles 
all of which gave good to excellent yields and selectivities (77-88% yields, 91:9-97:3 
(E/Z), 5 examples). 
 
Scheme 9: Heck-carbonylation of bromide 45 in continuous flow. 
 
Scheme 10: Formation, carbonylation and quenching of 1-silylallyllithium intermediate to give 
the dienol silyl ether in flow, also showing the comparison with the batch protocol. 
A synthesis of a phenyl isocyanate starting from nitrobenzene (57) in flow was reported 
by Takebayashi and co-workers using carbon monoxide as a reductant (Scheme 11).43 
The carbon monoxide was delivered at a 90° angle to the liquid flow through a T-piece 
connector, resulting in a segmented flow system, which was directed into a tubular reactor 
heated at 220 °C. The direct comparison of the corresponding batch protocol 
demonstrated that the flow procedure gave a higher yield, although the authors did not 
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quantify the yield or how it was measured. It was shown that changing the inner diameter 
(i.d.) of the tubular reactor had a significant impact on the reaction efficiency. The use of 
a 1.0 mm i.d. tube reactor gave a lower yield than using a 0.5 mm i.d. tube reactor. This 
was explained as being due to a higher surface to volume ratio of the carbon monoxide 
within the liquid plug, thus a smaller inner diameter tube will maintain a higher 
concentration of dissolved carbon monoxide in the reaction mixture. 
 
Scheme 11: Flow carbonylation of nitrobenzene to give phenylisocyanate 58. 
1.1.4.2 Carbon dioxide 
Carbon dioxide is normally used as a building block in synthesis by making use of its 
weak electrophilic characteristic. A flow procedure to trap carbon dioxide in the 
formation of carboxylate group has been developed. Grignard substrates were passed 
through a conventional ‘tube-in-tube’ reactor to deliver the carbon dioxide (Scheme 
17).44 Optimum conditions were determined at 4 bar of carbon dioxide enabling near 
quantitative conversions even at moderate flow rates (0.4 mL/min, residence time = 42 
s). A set of ten different carboxylic acids were prepared in good to excellent yields (75-
100% yields), unfortunately, no examples using electron-withdrawing substituents were 
reported. An efficient ‘catch-and-release’ protocol was used to facilitate in-line 
purification of the carboxylic acid using a cartridge containing a polymer supported 
ammonium hydroxide species (A-900). Following trapping of the carboxylic acid, the 
cartridge was washed with THF to remove any unwanted organic impurities, then 
‘released’ by treatment with a solution of formic acid in THF (1:9) to yield the pure 
carboxylic acid. Similarly, the Rutjes group reported on the formation of benzoic acid 
through the hydroxycarbonylation of phenylmagnesium bromide in flow delivering a 








Scheme 12: Flow carboxylation of Grignard substrates using carbon dioxide. 
The flow synthesis of Amitriptyline (60) using carbon dioxide in flow was reported by 
the Kirschning group.46 As part of the process development it was noted that excess 
carbon dioxide was possibly reacting with the n-BuLi required for the second stage 
Parham cyclisation (Scheme 13). Ultimately, the excess carbon dioxide was removed by 
passing the liquid stream through a Teflon AF-2400 tube acting to degas the pressurised 






Scheme 13: The synthesis of Amitriptyline using carbon dioxide in flow. 
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A related transformation was performed by the Yoshida group, using in situ generated 
organilithium species (Scheme 14).47 The organolithium intermediate formed by lithium 
halogen exchange was immediately trapped with carbon dioxide in an annular flow set-
up. A stream of MeOH quenched the excess n-BuLi prior to collection of the product into 
a saturated sodium bicarbonate solution. Beneficially, the flow protocol did not yield any 
benzophenone or triphenyl MeOH derivatives which are normally observed in the 
corresponding batch reactions. Using this set-up (Scheme 14), a selection of carboxylic 
acids were synthesised in good yields (59-89% yield, 13 examples) representing a range 
of different electronics which appear not to influence the carboxylic acid yield. 
 
Scheme 14: Flow carbonylation of organolithiums using carbon dioxide. 
A similar concept was later demonstrated by the Kappe group using lithium 
bis(trimethylsilyl)amide (LiHMDS) or  lithium diisopropylamide (LDA) solutions to 
achieve the lithiation of terminal alkynes or heterocycles.48 The lithiation was shown to 
happen very rapidly (~0.5 seconds at room temperature) but they opted for a ~3 second 
residence time after which the lithiated substrate was carboxylated with carbon dioxide 
through a T-mixer. In order to stabilize the CO2 flow, the gas was preheated at 65 °C 
before going through the mass flow controller (Scheme 15). Additionally a water quench 
was introduced before the back pressure regulator to dissolve any small amounts of 
precipitate formed during the reaction. Using the optimised conditions a number of 
alkynes were carboxylated generally giving very good yields (66-90% yields, 8 
examples). A couple of examples gave no results due to problems encountered with the 
reactor clogging. The carboxylation of some additional heterocycle substrates was also 
demonstrated using the same set-up with LDA giving moderate to good yields (43-86% 
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yields, 6 examples). Clogging issues were also observed despite the water quench but 
were overcome by changing to a dilution mixture of water and acetic acid (10:1).  
 
Scheme 15: Flow set-up for the carboxylation of lithiated species using CO2 gas. 
The Jamison group have taken this approach a step further and shown the feasibility of 
quenching the intermediate lithium carboxylate with another organolithium to form 
unsymmetric ketones (Scheme 16).49 Peristaltic pumps were used to pump the 
organolithium species (kept between 0 and 20 °C due to their instability) at a low 
concentration (0.1 M in THF) to prevent issues of precipitation and potential reactor 
clogging. For some substrates, a degasser was used to remove the excess CO2 before the 
organolithium quench to prevent symmetric ketone by-product formation. The sequence 
was shown to be general for most substrates giving good to excellent yields (40-92% 
yields, 18 examples). 
 
Scheme 16: Flow set-up for the synthesis of unsymmetric ketones using CO2 gas. 
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Another interesting transformation reported by the Jamison group involves the synthesis 
of cyclic carbonates through a bromine-catalysed conversion of CO2 and epoxides in 
continuous annular flow (Scheme 17).50 A mixture of N-bromosuccinimide (NBS) and 
benzoyl peroxide (BPO) was used to form bromine, which activates the epoxide to 
nucleophilic attack. Substrates with aliphatic and aromatic substituents generally resulted 
in good to excellent yields (72-90% yields, 7 examples) with moderate yields being 
achieved for substrates with olefinic substituents (51-58% yields, 3 examples). Even 
though the authors postulate that the pendant alkene group might be interfering with the 
active catalyst, they do not report any bromination occurring on the alkene. 
 
Scheme 17: Micro-flow synthesis of cyclic carbonates through bromine-catalysed conversion of 
CO2 and epoxides. 
Recently the continuous flow synthesis of 2,4,5-trifluorobenzoic acid (62) was reported 
through the Grignard reaction of  2,4,5-trifluorobromobenzene (61) and subsequent CO2 
trapping (Scheme 18) using a falling film microreactor (FFMR) (Figure 3).51 The use of 
ethylmagnesium bromide as a Grignard exchange reagent was used due to the stability of 
the reagent, allowing the authors to conduct the reaction at 30 °C. As part of the study, 
the size of the T-mixer was investigated to avoid blockage of the system due to 
precipitation. An inner diameter of 1200 µm was found to be optimal which prevents 
clogging and still allows for efficient mixing. Although the authors describe an efficient 
way of forming the carboxylic acid through this set-up, the FFMR used has one 
drawback; the maximum flow rate was 0.83 mL/min and thus achieving high space-time 




Scheme 18: Use of a FFMR for the synthesis of 2,4,5-trifluorobenzoic acid (62) as a continuous 
process. 
1.1.4.3 The use of oxygen gas in flow 
With the recent move towards even more environmentally friendly and sustainable 
oxidation chemistry, metal oxidants like permanganate and chromium(VI) compounds 
are receiving less attention. Oxygen is however considered to be a good alternative either 
alone or in conjunction with various promoting catalysts. 
As an early example, the Glaser-Hay coupling in continuous flow was reported by the 
Ley group, with oxygen being used to re-oxidise the copper catalyst.52 A conventional 
‘tube-in-tube’ module was used to pre-saturate the solvent with oxygen which was then 
mixed with an additional liquid substrate stream containing the copper(I) complex and 
the terminal alkyne (Scheme 19). A polymer-supported thiourea scavenger cartridge was 
used post reaction to remove the copper catalyst from the flow stream with an additional 
polymer-supported sulfonic acid cartridge to sequester the N,N,N′,N′-tetramethylethane-
1,2-diamine (TMEDA) base facilitating direct in-line purification. A range of aromatic 
and aliphatic terminal alkynes gave 1,3-butadiynes in moderate to excellent yields (49-







Scheme 19: Glaser-Hay coupling in continuous flow using oxygen to reoxidise the copper 
catalyst. 
Oxygen has also used in continuous flow aerobic anti-Markovnikov Wacker oxidation.53 
Optimisation of the reaction temperature, oxygen pressure and water content was 
performed to achieve a good conversion and selectivity towards the desired aldehyde 
product. The reaction was successfully performed on a selection of styrenes possessing 
both electron withdrawing as well as electron donating groups, in good yield (56-80%, 
12 examples) and good to excellent selectivities (from 77:2:14 to 92:2:3 [A:B:C – 
Scheme 20]). Some further optimisation on the set-up was performed to demonstrate a 
scale-up of the reaction (96 mmol over 6 h) with the addition of an extra ‘tube-in-tube’ 





Scheme 20: The anti-Markovnikov Wacker oxidation of alkenes using oxygen in flow.  
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The air-promoted oxidation of 2-benzylpyridine derivatives (63a-c) to their 
corresponding 2-benzoylpyridines (64a-c) has been reported by the Kappe group 
employing propylene carbonate as a solvent (Scheme 21).54 A microreactor was used 
with oxygen (delivered as atmospheric air) added through a T-mixer to give plug flow 
with the gas addition being supplied through a mass-flow controller. A high temperature 
(200 °C) and low residence time (13 min) combination was used to give the oxidation 
products in good yields (69-83% yields, 3 examples). 
 
Scheme 21: Aerobic oxidation of the 2-benzylpyridine derivatives to their corresponding 2-
benzoylpyridines in flow. 
The Kocsis group have made use of the X-CubeTM to deliver oxygen for a number of 
industrial relevant oxidations and N-alkylation reactions (Scheme 22).55 The oxidation of 
indoline and 1-phenylethanol were used for the optimisation reactions in continuous flow 
with a range of catalysts, oxidants, solvents, temperatures and flow rates being evaluated. 
Subsequently the derived conditions were used to convert a small collection of alcohol 
substrates to the corresponding ketones or aldehydes in good yields (80-92%, 8 
examples). The optimisation of the N-alkylation reaction using alcohols was performed 
in moderate yields (47-64% yields, 6 examples) employing activated Raney nickel as a 
catalyst for the oxidation of the alcohol in a ‘borrowing hydrogen’ process. The 
intermediate imine formed, through the condensation of the amine and aldehyde, was 





Scheme 22: Oxidation of alcohols using oxygen in flow (top) and N-alkylation of alcohols using 
oxygen in continuous flow (bottom). 
The Kirschning group have used oxygen gas delivered through a conventional ‘tube-in-
tube’ reactor to oxidise allylic and benzylic alcohols using gold-doped superparamagnetic 
nanostructured particles as the catalyst (Scheme 23).56 The gold catalyst was immobilised 
on MAGSILICA® which facilitates inductive heating at medium frequency induction (25 
KHz). Using this set-up no over-oxidation was observed which is encountered when the 
same process is conducted in batch.57 Unfortunately, this set-up worked best with 
benzene as the solvent as other solvents such as MeOH, EtOAc, MeCN and DCM did not 
give full conversion. Toluene gave full conversions but produced by-products derived 





Scheme 23: Oxidation of allylic and benzylic alcohols using oxygen as the oxidant and gold-
doped superparamagnetic nanostructured particles as catalysts under inductively-heated flow 
conditions. 
The continuous flow synthesis of carboxylic acids through the aerobic oxidation of 
aldehydes was reported by the Favre-Réguillon group using a plug flow approach 
(Scheme 24).58 The process was run at ambient temperature with 5 bar of oxygen pressure 
without any added metal catalysts. This was claimed to cleanly (98% purity) generate the 
carboxylic acids in high yields (61-91% yields, 4 examples). The aerobic oxidation of the 
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aldehydes goes through a free radical chain reaction to form the corresponding peracid 
which reacts with the remaining aldehyde to produce a tetrahedral adduct (similar to the 
Criegee intermediate in the Baeyer-Villiger reaction). The tetrahedral adduct then 
rearranges, through a migration of hydrogen or alkyl group from the aldehyde to give the 
corresponding carboxylate. The authors also described how through the use of EPR 
spectroscopy and spin trap methodology,59 they could show that their process goes 
through a free radical auto-oxidation pathway which was initiated by a trace amount of 
carboxylic acid present in the starting materials at ppm levels.  
 
Scheme 24: Metal free oxidation of aldehydes to form carboxylic acids using oxygen in flow.  
The synthesis of functionalised phenols using aerobic oxidation of Grignard substrates 
has been reported as a continuous flow procedure again using a plug flow system to 
deliver the oxygen.60 The effect of temperature and system pressure were studied for the 
oxidation of phenylmagnesium bromide. Ultimately, a combination of 14 bar pressure 
and -25 °C was used to deliver a near quantitative conversion to the corresponding phenol 
in 3.4 min. These conditions were then applied to a wider range of Grignard reagents with 
electron-rich systems forming the corresponding phenols in moderate to good yields (57-
87%, 13 examples). The corresponding electron-deficient substrates required elevated 
temperatures (-10 °C to 25 °C) but also gave comparable yields (53-81%). Some 
heteroaryl magnesium reagents were also tested, with thiophene and benzothiophene 
giving the ketone derivatives (24% and 32% yields respectively). Other heteroaryl 
magnesium reagents gave the expected phenol products (47-86% yields, 3 examples). 
This transformation was also utilised for the preparation of ortho-functionalised phenols 
in an integrated three-step continuous process using compressed air instead of pure 
oxygen (Scheme 25). A number of substrates were prepared within a residence time of 




Scheme 25: Integrated flow system for the synthesis of ortho-functionalised phenols using air in 
flow. 
The C-H activation of indoles via a cross-dehydrogenative coupling was reported in a 
segmented flow reactor (Scheme 26).61 The oxygen has a similar role as in the earlier 
example of the oxidative Heck reaction reported in a dual-channel microreactor.62 During 
the optimisation phase the authors reported that better conversions were obtained when 
the reactor size was doubled and the flow rate was maintained rather increasing the 
residence time by decreasing the flow rates. This was highlighted as being due to better 
mixing in the segmented flow path when higher flow rates were applied, ensuring 
efficient palladium reoxidation. Using optimised conditions a number of vinyl indoles 
were synthesised in moderate to excellent yields (27-92%, 15 examples). The choice of 
solvent, DMSO, was based on the solubility of the palladium catalyst and its propensity 
to decrease palladium black formation which could ultimately block the tubular reactor. 
Although practical at these small lab scales the use of DMSO is not ideal for scale-up due 
to the difficulty of its removal and so this process would require reaction reengineering 
before being more widely applicable. Additionally, the authors did not mention any use 
of back pressure regulators/pressure control, which would be essential to maintain a 




Scheme 26: Pd(II)-catalysed cross-dehydrogenative Heck reaction using oxygen gas in flow as 
an oxidant to reoxidise the palladium catalyst. 
An iron-catalysed aerobic nitro-Mannich reaction was published by the CSIRO which 
affords a direct α-C(sp3)-H functionalisation of N-aryl tetrahydroisoquinolines.63 The 
oxygen was delivered through a conventional ‘tube-in-tube’ reactor with a stainless steel 
tube reactor being used as a residence time unit and to heat the flow stream (Scheme 27). 
A back pressure regulator was placed just after the ‘tube-in-tube’ reactor which precludes 
in-line degassing. The reaction was quenched by dropping the liquid output stream onto 
2 equivalents of triethylamine which enabled isolation of the products in moderate to 





Scheme 27: Iron-catalysed aerobic nitro-Mannich reaction with oxygen gas as an oxidant in flow. 
The biocatalytic production of catechols was demonstrated through a 2-hydroxybiphenyl 
3-monooxygenase (HbpA) catalysed conversion of 2-hydroxybiphenyl to 3-
phenylcatechol using a conventional ‘tube-in-tube’ to deliver an oxygen feed.64 Although 
the authors showed a number of optimisation steps to increase the gas transport into the 
solution, when the transformation was carried on an 80 mmol scale, only a 5% isolated 
yield was obtained, indicating that the enzyme catalyst employed was the limiting aspect 
of the process. 
34 
 
The use of oxygen in flow photochemistry has also been extensively reported.65 The 
addition of singlet oxygen to α-terpinene (70) to yield anthelmintic ascaridole (71) was 
realised using Rose Bengal as the sensitiser in a micro-chip reactor equipped with a 20 
W tungsten lamp. The oxygen stream was introduced as a laminar flow (Scheme 28).66 
A direct comparison of the flow process with the batch process using a 500 W tungsten 
lamp shows a higher yield obtained for the flow process (85% vs 67%) but a lower 
productivity for the flow reactor (1.5 mg/h vs 175 mg/h). On the other hand, as the flow 
process should have a linear scalability, higher productivities could be achieved by 
multiple reactors in parallel rather than direct reactor scaling. 
 
Scheme 28: Micro-flow preparation of anthelmintic ascaridole 71. 
Recently, the photo-oxidation of 4-substituted toluene derivatives was described using a 
microchip reactor and oxygen delivered as a segmented flow using 2-tert-
butylanthraquinone (72) as a photosensitiser (Scheme 29).67 Even though the yields 
obtained in flow were comparable to batch (30-83% yields) much shorter reaction times 
were needed - between 12 and 36 h were needed to achieve similar yields in batch.    
 
Scheme 29: Photo-oxidation of 4-substituted toluene derivatives using oxygen in micro-flow. 
The oxidation of (-)-β-citronellol, using a borosilicate glass-loop microreactor with a 
diode array as a light source, was demonstrated in the synthesis of the fragrance rose 
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oxide, with Rose Bengal as an oxygen sensitiser. However, the reaction time needed for 
reasonable conversion on a 1 mmol scale (400 min) was deemed too long for the reactor 
to be used for efficient scale up.68  
The use of a TiO2 deposited photocatalyst within the channels of a flow microreactor has 
received attention for the oxidative degradation of para-chlorophenol,69 toluene,69 
phenol70 and methylene blue.70 Other synthetically useful transformations were also 
reported such as the oxidation of α-terpinene (70) to yield ascaridole (71),71 oxidation of 
L-methionine to the corresponding sulfoxide,71 for the oxidation of β-citronellol72 and the 
oxidation of allylic alcohols for the synthesis of the antimalarial artemisinin (Scheme 
30).73 The concept of this reactor is similar to that of the ‘tube-in-tube’ reactors but 
employing a poly(dimethylsiloxane) (PDMS) membrane separating the two channels 
allowing oxygen to permeate through the membrane and saturate the reaction mixture 
(Figure 5). 
 
Scheme 30: Flow photo-oxidation of allylic alcohols for the synthesis of artemisinin using a 




Figure 5: (A) Schematic illustration for the fabrication of a dual-channel microreactor with 
polyvinylsilazane (PVSZ) shielded upper channel. (B) Cross-sectional view of dual microchannel 
with the PVSZ shielded upper channel. (C) The PVSZ shielded dual-channel microreactor filled 
with O2, methylene blue (photosensitizer), and α-terpinene (reagent). 
Reproduced with permission from reference 73. Copyright 2011 The Royal Society of 
Chemistry. 
The photochemical rearrangements of an N-oxide moiety has been used for the synthesis 
of 4-substituted quinolone derivatives (Scheme 31).74 Oxygen was used as a triplet 
quench to suppress the [2+2]-dimerisation of the quinolones. This gave the desired 
quinolones (79-82) in good to excellent yields (72-99% yield, 4 examples), which were 
superior to the equivalent batch reactions. The flow reactor was built from a double coiled 
tubular reactor (Duran tube 7 mm, coil outer diameter: 75 mm, height: 200 mm, internal 
volume: 150 mL) placed in the middle of a Rayonet (RPR-100) photoreactor equipped 
with 16 lamps of fixed wavelength. The oxygen was bubbled through the solvent to pre-
saturate the solution. The authors claimed this approach could be used to deliver gram 
scale quantities of products. They also used the same set-up for the synthesis of 
quinolones with tethered alkenes at the 4-position which enabled subsequent 




Scheme 31: Photochemical rearrangement of N-oxides to quinolones. 
The high solubility of molecular oxygen in supercritical carbon dioxide (scCO2) has been 
exploited in the oxidation of citronellol (83) using 5,10,15,20-
tetrakis(pentafluorophenyl)porphyrin (TPFPP, 84) as a photosensitiser (Scheme 32).76 
Oxygen was delivered through a Rheodyne dosing unit and combined with the scCO2 
before mixing with a solution of 83 in dimethyl carbonate (DMC) (1:1 v:v). The combined 
stream was then passed through a second micro-mixer before it was transferred into a 
sapphire cell equipped with four LEDs (1000 lumen). Complete consumption of 83 was 
achieved with 52% selectivity for 85 and 48% for 86 at a flow rate of 0.1 mL/min (1:1 
v:v DMC:83), 1.0 mL/min of scCO2 and 2 equivalents of oxygen at 180 bar. Although 
scCO2 was completely miscible with oxygen in all proportions used,
77 it is not an ideal 
solvent for most organic compounds which can limit its use as a solvent in flow 
chemistry.78 
 
Scheme 32: Photo-oxidation of citronellol in flow using scCO2. 
The oxidation of citronellol (83) has also been reported by the Seeberger group using 
oxygen in a segmented flow regime with tetraphenylporphyrin (TPP) as the 
photosensitiser.79 In their set-up (Scheme 33), the system could deliver up to 2.5 
mmol/min of product. The same set-up was also used for the photo-oxidation of other 
substrates to show the scope of the method developed including the flow synthesis of the 
anti-malaria drug artemisinin.80 A modified version of this set-up using 420 nm LED 
lamps was subsequently applied to the transformation of amines to α-cyanoepoxides 
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through an oxygen based oxidation (Scheme 34)81 and the photo-oxidative cyanation of 
secondary amines to give 89-91 and primary amines to give 92-95 using singlet oxygen 
(Scheme 35).82 
 
Scheme 33: Photo-oxidation of citronellol using oxygen in a segmented flow regime. 
    
Scheme 34: Photo-oxidation of amines for the synthesis of α-cyanoepoxides. 
 




1.2 Perspectives on the Future of Flow Chemistry 
With many different transformations already having been demonstrated using continuous 
flow processes, the next major challenge is to illustrate other advantageous aspects of 
flow chemistry. Some researchers have already demonstrated the feasibility of scale-up 
in flow rather than just inferring that their processes can be scaled up. Understandably, 
academic groups with no connection to industries find little use for actual scaling up of 
reactions in flow. However, with a considerable amount of academic funding nowadays 
coming from industrial partners, interest within academia is also changing, with a 
preference for both discovery chemistry as well as scale up chemistry.  
In-line analysis is another technique that may be used in conjunction with continuous 
processes. Some of the examples shown above (Schemes 4 and 24) illustrate how 
analytical instruments such as IR, UV, Raman, NMR and MS spectrometers can be 
integrated into continuous flow streams to collect analytical data such as conversion, 
while the process is ongoing. This ultimately provides a way of enabling fast optimisation 
of conditions which can also be integrated with intuitive programmes which perform self-
optimisation of reactions.83 Although in theory this sounds excellent, the initial input 
from the researcher to “teach” the programme to become “intuitive” provides a barrier to 
most researchers. Consequently, groups or industries that are not interested in allocating 
a considerable amount of resources for the optimisation of one particular reaction prefer 
to perform manual optimisation, which, although most probably does not achieve the 
absolute optimum conditions, requires much less effort and time to achieve. 
In the following chapters, the thesis will focus on innovative gas-liquid flow chemistry 
(CO, CO2 and O2) that was performed during this project as well as the development of 
a novel synthetic methodology for the synthesis of thiazoles using microwave reactors.   
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2 Results and Discussions 
 
2.1 Carbonylation of Ortho-Substituted Substrates: Using Flow to 
Enhance and Facilitate Difficult Transformations 
 
2.1.1 Introduction 
As highlighted in the introduction section, the issues associated with the use of carbon 
monoxide (CO) as a reagent (such as toxicity and low solubility in solvents) has prompted 
some chemists to avoid CO, substituting it for other gases or changing the chemistry 
where needed. However, the use of flow chemistry has introduced a safer way of using 
toxic gases such as CO at variable scales (mg-kg). Heck-carbonylation reactions have 
received a lot of attention both in batch as well as in flow and generally produce the 
desired products in good yields. Carbonylation of ortho-substituted substrates can, 
however, still be challenging as highlighted by the limited literature precedence.84 
The low yields associated with such transformations indicate that the CO attack on the 
intermediate aryl complex is being inhibited by the sterics present.84a This can be 
explained by considering an associative mechanism for the CO substitution where one 
ligand is substituted before a migratory insertion takes place. The initial CO coordination 
takes place on the axial coordination site of the square planar complex, with the aryl 
group oriented perpendicularly to minimise the steric interactions and placing the ortho-
substituent straight over the axial position (Figure 6). The ortho-substituent imposes 
steric restrictions to the incoming CO thus slowing down the rate of the reaction. An X-
ray structure of trans-bromo(o-tolyl)bis(triphenylphosphine)palladium(II) complex was 
reported by Cross et al (Figure 7).85 The molecular structure of 96 comprises of a Pd atom 
with near perfect square planar geometry with a slight out of plane displacement of Br 
and C(1) where Br˗Pd˗C(1) angle is 170.9º. As a whole, the molecule has approximate 
Cs symmetry with the PPh3 ligands almost eclipsing each other if viewed along the P˗Pd˗ 
P axis and with the tolyl group sandwiched in-between two phenyl groups (Figure 7 
structure B). Focusing on the tolyl group only, structure C (Figure 7) shows how the 
methyl of the tolyl group is placed straight over the axial position of the palladium. 
Structure D (Figure 7) is a top view of the crystal structure illustrating how the methyl 
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group is positioned directly over the axial position of the palladium which would 
introduce steric hindrance with regards to the CO attack on the intermediate aryl complex. 
 









Figure 7: A) molecular structure of complex 96; B) ball and stick representation of X-ray 
structure; C) ball and stick representation of X-ray structure showing the tolyl group only; D) 
topside view of X-ray structure.85  
If the carbonylation step is indeed slow, the dehalogenation pathway becomes dominant, 
giving low yields of the carbonylated product. By increasing the CO concentration (by 
increasing the CO pressure) together with an increase in temperature an increase in the 
amount of the carbonylated product should be seen. However, an increase in carbon 
monoxide concentration can also decrease the amount of active Pd0 catalyst in the 
catalytic cycle (Scheme 36) due to the π-acidic nature of CO as a ligand, thus slowing 
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down the reaction. Increasing the temperature will also increase the rate of side product 
formation.  
 
Scheme 36: General catalytic cycle for carbonylation mechanism.  
Due to the low yields associated with the carbonylation of ortho-substituted substrates, 
such transformations are typically avoided. For example the simple compound, 2-chloro-
6-methylbenzoic acid (99), has proved to be a challenging structure to synthesise on a 
large scale at high purity.84b This compound was required in multi-kilogram quantities 
for a programme at Roche which was previously obtained through three known routes 
(Scheme 37).86 However, the Sandmeyer route is not suitable for large scale synthesis 
due to the low yields, tar formation, high dilution needed and the safety concerns 
associated with diazonium chemistry.86a The ortho-methylation via α-amino-alkoxide 
101 route requires more than three equivalents of methyl iodide and butyllithium and the 
final product contains an impurity profile that was difficult to purify.86b Finally, the direct 





Scheme 37: Previously used routes for the synthesis of 2-chloro-6-methylbenzoic acid 99. 
The team at Roche decided to explore on two new routes targeting high quality 99 in an 
economical manner. Route one involved the use of direct nucleophilic aromatic 
substitution and the other made use of a carbonylation reaction (Scheme 38). The 
nucleophilic aromatic substitution route starts from the cheap starting material 104 giving 
the desired product in 81% overall yield with a very high purity. The second route, 
involving the carbonylation step on four m-chlorotoluene derivatives (106a-d), could not 
be directly executed as attempts to prepare the hydroxy-carbonylation with water as the 
nucleophile proved to be problematic, with the undesired 3-chlorotoluene obtained as the 
main product (50-80%). Also, the metalation of 106a (via Grignard or lithiation) followed 
by trapping with CO2 did not give any product, possibly due to benzyne formation (route 
E, Scheme 38). Product formation was only achieved when very high pressures of CO 
were used and water was replaced by MeOH to give the methylester which had to be 
hydrolysed in a separate step (route F, Scheme 38).  
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Scheme 38: Attempted routes for the synthesis of 2-chloro-6-methylbenzoic acid 99. 
In addition to the intermediate 99, other important intermediates/products can be prepared 
using this method (carbonylation of ortho-substituted substrates). One such intermediate 
is 2,4,5-trifluorobenzoic acid 62 which serves as a starting material to several 
antibacterial drugs such as ciprofloxacin (Cipro™), norfloxacin (Noroxin™) and 
pefloxacin (Peflacine™).51 A number of different approaches have been described for the 
synthesis of 2,4,5-trifluorobenzoic acid including the use of highly toxic CuCN,87 AlCl3-
promoted Friedel-Craft acylation,88 multi-step procedures including fluorination 
followed by decarboxylation89 and metalation followed by carboxylation (Scheme 39).51 
The effort put into the syntheses of both 2-chloro-6-methylbenzoic acid and 2,4,5-
trifluorobenzoic acid show the difficulty such a simple looking transformation can 
present and highlights the need for more research into a safe and scalable procedure for 









2.1.2.1 Flow hydroxy-carbonylation of ortho-substituted substrates  
As part of a collaboration with Syngenta, an efficient carbonylation of ortho-substituted 
aromatic was required with specific interest in 2-chloro substituted aromatics. Similar to 
the above described 2,4,5-trifluorobenzoic acid (62) and 2-chloro-6-methylbenzoic acid 
(99), the carboxylic acid derivatives would be an ideal intermediate for several important 
agrochemicals. Unfortunately, using water as a nucleophile can be challenging due to its 
weaker nucleophilic nature when compared with alcohols, as illustrated through the 
synthesis of 99. 
The use of flow chemistry has already been shown to be beneficial for carbonylation 
reactions (See Section 1.1.4.1). For this reason we decided to investigate a flow protocol 
to provide a safer and scalable way of obtaining various ortho carbonylated products such 
as 2-chloro benzoic acids. Two types of reactors were considered for the carbonylation 
transformation, the reverse “tube-in-tube” reactor and a plug flow reactor. Iodobenzene 
(1a) was selected as a test substrate for evaluation (Scheme 40). The reverse “tube-in-
tube” reactori provided a more efficient means of delivering the CO gas to the liquid 
phase for carbonylation of 1a. This was due to the higher surface area to volume ratio of 
CO gas provided by the “tube-in-tube” reactor, as described in section 1.1.3.  The “tube-
in-tube” reactor should deliver sufficient CO for coordination to the square planar aryl 
complex intermediate of ortho-substituted iodoarenes, in accordance with the standard 
associative mechanism explained above.  
The gas-liquid unit was attached to a commercial flow system; a Vapourtec R2+ Series 
along with an R4 heating unit. It was decided that all the reactions would be conducted 
using 5 mol% of Pd(OAc)2 and 10 mol% of the different phosphine ligands, which could 
be reduced further,24b this would allow for an efficient catalytic cycle and short reaction 
times in the region of two hours.38 
 
 
                                                 
i A commercially available reverse “tube-in-tube” reactor form Vapourtec was used throughout. 
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Scheme 40: Comparison of plug flow reactor carbonylation (left) and “tube-in-tube” reactor 
carbonylation (right). 
2.1.2.2 Optimisation of the hydroxyl-carbonylation of ortho-substitution substrates 
in flow 
As a test substrate, 2-chloro iodobenzene (103) was used for the initial screening to devise 
a set of general reaction conditions (Scheme 41). Five different phosphine ligands were 
tested, three of which were monodentate with a variable cone angle (115-117; 145-
265°)90 with the other two 1,4-bis(diphenylphosphino)butane (DPPB) and Xantphos 
(118-119, bite angles 98° and 111° respectively)91 representing bidentate phosphine 
ligands (Figure 8).  
 





Figure 8: Phosphine ligands used for the carbonylation reaction. 
Initially, using 5 bar of carbon monoxide and a temperature of 110 °C, the five ligands 
gave similar yields with DPPB (118) giving the highest yield and X-Phos (116) the 
lowest. However, the highest selectivity for the desired product was obtained with S-Phos 
(117) and triphenylphosphine (115) (Table 6, entries 2 and 5), with the difference 
between the conversion and the isolated yield due mainly to the formation of the 
dehalogenated product, chlorobenzene.   










of 103 (%) 
1 X-Phos 110 5 68 31 
2 S-Phos 110 5 43 36 
3 DPPB 110 5 90 38 
4 Xantphos 110 5 57 36 
5 PPh3 110 5 44 36 
6a PPh3 110 5 59 36 
7b PPh3 110 5 80 33 
8c PPh3 110 5 N/D 18 
9 PPh3 100 5 41 31 
10 PPh3 120 5 60 37 
11 PPh3 130 5 N/D 33 
12d PPh3 110 10 67 46 
13d PPh3 110 15 74 62 
14d,e PPh3 110 15 N/D 31 
15f PPh3 110 15 N/D 68 
16f,a PPh3 110 15 99 90 
17f,b PPh3 110 15 99 73 
a 1.6 equiv. of base instead of 1.1 equiv. b 2.0 equiv. of base used. c 1.1 equiv. of DBU used 
instead of NEt3. 
d 10 mL reactor was not “tube-in-tube”. e 20 mol% DMF added. f 2 x 15 mL 
“tube-in-tube” reactors used.  




Changing the amount of triethylamine used to 1.6 equiv. and 2.0 equiv., did not 
significantly change the isolated yield of 103. However, after changing to a stronger base 
such as DBU (pKa in water at 25 ºC = 13.5)
92 the isolated yield dropped by half when 
compared to that obtained with 1.1 equiv. of triethylamine (Table 6, entry 8). A wider 
temperature range was then investigated utilising ligand 115 (Table 6, entries 9-11). 
However, only a small increase in the yield on going from 100 °C to 120 °C was achieved 
and a marginal decrease when the temperature was further raised to 130 °C. As there was 
no significant difference between 110 °C and 120 °C (Table 6, entries 5 and 10), the 
lower temperature was selected for the use in the next set of experiments. As anticipated, 
an increase in carbon monoxide pressure dramatically increased the product yield up to 
62% (Table 6, entries 12-13). The addition of 20 mol% of dimethylformamide (DMF) as 
an additive did not improve the yield as suggested by its use in similar reactions in the 
literature.35, 40 The effect of gas contact time was also evaluated by using two “tube-in-
tube” reactors linked in series; this resulted in a modest improvement in yield, indicating 
that the carbon monoxide concentration was still limited (Table 6, entry 15). A further 
increase in product yield was observed when a larger excess of the triethylamine base 
(1.6 equiv.) was used (Table 6, entry 16), but the isolated yield dropped with a higher 
ratio of triethylamine (2.0 equiv.) (Table 6, entry 17). This indicated that the reaction was 
being inhibited by the low pH generated at higher conversions when insufficient base was 
present to neutralise the carboxylic acid being formed. The requirement for a higher 
excess of base during initial screening (Table 6, entries 6-7) had been masked due to the 
initial low conversions achieved. 
 
For comparison, two additional batch carbonylation reactions were performed. The first 
of these batch reactions (conducted in a conventional lab) was set up using 
triphenylphosphine as the ligand under refluxing conditions with a double-walled balloon 
used to deliver the carbon monoxide (Scheme 42). This would constitute a normal set up 
used by many laboratory chemists when reactions involving gases are attempted if no 
specialised equipment is available. For further evaluation, one reaction was quenched 
after 2 hours and after purification it yielded 5% of product 103, while an additional 
reaction was quenched after 24 h yielding 9% of purified 103. The difference in the yields 
obtained in batch when compared to the reactions conducted in flow, most probably arises 
from the fact that not enough carbon monoxide is being delivered to the reaction mixture. 
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The dehalogenation pathway is then preferred, yielding chlorobenzene as the main 
product (9% of 103 and 65% chlorobenzene). 
 
The second batch reaction, conducted in the departmental high pressure lab (HPL), was 
set up in a Parr autoclave using carbon monoxide at 15 bar and 110 °C for 2 hours. After 
purification, a yield of 87% for product 103 was obtained. This compares well with the 
flow protocol yield, however, the reaction “processing” time is in reality much longer 
due to the long cooling and heating times (4 h 15 min “processing” time, see experimental 
section for more details). Also, the time required due to the extra precaution measures 
needed when using high pressure facilities, means that the turnaround time is much 
longer. This makes the flow reactor more efficient in terms of processing time compared 
to the batch reactions conducted in the HPL. Additionally, the added safety and potential 
for scale up associated with the flow reactor makes it highly favourable. 
 
Scheme 42: The batch carbonylation of 2-chloro-iodobenzene in conventional lab conditions 
(top) and using a Parr autoclave in high pressure lab (bottom). 
Having identified a set of standard conditions for this process, a number of additional 
substrates were assessed to determine the generality of the flow reaction. Substrates 122 
and 128 were synthesised through known literature procedures (Scheme 43). Substrate 
122 was obtained through the sodium borohydride reduction of 120 followed by 
metalation with iodoethane to give 122. Substrate 128 was obtained from the formation 
of imine 124 followed by its dipolar-cycloaddition with tert-butyl methacrylate (125) to 
give the pyrrolidine 126. Acylation of 126 with pivolyl chloride (127) gave substrate 128 




Scheme 43: Synthesis of substrates 122 and 128. 
2.1.2.3 Library formation 
No significant change to the yield was observed upon altering the ortho-substituent to a 
bromo, fluoro or trifluoromethyl group. However, a slight decrease occurred with the 
bromo and trifluoromethyl groups due to their larger sizes (Scheme 44, 129-131). A more 
pronounced decrease in yield was obtained for 132 and 133 (Scheme 44, 63% and 60% 
respectively) probably due to the larger size associated with these groups as well as 
electronic effects. Indeed, the more electron withdrawing trifluoromethyl group of 131 
gave a better yield (71% yield) than both 132 and 133. For comparisons of the sizes of 
the ortho-substituents used, A-values can be used as a guide (Cl: 0.43 kcal/mol, Br: 0.38 




Scheme 44: Structures of ortho-substituted carboxylic acids prepared via a continuous flow 
hydroxy-carbonylation method. 
Using pyridine as a heteroaromatic substrate also gave an acceptable yield of 134 but 
lower than the phenyl equivalent (103). Substitution at the 4-position of the aryl gave 
moderate to good yields (Scheme 44, 135-139) with weakly electron withdrawing 
substituents or electron donating groups giving better yields (Scheme 44, compounds 
135, 137-139) than the more electro-withdrawing CF3 group (Scheme 44, compound 
136). In the case of 140 the attached aromatic ring introduces both the ortho substituted 
sterics and the electronic effects from the additional aromatic ring attached. For 
comparison 2-iodonaphthalene (149) was carboxylated under the same conditions to give 
2-naphthoic acid (150) showing that reducing the steric encumbrance at the ortho position 




Scheme 45: Flow carbonylation of 2-iodonaphtalene. 
Moderate yields were obtained with 5-substituted substrates (Scheme 44, compounds 
141-146). Both electron withdrawing groups (Scheme 44, compounds 141-144) and 
electron donating groups gave similar yields (Scheme 44, compounds 145-146) 
indicating that inductive effects were not affecting the yield. Comparing the yield 
obtained for 145-146 also indicates that sterics at the 5-position do not have an influence 
including the large group at the 5-position of substrate 146 (see X-ray structure of 
substrate 128, Figure 9). 
 
Figure 9: X-ray structure of substrate 128. 
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The lowest yields of the array were obtained for compounds 147 and 148, demonstrating 
the importance of sterics and electronics adjacent to the leaving group. In both cases, the 
carbon monoxide insertion is assumed to be slow as both axial positions of the aryl 
complex would be hindered, meaning the competing proton-dehalogenation pathway 
becomes preferred, giving 1,3-dimethoxybenzene as the main product, which was 
isolated in 31% yield in the case of 147 and 3-chlorotoluene in the case of 148 which was 
isolated in 52% yield (Scheme 44). 
To exemplify the scalability of the reaction conditions, the synthesis of 138 was repeated 
at 16 mmol scale, a factor of twelve times the original 1.3 mmol test scale (Scheme 46). 
The yield obtained for the larger scale was 85% which is consistent with the original 89% 
obtained at the 1.30 mmol scale, indicating that the processes is robust and reliable 
delivering 1.19 g h-1 of 138 at 85% isolated yield. 
 
Scheme 46: Scale up synthesis of 2-chloro-4-fluorobenzoic acid (138).  
2.1.2.2 Synthesis of 2-(methylthio)-4-(trifluoromethyl)benzoic acid intermediate 
The synthesis of a range of 2,4-disubstituted aromatic amides was the focus of an 
extended evaluation being explored by our collaborative partner, Syngenta. This array 
relates to a biologically active set of 2-cyano-1,3-diones, possessing a 2-(methylthio)-4-
(trifluoromethyl)benzene scaffold, that protect maize as a surface active herbicide.94 Prior 
to this work, researchers at Syngenta attempted to use a CO surrogate as part of a Heck-




Scheme 47: Initial synthetic approach of 2,4-disubstituted aromatic amides. 
The process involved manually loading the starting material 152 in a 2-5 mL microwave 
tube, then carefully layering DMF on top of the starting material making sure the two 
liquids did not mix. This was followed by the careful addition of palladium acetate, 1,4-
bis(diphenylphosphino)butane (DPPB), N-formylsaccharin and the required amine (153). 
The vial would then be quickly sealed to avoid loss of CO. The need for carefully layering 
of the different liquids was to prevent premature CO release from the N-formylsaccharin 
CO surrogate. In the original publication, Mannabe reported that the in situ formation of 
CO ensues in a few min.6 The reaction would then be heated using a microwave for the 
appropriate time and worked up to obtain the desired amides (155). As a large set of 
amides were needed and therefore an automated system would ideally be used 
(Chemspeed® Technologies). However, automation was not possible here due to the 
careful manual addition of the different components. Additionally, the reactions gave 
very low yields (not specified by the company). A more efficient approach was thus 
needed for the amide formation.   
In an effort to find an alternative, efficient synthetic route for this amide collection, we 
decided to avoid the use of carbon monoxide in the amide formation step. Instead, it was 
decided that the benzoic acid intermediate 157 would be synthesised and subjected to 
thioether group oxidation to give the air stable compound 156. This intermediate could 
then be fed into an automated system (such as the Chemspeed® Technologies used at 
Syngenta) to form the amides needed in a fast and efficient way (Scheme 48).  
Scheme 48: Retrosynthetic approach for the synthesis of the amide library. 
Using the optimised conditions for the hydroxy-carbonylation of ortho-substituted iodo 
arenes in flow (Table 6), 152 did not yield any of the desired product 157 (Scheme 49). 
This was ascribed to a slow rate of the oxidative addition as observed with bromo arenes 
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when compared to the iodo arenes. In a second flow experiment, MeOH was used as the 
solvent and Xantphos (119) as the ligand, with the methyl ester 158 obtained in 22% yield 
(Scheme 49). The use of Xantphos as the ligand increases the rate of the oxidative 
addition while the use of MeOH as the nucleophile increases the rate of the reductive 
elimination step, making the overall catalytic cycle more efficient. However, as both the 
direct hydroxy-carbonylation and the more efficient alkoxy-carbonylation did not give 
the desired product in a high enough yield, other approaches were considered.  
 
Scheme 49: Direct hydroxy-carbonylation of 152 (top) and alkoxy-carbonylation of 152 (bottom) 
A metalation of the bromoarene 152 followed by trapping with carbon dioxide and a 
subsequent acid quench, was also explored as an alternative route (Scheme 50). 
 
Scheme 50: Metalation of 152 followed by trapping with carbon dioxide and a subsequent acid 
quench to obtain 157. 
Isopropylmagnesium chloride lithium chloride complex solution (so called “turbo-
Grignard”) was used to form the exchanged Grignard salt 159a which was then trapped 
with carbon dioxide followed by an acid quench. In batch, the first step required 2 hours 
mixing in THF prior to the addition of carbon dioxide and quenching with a dilute 




Scheme 51: Formation of target intermediate 157 through batch formation of Grignard salt. 
In an effort to transfer the three step reaction to a continuous flow process, bromobenzene 
(160) was used as a test substrate with the “turbo-Grignard” to form the corresponding 
magnesium intermediate. Initially the carbon dioxide was loaded through a conventional 
“tube-in-tube” reactor as shown in Table 7. The metalation step was attempted at -40 ºC, 
-5 ºC and room temperature but none of these conditions gave any conversion (Table 7). 
Heating to 70 ºC gave 10% yield of the desired product 68, along with some additional 
unidentified products also being observed.  
Table 7: Grignard formation of bromobenzene followed by trapping of carbon dioxide and acid 













1 0.5 0.5 0.5 -40 0 
2 0.2 0.2 0.4 -5 0 
3 0.3 0.3 0.6 18 0 
4 0.3 0.3 0.6 70 10 
 
Altering the delivery of the carbon dioxide loading to a reverse “tube-in-tube” reactor 
design in order to increase the carbon dioxide concentration and ensure it was not 
limiting, did not change the outcome, with still only 10% yield being obtained (Scheme 
52). The same set up was eventually also used with 152 as a substrate but gave yields of 




Scheme 52: Grignard hydroxy-carboxylation of bromobenzene (top) and 152 (bottom) using the 
reverse “tube-in-tube” reactor (Bottom). 
Inspired by the work of the Yoshida group, the use of a lithium-halogen exchange process 
was explored.47 It was possible to lithiate 152 using n-BuLi to form 158b, which was then 
trapped by carbon dioxide (dry ice) in batch followed by acidification using 1 M HCl 
solution to give 157 in 83% yield. A flow protocol was also attempted but a lower yield 
of 60% was obtained (Scheme 53). The lower yield is probably due to the specific reactor 
set up used which could be improved by using mixing chips for the lithiation step. 
Additionally, due to solubility issues, a different concentration of n-BuLi in hexane had 
to be used in the flow procedure, which could also account for the lower yield obtained. 
Changing to an annular flow reactor, it was observed that the T-piece where the CO2 gas 
was introduced, repeatedly blocked, making this process unreliable (Scheme 53). The 
batch process was thus used for this step. 
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Scheme 53: Lithiation of 152 followed by hydroxy-carbonylation in batch (top) and in continuous 
flow (bottom).  
The subsequent oxidation of the thioether product 157 to the desired sulfone 156 has been 
reported for similar thioether products using different oxidants such as Oxone®,95 
hydrogen peroxide94 and HOF-MeCN solution.96 Using Oxone®, the sulfoxide 161 was 
obtained as the main product (71%) with only minor amounts (5%) of the desired sulfone 
156 (Scheme 54). The work up (involving dilution with brine and extracting with EtOAc) 
of this reaction was also prone to forming persistent emulsions. Using hydrogen peroxide 
(27%) with acetic anhydride (Ac2O) in acetic acid, formed the desired sulfone 156 in 
63% yield with no sulfoxide intermediate present (Scheme 54).  
Using sub-stoichiometric amounts of sulfonic acid bound reagent (QP-SA) as an acid 
catalyst with hydrogen peroxide in acetic acid gave 55% yield in batch and when the 
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same method was used in flow (using a packed column of QP-SA), an 85% yield was 
realised (Scheme 54). The improved yields obtained in flow being most likely due to the 
“local” excess of acid catalyst. As the acid resin was packed in a column through which 
the substrates would flow, the dissolved substrates are always in contact with a large 
excess of acid at any one time, which increases the rate of reaction. The use of a variable 
back pressure regulator (BPR), was employed as some precipitate was formed during the 
reaction and this type of BPR was resistant to small amounts of precipitates avoiding 
potential blockages.  
The use of HOF-MeCN as an oxidant gave a 90% yield in batch (Scheme 54), however 
as HOF-MeCN oxidation is normally very fast (seconds),96 the flow protocol was not 
attempted as large amounts of substrate would be needed to operate the available flow 




Scheme 54: Different methods explored for the oxidation of 157 to obtain the desired sulfone 
156. 
Having explored a number of different ways to form the intermediate 157, the batch 
lithiation procedure was the most promising for this step (Scheme 53) followed by either 
hydrogen peroxide oxidation with acetic anhydride in batch or hydrogen peroxide with 
QP-SA in flow. The latter, although it gave better yields, needed careful monitoring to 
avoid blockage of the system. The batch sequence was used to produce 20 g of the 
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intermediate 156 as an air stable solid to be used by Syngenta for the array generation 
through amide synthesis using the Chemspeed® Technologies equipment (Scheme 55).  
Scheme 55: Synthesis of 159 intermediate in batch. 
There are several amide coupling strategies that are routinely used,97 such as the use of 
1,1′-carbonyldiimidazole (CDI),98 diphenylphosphonic azide (DPPA)99 and dicyclohexyl 
carbodiimide (DCC)100 as coupling agents (Scheme 56). A one-pot procedure using CDI 
as a coupling reagent is normally preferred for scale up reactions. Initially the acyl 
carboxy imidazole (166) and imidazole (165) are formed which readily react together 
yielding the activated species as the acylimidazole 167 (Scheme 56). Upon complete 
conversion to the acylimidazole, the amine is added to give the amide product. As this 
reaction generates imidazole in situ, no additional base is needed meaning this technique 
is also compatible with HCl salts of the amines. The use of DPPA involves a convenient 
one-pot process which normally is not used for scale up due to possible formation of the 
highly toxic hydrazoic acid. DCC is used to form the activated intermediate (174) which 
reacts with an amine to form the amide product (168) and urea by-product (175) in a mild 
and efficient way. The main side reaction is that where the activated intermediate reacts 
with another carboxylate forming the anhydride (176) which then reacts with an amine 
to form the amide product and urea by-product (175). The milder version of this coupling 
reaction involves the use of two equivalents of the carboxylic acid for every DCC which 
unfortunately favours the anhydride formation and wastes half the carboxylic acid 











The use of flow chemistry as a safe and scalable way of delivering carbon monoxide was 
demonstrated to be useful for the carbonylation of ortho-substituted substrates. 
Furthermore, the use of water as a nucleophile to directly obtain the carboxylic acid was 
also achieved, giving a number of different ortho-substituted carboxylic acids. 
Comparison of 140 with 150 also showed that the steric encumbrance on the ortho 
position has an effect on the yield even when other electronic effects are in place such as 
those coming from the additional aromatic ring attached. A scale-up of the reaction 
conditions was performed providing comparable yields to those obtained from the initial 
smaller test scale. This method could thus be an efficient and scalable approach to 
synthesising important intermediates containing ortho-substituted carboxylic acids. Two 
batch processes were also performed as a direct comparison with the flow method 
developed. It was clear that the carbonylation reaction in a round bottom flask equipped 
with a CO balloon is much less effective than the flow carbonylation due to the mass 
transfer limitations of CO. On the other hand, the batch carbonylation performed in the 
Parr reactor gave a similar yield to flow. The Parr reactor, however, has to be used in 
dedicated high pressure facilitates due to additional safety requirements. Furthermore, 
the Parr reactor carbonylation has a longer processing time due to the extra time required 
to reach the necessary temperature and the additional long cooling time after the reaction 
has finished. Limitations in terms of the size of the reaction vessel can also become an 
issue at large scale. One advantage with regards to carrying out carbonylations in Parr 
reactors is that, at the present time, they are simply more frequently encountered in a 
University environment than the “tube-in-tube” reactor.  
A number of different approaches have been studied for the synthesis the air stable 
intermediate 157 as an alternative to the direct amide synthesis using a CO surrogate. Of 
the different approaches trialled, the best results were achieved through the lithiation of 
the starting material (152) followed by carbon dioxide trapping and subsequently 
quenching with dilute aqueous acid. The thioether intermediate (157) was then oxidised 
using hydrogen peroxide with acetic anhydride in acetic acid to give the final intermediate 
156 in an overall isolated yield of 52%. The different flow procedures developed were 
not as efficient as the batch procedures. For the first step (hydroxy-carbonylation through 
a lithiation step and subsequent CO2 trapping), the batch reaction gave superior yields to 
the flow process. As only small quantities of the material were needed the batch reaction 
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was preferred. If larger quantitates had been required, the batch process would suffer 
from scalability issues, however, for larger quantities the transformation itself would 
probably be avoided due to the low temperatures needed. The oxidation of the thioether 
intermediate worked best in flow although it was prone to precipitation, which if left 
unsupervised, could lead to blockage of the back pressure regulator. Better engineering 
of the flow system should make this process more favourable than the batch oxidation, 
however, the batch process was again chosen as it was more viable with regards to 
producing the required amount of material under the given time constraints.   
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2.2  Catalytic Chan-Lam Coupling Reactions in a Continuous Flow 
Reactor Using the “Tube-in-Tube” Approach to Deliver the Oxygen 
 
2.2.1  Introduction 
The functionalisation of aromatic and aliphatic amines has received considerable 
attention due to the number of biologically active compounds represented by these 
classes. For this reason many different synthetic methods for C ̶ N bond formation have 
been developed over the years.   
In 1901 Fritz Ullmann observed the Cu catalysed biaryl formation through coupling of 
two aryl halides, this is now referred to as the “classical Ullmann reaction”.101 The 
generally accepted mechanism for this transformation involves the formation of an 
organocuprate intermediate (177) from the aryl halide followed by its reaction with a 
second aryl halide through an oxidative addition. A reductive elimination process yields 
the biaryl product (179, Scheme 57). 
 
Scheme 57: General mechanism for the “classical Ullmann reaction”. 
Ullmann subsequently reported upon the use of these conditions to synthesise N-aryl 
amines (using stoichiometric Cu) and ethers in 1903 and 1905 respectively (Scheme 
58).102 Shortly after, in 1906 the first Cu-catalysed synthesis of aryl amides was reported 
by Irma Goldberg.103 Almost 25 years later, in 1929, William Hurtley reported the 







Scheme 58: Early methods of C ̶ N/C ̶ O bond formation. 
These early coupling reactions, generally required harsh conditions (high temperature, 
strong bases, long reaction time and stoichiometric amounts of the copper reagent). 
Electron-poor aromatic substrates and high-boiling polar solvents were also often 
necessary. Moreover, problems related to the solubility of many Cu compounds were 
evident, hence, excess Cu often had to be used. Over the years, variations upon the 
Ullmann coupling have been reported which utilise milder conditions, this is especially 




Scheme 59: Examples for modified variations of the Ullmann reaction.  
In 1983 Mitiga reported the use of palladium as a catalyst with tinamines and 
arylbromides.106 Ten years later, Hartwig took a closer look at the mechanism and 
proposed a catalytic cycle in which transmetallation is the rate limiting step (Scheme 
60).107 
 
Scheme 60: Proposed mechanism for the palladium catalysed C ̶ N coupling. 
In quick succession, Buchwald and Hartwig published methods for a tin-free aryl-amine 
coupling and proposed a new catalytic cycle where oxidative addition is the rate limiting 
step (Scheme 61).108 This major breakthrough made the C  ̶N coupling reaction accessible 
to a wider range of substrates, including anilines, which did not react very well under the 
previous conditions. However, despite the improvements achieved with the Buchwald-
69 
 
Hartwig coupling, limitations such as sensitivity to air and moisture, functional group 
tolerance and the high cost of palladium, reignited the search for improved methods. 
 
Scheme 61: Proposed mechanism for the tin-free palladium catalysed C ̶ N coupling. 
In 1998, the groups of Chan,109 Evans110 and Lam111 independently reported a mild 
method for the C(aryl) ̶ N and C(aryl) ̶ O coupling reaction. Their method made use of 
stoichiometric amounts of copper(II) acetate as the catalyst and boronic acids as the aryl 
donors. In the presence of a base, the C(aryl) ̶ N and C(aryl) ̶ O coupling could be 
performed at room temperature. This reaction was subsequently shown to work with a 
large number of different nucleophiles and tolerated a variety of different substrates, 
making it one of the most efficient ways for the C ̶ N/C ̶ O coupling (Scheme 62).112 
Several modifications of the Chan-Lam reaction have been reported, expanding its scope 




Scheme 62: Comparison of different C ̶ N/ C ̶ O coupling methods. 
 
Figure 10: Biologically active compounds synthesised through a Chan-Lam reaction.113 
Although the catalytic cycle is still somewhat debatable, kinetic and EPR spectroscopy 
for the methoxylation of tolylboronic acid methylester (Scheme 63) indicates that the 
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resting state of the catalyst is a Cu(II) with weak anionic ligands such as acetate or 
methoxide. Transmetalation is considered to be the rate limiting step.114 Analysis of the 
reaction stoichiometry suggested that the C ̶ O bond formation, through a reductive 
elimination step, does not happen from the Cu(II) oxidation state but instead from a 
Cu(III) species. The oxidation of Cu(II) to Cu(III) occurs from the disproportionation of 
another Cu(II) to give one equivalent of aryl-Cu(III) and one equivalent of Cu(I). Both 
the Cu(I) species from the disproportionation reaction and from the  C ̶ O reductive 
elimination step are quickly oxidised to Cu(II) by oxygen in a 4:1 Cu(I)/O2 ratio.  
 
Scheme 63: Proposed catalytic cycle for the methoxylation of tolylboronic acid methylester. 
In 2009, the groups of Stevens and van der Eycken reported on the Chan-Lam reaction 
as a continuous flow protocol using copper acetate (1.0 equiv.), pyridine (2.0 equiv.) and 
triethylamine (1.0 equiv.) in DCM.115 Generally, when using anilines (Table 8) or phenols 
(Table 9) as the nucleophilic partner, moderate to good yields were obtained (56-71% 
yields, 9 examples).  
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Table 8: N-Arylation of differently substituted anilines.  
 
Entry Product R1 R2 Isolated (g) Yielda (%) 
1 205a H (203a) H (204a) 1.2 71 
2 205b H (203a) 3-OEt (204b) 1.5 73 
3 205c 4-Cl (203b) H (204a) 1.3 67 
4 205d 4-Cl (203b) 3-OEt (204b) 1.7 59 
5 205e 2,4,6-Cl (203c) 3-OEt (204b) No reactionb - 
6 205f 2,4-NO2 (203d) 3-OEt (204b) 1.7 56 
a 10.0 mmol scale reactions. b Only starting material was recovered. 
 
Table 9: O-Alkylation of substituted phenols.  
 
Entry Product R1 R2 Isolated (g) Yielda (%) 
1 207a 3-OCH3 (206a) H (204a) 1.44 72 
2 207b I (206b) 4-OMe (204c) 2.25 69 
3 207c 4-Et (206c) 4-OMe (204c) 1.59 70 
a 10.0 mmol scale reactions. 
 
Recently, the Tranmer group reported the use of a copper-filled column as a catalyst with 
TEMPO as a co-oxidant in MeCN (acetic acid additive) with moderate to good yields of 
the coupled products being obtained (25-79% yields, 16 examples, Table 10).116 The use 
of copper tubing, which serves as both the reactor and the catalyst, with tert-butyl 
peroxybenzoate as the oxidant in MeCN was also described but was outperformed by the 
copper filled column system.  
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Table 10: C–N Arylation library using solid copper column. 
 
Entry Aniline (R1 =) Boronic acid (R2 =) Yielda (%) 
1 H H 71/79b/72c 
2 2,4,6-CH3 H 52
b/68c 
3 2-OCH3 H 66/82
b 
4 4-Cl H 68/72b 
5 4-F H 71b 
6 2,4-CH3 H 64/77
b 
7 Morpholine H 51/57b/65c 
8  H 4-CH3 71/66
b 
9 2-OCH3 4-CH3 45/59
b 
10 4-Cl 4-CH3 59/57
b 
11 Morpholine 4-CH3 51
b 
12 H 4-Cl 39/51b/52c 
13 2-CH3 4-Cl 38/47
b 
14 Morpholine 4-Cl 25b 
15 2,4-CH3 4-Cl 37
b 
16 2-CH3 4-OCH3 31
b 
a Isolated yields (%) with 1 equiv. of acetic acid. b 2.0 equiv. of acetic acid. c Isolated yields (%) 
using copper coil, (2.0:1.5) acetic acid:TEMPO. 
Although the use of elemental copper is an improvement on the use of stiochiometric 
copper acetate in continuous flow, the use of TEMPO or tert-butyl peroxybenzoate as an 
oxidant introduces more waste. Employing oxygen gas as an oxidant is preferred as it is 
cheap, renewable and environmentally benign. We therefore set out to develop a more 
atom economical way of catalysing the Chan-Lam reaction using a sub-stoichiometric 





2.2.2  Results 
2.2.2.1 Synthesis of herbicidal intermediate using the Chan-Lam synthesis in flow 
As part of an ongoing study carried out at Syngenta, this investigation was geared towards 
the synthesis of a pyridazine containing herbicide. The original synthesis (Scheme 64) 
involved hydrazone formation from a substituted phenylhydrazine such as 208 with 1,1-
dimethoxypropan-2-one (209) catalysed by Zn(ClO4)2·6H2O. The resulting aldehyde 
(300) then undergoes a condensation reaction with Meldrum’s acid followed by base 
hydrolysis to give the pyridazine 302 which would then be derivatised to yield various 
amides (yields not disclosed). 
Scheme 64: Original synthesis for pyridazine containing herbicide intermediate 302. 
However, as part of the library synthesis, studying the effect of substituents on the 
biological activity, some substrates could not be prepared through the original synthesis. 
Therefore, an alternative route involving C-N coupling through a Chan-Lam synthesis 
between pyridazine 306 and the appropriate boronic acid 307 was envisaged to yield 305 
(Scheme 65). This would be followed by ester hydrolysis to furnish the carboxylic acid 
304 which was to be coupled with the appropriate amine to form the active herbicide 
structure 303.117 
Scheme 65: Synthesis for pyridazine containing herbicide 303 through a Chan-Lam coupling. 
The synthesis of the lead compound 309, containing a 3,4-dimethoxybenzene moiety 
could only be achieved through the Chan-Lam route. However, it was noticed that the 
conditions used for this transformation in batch only work well on a small scale (<10 g), 
when the reaction was scaled up (>10 g) the yield dropped significantly (Scheme 66). 
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Furthermore, the long reaction times led to hydrolysis of the ester which made the 
purification harder.  
Scheme 66: Chan-Lam synthesis of key building block 309 in batch. 
As large quantities of 309 were required for field trials, an improved scale up synthesis 
of this herbicide intermediate was needed. It is well known that flow chemistry provides 
reliable means of scaling up of reactions, this prompted us to develop a catalytic flow 
method for the Chan-Lam synthesis of 309. The use of oxygen provides the necessary 
oxidant to reoxidise the Cu(I) that forms after the C ̶ N reductive elimination back to 
Cu(II), allowing for sub-stoichiometric amounts of copper to be used. Based on our 
previous experience of using the reverse “tube-in-tube” reactor with other gases, it was 
decided that the oxygen would be delivered via this reactor type (Scheme 67). 
Furthermore, a work-up which avoids the use of silica column purification was also 
required for the scale-up.  
From the four different organic solvents investigated (toluene, DCM, MeCN and EtOAc), 
Cu(OAc)2 only completely dissolved in DCM. Pumping DCM through the HPLC pumps, 
used as part of the flow system, initially presented some issues. This was mainly due to 
cavitation just before the pump inlet, attributed to the shear forces present, causing 
outgassing (air). These bubbles, if left in the system, disturb the flow, resulting in an 
unstable system. This problem was solved by sonication of the DCM (30 min of 
sonication per 500 mL of solvent) prior to use, keeping it under positive pressure 




Scheme 67: Setup for the catalytic Chan-Lam reaction of 309 using the “tube-in-tube” reactor. 
In an effort to identify the optimum conditions for this reaction, the amount of copper 
catalyst and the oxygen pressure were studied (Table 11). By starting with one equivalent 
of Cu(OAc)2 and no oxygen, a 63% yield of 306 to 309 was obtained (Entry 1, Table 11). 
The yield was reduced to 56% when 0.5 equiv. of Cu(OAc)2 were used (Entry 2, Table 
11) fixing the Cu(OAc)2 at 0.5 equiv. an increase in the yield to 83% (Entry 3, Table 11) 
was observed when 4 bar of oxygen was supplied through the “tube-in-tube” reactor. A 
further increase in oxygen pressure to 8 bar, 10 bar, 12 bar and 14 bar (Figure 11) 
indicated that the best yield was obtained at 10 bar (Entries 4-7, Table 11). It is not yet 
clear as to why there was a slight decrease in yield at 12 bar and 14 bar but this could be 
due to a slight decrease in residence time associated with an increase in the gas pressure. 
Lowering the amount of Cu(OAc)2 to 0.25 equiv. and 0.10 equiv., resulted in yields of 













1 1.00 0 63 
2 0.50 0 56 
3 0.50 4 83 
4 0.50 8 86 
5 0.50 10 92 
6 0.50 12 86 
7 0.50 14 79 
8 0.25 10 88 
9 0.10 10 77 
a Yield calculated using 1,3,5-trimethoxybenzene as an internal NMR standard. 
 
 
Figure 11: Observed trend for the effect of changing the oxygen pressure on the NMR yield of 
309. 
The effect of temperature and residence time on the yield was next studied (Table 12). 
Increasing the temperature to 40 ºC while maintaining the residence time at 2 h gave a 
higher yield of 96% (Entry 1, Table 12) and afforded an 83% yield when the residence 
time was reduced to 1 h (Entry 2, Table 12). Further decreasing the residence time to 0.5 






















with a residence time of 0.5 h compared to 1 h may be due to the better mixing attained 
at the higher flow rates. A small decrease in yield to 81% was observed when the 
temperature was increased to 60 ºC while keeping the residence time at 0.5 h (Entry 4, 
Table 12).  
Table 12: Optimisation of residence time and temperature. 
 
Entry 






1 2 40 96 
2 1 40 83 
3 0.5 40 85 
4 0.5 60 81 
a Yield calculated using 1,3,5-trimethoxybenzene as an NMR internal standard. 
Although the highest yield was obtained at 2 h residence time at a temperature of 40 ºC, 
it was decided that the best conditions so far were those obtained at 0.5 h with a 
temperature of 40 ºC as this represents a productivity of 1.27 g h-1 when compared to 0.36 
g h-1 for the 2 h residence time. Productivity was very important for this substrate due to 
time constraints associated with gaining sufficient material for field trials. 
Further optimisation of the process was targeted towards the amount of triethylamine, 
boronic acid excess and the concentration used (Table 13). An increase in the excess of 
triethylamine used resulted in an increase in the yield to 92% (Entry 2, Table 13). An 
attempt to reduce the excess of boronic acid used to 1.4 equiv. and 1.1 equiv. only resulted 
in lower yields of 83% and 73%, respectively (Entries 3-4, Table 13). Changing the 
concentration to 0.106 M and 0.142 M resulted in improved yields of 96% and 93% 
respectively (Entries 5-6, Table 13). An attempt to decrease the boronic excess used to 
1.4 equiv. and 1.2 equiv. at 0.106 M concentration proved to be unprofitable as the yields 




Table 13: Optimisation of the amount of boronic acid, triethylamine and concentration used. 
 







1 1.0 1.6 0.078 85 
2 2.0 1.6 0.078 92 
3 2.0 1.4 0.078 83 
4 2.0 1.1 0.078 73 
5 2.0 1.6 0.106 96 
6 2.0 1.6 0.142 93 
7 2.0 1.4 0.106 83 
8 2.0 1.2 0.106 81 
a Yield calculated using 1,3,5-trimethoxybenzene as an NMR internal standard. 
Using the optimised conditions, a scale up of the continuous process was performed 
(Scheme 68). Using 12.7 mmol of 306 resulted in a 70% isolated yield of pure 309 which 
represents a productivity of 1.42 g h-1. When the scale was almost doubled to 24.4 mmol 
of 306 an isolated yield of 71% was obtained with a productivity of 1.44 g h-1. This shows 
that the flow protocol developed represents a reliable and scalable method for the 
preparation of 309 through a catalytic Chan-Lam reaction using oxygen gas. 
80 
 
Scheme 68: Optimised process for the synthesis of 309. 
The work up of compound 309 was achieved by washing the crude mixture with diluted 
HCl aqueous solution (1 M). Purification was then performed through trituration 
followed by recrystallisation (see experimental), which gave the pure product in 99+% 
purity (purity measured by 1H NMR spectroscopy with 1,3,5-trimethoxybenzene as an 




2.2.2.2 Scope of Catalytic Chan-Lam Synthesis in Flow  
Having identified the optimum conditions for the scale up of herbicidal intermediate 309 
through a continuous flow catalytic Chan-Lam synthesis, the scope of this reaction was 
next evaluated. As the objective was to synthesise a small array of C  ̶N coupled products, 
a second optimisation using 3-phenyl-1H-pyrazole (310) as the nucleophilic partner and 
4-methoxyphenylboronic acid (204c) as the aryl donor was performed (Table 14). 













1 1.00 1.6 20 0 66 
2 0.50 1.6 20 0 48 
3 0.25 1.6 20 0 25 
4 0.50 1.6 20 4 81 
5 0.50 1.6 20 8 85 
6 0.50 1.6 20 10 97 
7 0.50 1.6 20 12 85 
8 0.50 1.6 20 14 83 
9 0.25 1.6 20 10 94 
10 0.25 1.6 20 12 87 
11 0.10 1.6 20 10 50 
12 0.25 1.4 20 10 56 
13 0.25 1.1 20 10 48 
14 0.25 1.6 30 10 87 
15 0.25 1.6 40 10 95 
16 0.25 1.6 50 10 88 
17b 0.25 1.6 40 10 93 
18c 0.25 1.6 40 10 76 
a Yields calculated using 1,3,5-trimethoxybenzene as an internal NMR standard and represents 
the average of two runs. b 1.5 equiv. of pyridine, c 0.5 equiv. of pyridine. 
In the first three control experiments no oxygen was supplied to the system and the 
amount of copper acetate catalyst was varied from 1.0 equiv. to 0.5 equiv. and finally to 
0.25 equiv. (entries 1-3, Table 14). As anticipated, with no oxidant to reoxidize the 
catalyst, the yield dropped in proportion to the amount of catalyst used. Keeping the 
amount of copper acetate constant (0.5 equiv.), the effect of the oxygen pressure on the 
yield was investigated (entries 4-8, Table 14). A general increase was again noticeable 
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on going from 0˗10 bar after which a slight decrease in yield was observed at higher 
pressures (Figure 12). The same trend was also observed during the optimisation of 
herbicidal intermediate 309 (Figure 11). A decrease in yield was also observed when 
going from 10 bar to 12 bar of oxygen with 0.25 equiv. of copper acetate (entries 9-10, 
Table 14) 
 
Figure 12: Observed trend for the effect of changing the oxygen pressure on the NMR yield of 
311. 
When the amount of copper acetate was further reduced to 0.10 equiv. a drastic decrease 
in yield was observed indicating that the turnover frequency (TOF) of the catalytic cycle 
with this amount of copper acetate is not efficient enough to give good yields (entry 11, 
Table 14). A decrease in yield was also observed when the amount of boronic acid used 
was decreased to 1.4 equiv. and 1.1 equiv. respectively (entries 12-13, Table 14). 
Changing the temperature from 20 ºC to 50 ºC did not greatly affect the yields obtained, 
with 40 ºC giving the most promising result (entries 14-16, Table 14). However, it was 
observed that less particulate matter was formed in the reactor when higher temperatures 
were used (40 and 50 ºC), which helps in avoiding possible reactor blockages. Finally, 
the amount of pyridine added was also studied. Decreasing the amount of pyridine (0.5 
equiv.) resulted in a lower yield (76%) while increasing the amount of pyridine (1.5 
equiv.) did not show any noticeable change in the yield (93%). This indicates that the 
pyridine plays an important role in this coupling reaction which could be both due to its 


















Table 14). The amount of triethylamine was not varied as its quantity was needed to 
ensure the boronic acid remains soluble in the DCM solvent.   
To determine the time needed to reach steady state in the reactor, samples were 
periodically collected (2 min collection time) and analysed by 1H NMR spectroscopy 
using 1,3,5-trimethoxybenzene as the internal standard (Figure 13). As expected, the 
product eluted after 120 min which corresponds with the set residence time. A lower yield 
was obtained for 120 min (85% yield) which then rapidly increased to 99% and 98% 
yield at 125 min and 130 min respectively. The yield then stabilised at 96% for the next 
data points indicating that steady state was achieved at 135 min, which is 15 min after 
the product first started to elute from the reactor.   
 
Figure 13: Analysis of the steady state of the reactor. 
As it had been determined that the amount of arylboronic acid excess could not be 
lowered (entries 12-13, Table 14), the use of a polymer supported scavenger was tested 
in an effort to reduce the amount of excess phenylboronic acid present. The use of QP-
DMA, a polymer-supported tertiary amine base, was placed in an Omnifit® column 
positioned after the “tube-in-tube” reactor, through which the reaction mixture was 
flowed (Figure 14). It was noticed that this was sufficient to reduce the excess boronic 
acid present without affecting the yield of the product. The products were still purified 
using column chromatography, however, the reduction in boronic acid excess made the 



















Figure 14: Comparison of 1H NMR spectra of non-purified (top) and QP-DMA purified (bottom) 
continuous flow synthesis of 312. 
2.2.2.3 Library Formation 
Using the optimised conditions for the synthesis of 311, a small library of compounds 
was synthesised to demonstrate the scope of the reaction conditions. Excellent isolated 
yields were obtained when anilines were used as the nucleophilic partner with both 
phenylboronic acid 204a (90% yield) and 4-methoxyphenylboronic acid 204c (92% 
yield) as the aryl donors (313 and 205a, Scheme 69). Phenylboronic acid 204a also gave 
a moderate isolated yield when coupled with 2-amino-4-bromopyridine as the 
nucleophile (50% yield, 314, Scheme 69) and a good isolated yield with the electron 
withdrawing 4-chloroaniline (71% yield, 205c, Scheme 69). Using L-tyrosine methyl 
ester as the nucleophile with phenylboronic acid 204a, unfortunately, gave a poor isolated 
yield of 26% and also exhibited some epimerisation (315, 53% ee determined by chiral 
HPLC, Scheme 69). Additionally, a small amount of the product (315) reacted further 
with phenylboronic acid 204a through the phenol to give 316 in 3% isolated yield. In the 
case of L-leucine methylester an isolated yield of 60% was realised, which was also 
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accompanied by partial epimerisation (317, 71% ee determined by chiral HPLC, Scheme 
69).
 
Scheme 69: Scope of the catalytic Chan-Lam reaction in continuous flow. 
 
Using N-heterocyclic substrates as the nucleophilic partner with a range of different 
phenylboronic acids generally gave good isolated yields (311-312, 318-325, Scheme 69). 
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Compound 306 as the nucleophile with 4-methoxyphenylboronic acid 204c gave an 81% 
yield of 312, which is very close to the yield obtained for the herbicidal intermediate 309. 
However, using 3,4-dimethyl-1H-1,2,4-triazol-5(4H)-one (329), which was synthesised 
using a literature procedure (Scheme 70), with 3,4-dimethoxyphenylboronic acid gave a 
lower yield of 26% (318, Scheme 69). It is not yet clear as to why such a low yield was 
obtained but the reduced nucleophilicity and higher potential for coordination of the 
triazole to the copper catalyst might account for this.  
 
Scheme 70: Syntheses of substrate 329.  
Alternatively, using 3-phenyl-1H-pyrazole (310) as the nucleophile with a number of 
different phenylboronic acids gave moderate to good yields (38-82% yields). In general 
electron-rich phenylboronic acids (311, 319-322, Scheme 69) gave better yields than 
electron poor ones (323-325, Scheme 69). This is probably due to the more favourable 
thermodynamics with an increase in the electropositivity of boron, which in turn increases 
the rate of the transmetallation step. Changing the group at the 4-position of the 
phenylboronic acid gave good yields for both electron rich (311, 79% yield) and electron 
poor (323, 76% yield) phenylboronic acids. On the other hand changing the group at the 
3-position of the phenylboronic acid gave good yields for electron-rich (320 and 322, 
77% and 82% yields respectively) but a moderate yield of 40% for electron-poor (324) 
phenylboronic acids. This could be ascribed to both the lower electropositivity of boron 
associated with the electron-poor phenylboronic acids and also to some chelation of the 
nitrile group with copper when present at the 3 position. Lower yields for both electron-
rich (65% yield) and electron-poor (38% yield) 2-substituted phenylboronic acids were 
realised, possibly due to steric interactions around the active catalyst and chelation of the 
nitrile with copper as explained above (321 and 325 Scheme 69).  
It is noteworthy that for all of the 3-phenyl-1H-pyrazole couplings, only the 1,3-
disubsituted pyrazole products were obtained with no 1,5-disubsituted isomers being 
detected. For the characterisation of the 1,3-disubsituted pyrazoles, NOESY NMR 
experiments were used when no published data was available (Figure 15 for 320, Figure 
16 for 323 and Figure 17 for 325). An X-ray crystal structure for compound 323 was also 
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obtained, confirming the connectivity. Furthermore, only published data from reactions 
that can yield only the 1,3-disubstituted pyrazole were considered as it was noted that 
some of the literature examples were wrongly assigned when both isomers were present. 
One example is in the formation of 319 through a one-pot oxidation and rearrangement 
of propargylamine 330 which was reported to form as the main regio-isomer (Scheme 
71).118 However, analysing the 1H and 13C NMR data reported and comparing them with 
those reported by others, such as that synthesised through a copper-catalysed relay 
oxidation that can only give the 1,3-disubstituted pyrazole119 and the NOESY NMR 
experiments obtained for our sample, it was evident that the wrong assignments were 





Figure 15: NOESY NMR spectrum for 320 with the characteristic NOESY signal encircled. 
 
Figure 16: NOESY NMR spectrum for 323 with the characteristic NOESY signal encircled. 
 




Scheme 71: Reported formation of pyrazole 319 through different routes. 
The potential for scalability of these reaction conditions, was demonstrated through the 
synthesis of 311 at 10 mmol scale, a factor of fourteen times the original 0.7 mmol test 
reaction (Scheme 72). A slightly improved isolated yield (81%) was obtained for the 
larger scale experiment when compared to the 79% isolated yield obtained for the smaller 
scale experiment. The consistency of the yields obtained indicates that the processes is 
robust and can reliably deliver 0.216 g h-1 of 311 at 81% isolated yield. 
 
Scheme 72: Scale-up procedure for 311. 
For certain nucleophilic substrates no products were obtained when C-N coupling with 
4-methoxyphenylboronic acid (204c) was attempted (Figure 18). In the case of 333 
precipitation occurred as soon as the two solutions came into contact at the T-piece mixer, 
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which was probably due to strong coordination to the copper acetate by the imidazole 
ring. In the case of 334-336 the reduced nucleophilicity of these substrates might account 
for the 0% conversion. By comparison, all three substrates (334-336) also failed to react 
under batch conditions using 2 equiv. of Cu(OAc)2, 2 equiv. of NEt3 and 1 equiv. of 
pyridine at 40 ºC for 48 h confirming their low reactivity. 
 
Figure 18: Substrates that gave no products in flow. 
 
2.2.3 Conclusions 
The aim of using oxygen as an oxidant for a catalytic Chan-Lam reaction in an effort to 
reduce the amount of copper catalyst used and increase the rate of the reaction, was the 
main focus for the synthesis of the herbicidal intermediate 309 via C-N coupling. Making 
use of flow chemistry not only improved the mixing but also allowed a safe and efficient 
way of introducing the oxygen through a reverse “tube-in-tube” reactor. Optimisation of 
the reaction conditions allowed for a scalable and efficient synthesis of 309. The 
optimised conditions for the synthesis of 311 were also applied to a number of other 
substrates to show the scope of the reaction. When using 3-phenyl-1H-pyrazole as a 
nucleophile with a number of different boronic acids, it was noticed that 1,3-disubstituted 
pyrazoles were selectively obtained over 1,5-disubstituted pyrazoles. 
Considering all of these features together, this catalytic flow protocol for the efficient 
Chan-Lam reactions represents a valuable extension of C(aryl)-N coupling. When 
compared to current published protocols it is clear that the use of sub-stoichiometric 
amount of copper catalysts is an advantage over the stoichiometric amount used in studies 
published by the groups of Stevens and van der Eycken.115 Additionally, the use of 
oxygen as the oxidant is clearly advantageous over the use of TEMPO and tert-butyl 
peroxybenzoate as reported by the Tranmer group in terms of atom economy.116  
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2.3 Thiazole Formation Through a Modified Gewald Reaction 
 
2.3.1  Introduction 
The synthesis of sulfur-containing heterocycles has long attracted the attention of 
chemists due to their occurrence as motifs in biologically active compounds, polymers 
and dyes. Of the sulfur containing heterocycles, thiophenes and thiazoles are especially 
prevalent in many pharmaceuticals (Figure 19).120 There are several synthetic routes 
described for both thiophenes and thiazoles with the Paal-Knorr synthesis121 being the 
most common for thiophenes and the Hantzsch synthesis being the current first choice 
for thiazoles (Scheme 73).122 
 
Figure 19: A selection of pharmaceuticals containing thiazoles and thiophenes. 
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Scheme 73: Paal-Knorr thiophene synthesis123 and Hantzsch thiazole synthesis.124  
An alternative strategy is to use the Gewald reaction (Scheme 74),125 this transformation 
was first described in 1961. It involves a multi-component condensation between sulfur, 
an α-methylene carbonyl compound and an α-cyanoester to form 2-aminothiophenes. The 
mechanism is thought to proceed through an initial Knoevenagel condensation between 
the α-cyanoester 353 and the carbonyl compound 352, giving the intermediate 354 which 
undergoes sulfurisation followed by a 5-exo-dig cyclisation (Baldwin favoured ring 




Scheme 74: Gewald reaction mechanism. 
Several variations of the Gewald reaction have since been described,126 however, the use 
of 1,4-dithian-2,5-diol,127 which serves as both the sulfur and the α-methylene carbonyl 
component, sparked our interest as a means of synthesising 3-aryl-2-aminothiophene 
derivatives. The air stable, readily available 1,4-dithian-2,5-diol is also low cost and does 
not possess the unpleasant odour that is typically associated with sulfur containing 
compounds.  As well as in the Gewald reaction, 1,4-dithian-2,5-diol has also been used 
in the synthesis of tetrahydrothiophenes through a Michael/aldol cascade,128 2,3-
disubstituted thiophenes from alkynones,129 nitroalkenes,130 N-substituted imides,131 for 
the synthesis of 1,3-oxathiolanes132 and tetrahydrothiopyranols (Scheme 75).133 In an 
effort to further expand the scope of this synthetically useful substrate (358) and inspired 
by the Gewald reaction mechanism, other nitrile substrates were targeted with the hope 










With the premise of α-disubstituted nitriles blocking the aromatisation pathway in a 
Gewald type mechanism, ethyl 2-cyano-2-phenylacetate (362) was reacted with 1,4-
dithian-2,5-diol (358). It was expected that the intermediate (364) would be detected 
(Scheme 76), however, the main product formed showed two sets of new aromatic peaks 
(two doublets) in the 1H NMR spectrum which were typical of adjacent protons on a five 
membered aromatic ring (Figure 20). From the 1H NMR spectrum of the crude material 
it was evident that MeOH driven trans-esterification had occurred with the MeOH 
(Spectrum A, Figure 20). To aid with the characterisation of the product formed, the crude 
material was dissolved in 1 mL of MeOH with a stoichiometric amount sodium 
methoxide in order to transform all of the product to the corresponding methyl ester 
(Spectrum B, Figure 20). After careful assignment, the structure of the product obtained 
was assigned as the thiazole, 366.  
 
Scheme 76: Attempted synthesis of intermediate 364 through a Gewald type reaction (top). 




Figure 20: a) 1H NMR of crude reaction after 17 h showing a mixture of two diagnostic doublets 
at 7.54 ppm and 7.07 ppm (top); b) 1H NMR of crude reaction after adding NaOMe and MeOH 
to form the methyl ester only showing one set of two diagnostic doublets at 7.54 ppm and 7.07 
ppm (bottom). 
Although thiazole formation from nitriles has previously been shown to occur with 
ketones134 and carboxylic acids,135 yielding 2,5-disubstituted thiazoles, to our knowledge, 
aldehydes have only ever been shown to form 2-aminothiophenes.127 Even though 2-
substituted thiazoles are important structures in their own right, further substitution can 
also easily be achieved through published protocols, in which 2,4-substituted thiazoles, 
2,5-substituted thiazoles and also 2,4,5-substituted thiazoles are formed.136 This further 
demonstrates the need for a scalable and rapid synthesis of 2-substituted thiazole 
compounds as core building blocks. 
2.3.2.1 Study of the Bifurcation Pathway 
From the preliminary results obtained for the reaction of  362 with 1,4-dithian-2,5-diol 
(Scheme 76) and the published modified Gewald reaction with 1,4-dithian-2,5-diol127 we 
hypothesised that substitution at the α-carbon of the nitrile precursor predetermines the 
reaction outcome, yielding either the thiophene or thiazole product when reacted with 
1,4-dithian-2,5-diol. Therefore based on this premise, α-methylene substituted nitriles 




To evaluate our hypothesis, we decided to optimise the conditions for the reaction of 
ethyl phenylcyanoacetate (362) with the aldehyde precursor 358 as a model system. 
Initially, reactions were performed using conventional heating, however, to allow for a 
wider temperature range, microwave heating was introduced. This allowed access to 
higher temperatures above the solvents’ atmospheric pressure boiling points. 
In the initial screen, the temperature was fixed at 80 °C and the reaction time at 5 h. 
Variables included the solvent, base and the stoichiometry of 358 (Tab1e 15). Only a 
small impact upon conversion was observed upon changing the stoichiometry of 
compound 358 and so it was decided to also maintain this at an equimolar concentration 
(i.e. 0.5 equiv. of the dimer) as it would simplify the purification later on. All reactions 
were assessed for conversion of 362 to 365 using 1H NMR analysis of the crude reaction 
followed by work-up and purification via column chromatography to determine isolated 
yields. 
With regard to solvent selection, trifluroethanol showed by far the best results. This is 
ascribed to its high polarity (dipole moment at 25 ºC = 2.03) and its slightly acidic nature 
(pKa in water at 25 ºC = 12.4) when compared to the other solvents. This is thought to 
assist in solubilising 358, subsequently promoting the formation of the aldehyde 
monomer. MeOH, which was originally used as a solvent, was eliminated from further 
consideration in order to avoid the undesirably trans-esterification. Results indicated that 
triethylamine (NEt3) was the most effective base providing the highest conversion and 
isolated yield (58%) with tetramethylethylenediamine (TMEDA) also giving a yield of 
50% (Table 15, entries 1 and 10). The stronger guanidine base 1,1,3,3-
tetramethylguanidine (TMG) and 1,8-diazabicycloundec-7-ene (DBU) both gave full 
consumption of the nitrile starting material, but generated complicated product mixtures 
allowing only a moderate isolated yield of 33% in the case of TMG (Table 15, entries 7 
and 8). Interestingly, the use of piperidine led to no conversion of the nitrile (362) under 
the standardised reaction conditions (Table 15, entry 9). We believe this is due to its 
condensation with the aldehyde component (generated from 358), which inhibits the 
transformation. In addition, a sulfonic acid bound resin (QP-SA) was also trialled as an 
additive but showed no conversion, allowing full recovery of the starting nitrile (see later 
discussion on mechanism). These experiments imply that the deprotonation of the α-
methylene adjacent to the nitrile group is an essential step in the mechanism. 
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0.50 84 58 
2 0.55 85 50 













8 TMG 100 33 
9 piperidine 0 0 
10 TMEDA 67 50 
11 QP-SA 0 0 
a The reactions were carried out at 80 °C for 5 h. The reaction scale was 0.22 mmol and a 
concentration of 0.143 M. b Conversion of starting material (362) to product (365) was measured 
by 1H NMR spectroscopy. N/D: not determined. 
 
In an attempt to improve the isolated yield of the reaction, a design of experiment analysis 
(DOE) was performed initially testing three factors; temperature, concentration of 362 
and reaction time, while monitoring the response by measuring the isolated yield of 365. 
The starting point for the design of the array was the optimum conditions obtained from 
the initial scoping (Table 15, entry 1). These conditions were used as the centre point for 
the DOE where “000” refers to the three variables (temperature, time and concentration 
of 362) in their middle limits (i.e. temperature = 80 °C, time = 300 min and concentration 
of 362 = 0.14). We then decided to investigate a maximum limit and minimum limit for 
each variable. For the temperature, a range of ±40 °C was investigated, while for the time 
a range of ±120 min was chosen. The concentration of 362 was varied by ±0.07 M. These 
variations generated the profiles and results as shown in Tables 16 and 17. The cube plot 
for 1st full factorial screening (Figure 21) makes use of the difference in the middle points 
(Table 16, entry 3 and 10) as a factor of robustness and applies that factor to the yields of 














1 -++ 40 420 0.21 70 
2 ++- 120 420 0.07 31 
3 000 80 300 0.14 51 
4 +++ 120 420 0.21 18 
5 +-- 120 180 0.07 43 
6 +-+ 120 180 0.21 33 
7 --+ 40 180 0.21 67 
8 --- 40 180 0.07 68 
9 -+- 40 420 0.07 85 
10 000 80 300 0.14 58 
a Where ‘+’ refers to the maximum limit, ‘-’ refers to the minimum limit and ‘000’ refers to the 
middle limits.  
 
 
Figure 21: Cube plot for the 1st full factorial screening for 362. 
Having established that a combination of long reaction time, low concentration and low 
temperature gives the best yield (Table 16, entry 9), we decided to perform a second full 
factorial screening closer to this point. A temperature of 60 °C, reaction time of 390 min 
and concentration of 362 of 0.11 were used as the middle limits and a variation of ±20 
°C, ±90 min and ±0.07 M for temperature, time and concentration of 362 respectively 
(Table 17). The cube plot for the second factorial design (Figure 22) again shows the 




Table 17: 2nd Factorial screening for 362. 








1 ++- 80 480 0.04 71 
2 --- 40 300 0.04 66 
3 +++ 80 480 0.18 36 
4 +-+ 80 300 0.18 52 
5 -+- 40 480 0.04 76 
6 -++ 40 480 0.18 56 
7 +-- 80 300 0.04 66 
8 000 60 390 0.11 83 
9 000 60 390 0.11 81 
10 --+ 40 300 0.18 76 
aWhere ‘+’ refers to the maximum limit, ‘-’ refers to the minimum limit and ‘000’ refers to the 
middle limits.  
 
 
Figure 22: Cube plot for the 2nd factorial screening for 362. 
From the data it was concluded that elevated temperatures resulted in lower isolated 
yields, most probably due to decomposition of compound 358 or the resulting aldehyde. 
In general, lower concentration was beneficial but at a consequence of longer reaction 
times. The best results were entry 9, Table 16 and entries 8 and 9, Table 17 which 
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produced similar results. The latter conditions were selected to progress due to the 
increased productivity with regards to the higher concentration and shorter reaction time. 
 
Having established an optimised set of conditions for the formation of thiazole 365, we 
next turned our attention to exploring the versatility of the reaction by changing both the 
aromatic portion and the ester functionality of the substrate. 
 
The majority of the starting materials required as substrates were synthesised according 
to known procedures (Scheme 77). Transesterification was used to prepare 367 from its 
corresponding ethyl ester. For compounds 372 and 373 a nucleophilic 
addition/elimination reaction was used between the corresponding substituted 
phenylacetonitrile and ethyl chloroformate 369 or diethyl carbonate 372 respectively. A 
nucleophilic aromatic substitution (SNAr) reaction was used to generate 377 and 378 
while a carbon-carbon coupling reaction catalysed by copper(I) iodide was used to 
generate 380. A Knoevenagel condensation137 between the corresponding benzaldehyde 
and either methyl cyanoacetate (for 382), ethyl cyanoacetate (for 383) or cyanoacetamide 
(for 389 and 390) were used. The Knoevenagel condensation product was subsequently 
reduced to obtain the desired substrates (384-385, 391-392). Finally, compounds 396-
399, were all obtained from the alkylation of either ethyl phenylcyanoacetate 362 or ethyl 




Scheme 77: Synthesis of starting materials. 
To allow for direct comparison and evaluation of the influence of substrate variation on 
the reaction outcome, the optimal reaction conditions generated above were maintained. 
It should be noted that these reactions are therefore not optimised for each individual case 
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and that improvements in yield could be achieved as highlighted for substrate 411 
(Scheme 78). In general, esters, amides and nitriles are tolerated, with methyl esters 
giving generally lower yields (hydrolysis occurs from water generated in the reaction) 
than the corresponding ethyl analogues (compounds 362-363 and 406-407). The 
isopropyl ester 367 leads to a lower conversion and isolated yield of 400 presumably as 
a consequence of additional steric interactions. By changing the electronic character of 
the aromatic appendage, it was demonstrated that an electron donating group (401 and 
402) gives rise to superior yields compared to an electron withdrawing group (403 and 
404). This is presumably due to a subtle balance between the basicity and resulting 
nucleophilicity of the anion generated, which could, in the case of the more stable 
(electron withdrawing group) anion, enable a retro-aldol reaction to occur. Substituted 
malonitrile 380 were also tolerated forming the corresponding cyanothiazole 405 in good 
yield, with no indication of formation of the di-thiazole product. Benzyl groups can be 
incorporated (406-409) but give low yields (16-37% yields). Changing to an aliphatic 
group instead of the aromatic moiety (406-411) decreases the conversion. Substrates 
possessing a methyl or an ethyl group react well (410-411) but moving to an isopropyl 
group such as in molecule 399 (Figure 23), reproducibly failed to generate any product, 
indicating the steric limits of the reaction (A-values for methyl and ethyl substituents are 
1.70 and 1.35 kcal mol-1 respectively while that of an isopropyl is 2.15 kcal mol-1).93  
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Scheme 78: Scoping of the 2-substituted thiazole formation. 
a Conditions: 0.22-0.44 mmol scale.  b 0.50 equiv. 1,4-dithian-2,5-diol (358) followed by another 
0.50 equiv. of 358 after the first 6.5 h, 0.22 mmol of nitrile, NEt3 (1.10 equiv.), 2 mL 
trifluoroethanol, 80 °C, 10.5 h. 
 
Some of the substrates tested failed to generate any product under the standard reaction 
conditions (Figure 23) which helped to identify certain attributes of the mechanism. For 
example, phenyl acetonitrile (412) failed to react most likely due to the lower acidity of 
the α-methylene protons. It also failed to form any product when using different bases, 
namely; polymer supported 2-tert-butylimino-2-diethylamino-1,3-dimethylperhydro-
1,3,2-diazaphosphorine (BEMP), 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) or 
potassium tert-butoxide. Our observations led us to conclude that weaker bases 
(triethylamine and DBU) were insufficiently strong to deprotonate the benzylic position 
of 412 (pKa = 21.9 in DMSO)
138 whereas the stronger bases (BEMP and potassium tert-
butoxide) were too harsh and led to decomposition of the 1,4-dithian-2,5-diol (358).  
Diethyl 2-cyanomalonate 413 also proved unreactive, this substrate would be expected 
to form an extensively delocalised anion which would be a correspondingly poor 
nucleophile. In addition, substrate 398, lacking an acidic proton, was recovered 
quantitatively from the reaction. Finally, compound 399, as mentioned previously, 
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possessing a high degree of steric hindrance around the α-carbon adjacent to the cyano 
group evidenced inhibition of the reaction. 
 
Figure 23: Substrates which did not react under the optimised conditions. 
To ascertain that our hypothesis on the origin of selectivity in the synthesis leading to 
either a thiazole or a thiophene depends on the environment of the carbon adjacent to the 
nitrile group, the optimised conditions for 362 were used on three substrates (414, 376 
and 388). These all possessed an α-methylene adjacent to the nitrile group and upon 
reaction gave exclusively the 2-aminothiophene products (415-417) in good to excellent 
yields (Scheme 79).  
 
Scheme 79: Illustration of substrates that form thiophenes under Gewald-type conditions. 
 
2.3.2.2 Discussion on the Mechanism 
The pathway resulting in thiophene formation (Scheme 80) follows the Gewald 
mechanism,126 where the base-promoted deprotonated nitrile precursor (418) attacks the 
aldehyde component 361 (generated from 1,4-dithian-2,5-diol) to give intermediate 419. 
This intermediate undergoes a 5-exo-dig cyclisation to form intermediate 420 which after 
dehydration and proton transfer gives the 2-aminothiophene product 422. However, the 
alternative mechanism generating the alternative thiazole had not previously been 
reported and initially presented some queries. We envisaged two putative mechanisms 
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for the formation of the thiazole (Scheme 81), which could be involved depending on the 
specific nitrile substrate involved. Mechanism A is theoretically valid when a methine or 
methylene group is present in the α-position adjacent to the nitrile group, which is 
reminiscent of the original Gewald reaction mechanism (Scheme 80). Alternatively, 
mechanism B would be viable for molecules which possess no protons adjacent to the 
nitrile group. However, the fact that compounds 398 and 399 did not react implies 
mechanism A is the predominant pathway. The lack of reactivity encountered with 
substrate 399 can be attributed to the high degree of steric hindrance inhibiting the 
nucleophilic attack of the enol formed from 399. In summary, although the evidence 
indicates mechanism A is the most likely pathway under the conditions studied in this 
thesis, it should be noted that several benzonitrile derivatives have been shown to 
successfully result in thiazole formation when reacted with coupling partners such as 2-
mercaptopropionic acid therefore mechanism B may operate under certain conditions.139 
 
Scheme 80: Gewald mechanism for the synthesis of 2-aminothiophenes. 
 




2.3.2.3 Stability of 2-Substituted Thiazoles 
It was noted that ethyl 2-phenyl-2-(thiazol-2-yl)acetate (362) changed from a yellow oil 
to a semi-crystalline material on prolonged standing in air, which when analysed by TLC 
and 1H NMR spectroscopy showed that the composition had changed. Glycolate 441 was 
isolated as the main oxidation product through column chromatography. Some related 
oxidations have previously been described, however, these processes have employed 
either a palladium catalyst140 or strong bases such as Cs2CO3
141 in the presence of oxygen. 
To examine this oxidation in more detail, a fresh batch of 362 was synthesised and then 
left in a vial exposed to the atmosphere at ambient temperature. After 7 days the ratio 
of the degradation products was analysed by 1H NMR (71:5:24 for 362, 440 and 441 
respectively). The ratio changed further when left for longer periods (>10 months ratio 
was 26:7:67 for 362, 440 and 441 respectively, Scheme 82). Bubbling oxygen through 
a 0.5 M DMSO-d6 solution of 362 for 24 h did not show any formation of either 
440 or 441. 
 
Scheme 82: Aerobic oxidation of 362 to give glycolate 441. 
We hypothesise that the two oxidation products (440 and 441) are generated through 
initial enolisation and reactive trapping of oxygen. Even though no base is present for the 
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deprotonation, the natural enolisation would be sufficient for the reactive trapping of 
oxygen, albeit slowly. It has previously been reported that hydroperoxides such as 442a-
b  cyclise in the presence of a carbonyl moiety to generate a 1,2-dioxetane intermediate 
443 that upon decomposition generate carbonyl products 161 and 444 (Scheme 83).142 It 
has also been reported that hydroperoxides such as 445 can be reduced with DMSO in 
the presence of gold nanoclusters stabilized by poly(N-vinyl-2-pyrrolidone) (Au:PVP) to 
form 447 (Scheme 83).143  
 
Scheme 83: A) Formation of carbonyl products through 1,2-dioxetane intermediate.142 B) 
Formation of α-hydroxylated products with Au/PVP catalyst in DMSO.143  
Based on these reported reactions, it was hypothesised that the initially formed peroxide 
intermediate 453 could then potentially cyclise onto the adjacent ester moiety forming a 
dioxetane intermediate 455 which, after extrusion of CO2, would furnish product 440 
(Scheme 85). Alternatively, the peroxide intermediate 453 could undergo homolytic 
cleave to form the oxygen-centred radical (454) that abstracts a hydrogen atom to form 
the glycolate 441. It is also possible that compound 440 is the result of ester hydrolysis 
(water generated in the formation of 441), followed by decarboxylation to yield the 
simple 2-benzyl thiazole. Such compounds are known to oxidise to their corresponding 
ketones144 or undergo a 1,2-rearrangement followed by a spontaneous decomposition to 
form 440, such as the rearrangement observed with α-hydroperoxy α-alkoxy ketone 448 
in the formation of benzoic acid 68 and methyl acetate 450 through the intermediate 449 




Scheme 84: 1,2- Rearrangement of α-hydroperoxy α-alkoxy ketone 448. 
A further proposed mechanism, not involving the initial enolisation, could be one 
involving an initial homolytic cleavage of the C-H bond, forming a carbon centred radical 
456 which would then go on to react with oxygen to form the peroxo-radical 457 (Scheme 
85). The peroxo-radical 457 can then either react with a hydrogen atom to form 453 as 
part of the formation of 441, or form the dioxetane intermediate 455 to yield 440. Similar 
to mechanism A, there is nothing that induces the initial homolytic cleavage to initiate 
the reaction, however, we are convinced that considering the long reaction time needed 
for the transformation, small amounts of 451 or 456 are naturally formed due to the acidic 




Scheme 85: (Top) putative mechanism A for the formation of 441, (bottom) putative mechanism 




2.3.4 Conclusions  
In an effort to expand the scope of using 1,4-dithian-2,5-diol as a precursor for 2-
mercaptoacetaldehyde for the formation of sulfur containing heterocycles, it was 
successfully shown that α-substitution of the nitrile precursor predetermines the reaction 
outcome yielding exclusively a thiophene or a thiazole product (Scheme 86).  
 
Scheme 86: Bifurcation pathway giving the 2-aminothiophenes or 2-substituted thiazoles 
accordingly. 
The presence of an alkyl or aryl substituent adjacent to the cyano group leads selectively 
to the thiazole product by blocking the Gewald type reaction mechanism responsible for 
the formation of the 2-aminothiophene. In the study, the thiazole formation from the 
appropriately substituted α-methine nitrile compounds was evaluated using DOE to 
determine a general reaction conditions. The DOE derived conditions were used to 
evaluate the scope of the reaction and demonstrated that most substrates evaluated gave 
the expected 2-substituted thiazole in a range of yields which was dependant on the 
substitutents at the α-position of the nitrile group.  
The synthesis of 2-subsituted thiazoles from readily available, air stable 1,4-dithiane-2,5-
diol (358) as a precursor for 2-mercaptoacetaldehyde was thus demonstrated to be an 
effecient tranformation that can be used to functionalise α-disubstituted nitriles. One such 
example being (S)-dolaphenine (Doe), a highlighted part of dolastatin 10 (340 in Figure 
19), which could be directly synthesised using this methodology. This was previously 
synthesised through a multiple-step synthesis in overall low yields (65% yield and 51% 
both before amine deprotection).146 Further substitution of 2-substituted thiazoles can 
also be easily achieved through published protocols to form 2,4-substituted thiazoles, 2,5-
substituted thiazoles and also 2,4,5-substituted thiazoles making the synthesised products 
from this work valuable precursors.136 
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Finally, the natural air oxidation of ethyl 2-phenyl-2-(thiazol-2-yl)acetate 362 to the 
corresponding glycol was described which is thought to form through the enolisation of 
the substrate followed by reactive trapping of oxygen, cyclisation and subsequent 





Unless specified, reagents were obtained from commercial sources and used without 
further purification. Solvents were obtained from Fisher scientific, and H2O was 
deionised before use.  
NMR spectra were recorded on either Bruker Avance-400, Varian VNMRS-600 or 
Varian VNMRS-700 instrument and was calibrated to the residual solvent according to 
the literature.147 Assignments are based on DEPT-135, COSY, NOESY, HSQC and 
HMBC spectra. 
Liquid chromatography-mass spectrometry (LCMS) was performed on an Agilent HP 
1100 series chromatograph (Mercury Luna 3µ C18 (2) column) attached to a Waters 
ZQ2000 mass spectrometer with ESCi ionisation source in ESI mode. Elution was carried 
out at a flow rate of 0.6 mL/min using a reverse phase gradient of MeCN–water 
containing 0.1% formic acid. Gradient = 0–1 min: hold MeCN 5%, 1–4 min: ramp MeCN 
5–95%, 4–5 min: hold MeCN 95%, 5–7 min: ramp MeCN 95–5%, 7–8 min: hold MeCN 
5%. Retention times are reported as Rt. High resolution mass spectra (HRMS) were 
recorded on a Waters Micromass LCT Premier spectrometer using time of flight with 
positive electrospray ionisation (ESI+), an ABI/MDS Sciex Q-STAR Pulsar with ESI+ 
and an ASAP (atmospheric pressure solids analysis probe ionisation), or a Bruker 
BioApex II 4.7e FTICR utilising either ESI+ or a positive electron ionisation (EI+) source 
equipped with a direct insertion probe. The mass reported is that containing the most 
abundant isotopes (35Cl and 79Br). Limit: ± 5 ppm. 
IR spectra were recorded neat on a Perkin-Elmer Spectrum Two FT-IR spectrometer 
using Universal ATR sampling accessories. Letters in parentheses refer to the relative 
absorbency of the peak: w – weak (<40% of the most intense peak), m – medium (40–
75% of the most intense peak), s – strong (>75% of the most intense peak) and br – broad. 
Elemental analysis was carried out on an Exeter CE-440 Elemental Analyser with the 
combustion tube set at an initial 950 ºC which is then elevated at above 1800 ºC. 
Melting points were recorded on an Optimelt automated melting point system with a 
heating rate of 1 °C/min (70% onset point and 10° clear point) and are uncorrected. 
X-ray diffraction experiment for 128 was carried out on a D8 Venture 3-circle Bruker 
AXS diffractometer with a PHOTON 100 CMOS area detector, using graphite-
monochromated Mo-K radiation ( =0.71073 Å) from IS microsource and a 
Cryostream (Oxford Cryosystems) open-flow N2 cryostat.  The structure was solved by 
direct methods (SHELXS 2013/1 software148) and refined by full-matrix least squares 
against F2 of all reflections, using OLEX2149 and SHELXL 2014/7 software.150 
Crystallographic data for structure 128 have been deposited with the Cambridge 
Crystallographic Data Centre as supplementary publication CCDC- 1470506. 
X-ray diffraction experiment for 323 was carried out on a D8 Venture 3-circle 
diffractometer (Bruker AXS) with a PHOTON 100 CMOS area detector, using Mo-K 
radiation ( =0.71073 Å) from an IS microsource with focusing mirrors. The crystal 
was maintained at T=120 K using a Cryostream (Oxford Cryosystems) open-flow N2 
cryostat. The structure was solved by direct methods and refined by full-matrix least 
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squares against F2 of all reflections, using OLEX2,149 SHELXS 2013/1148 and SHELXL 
2014/7150 software.   
X-ray diffraction experiment for compound 441 have been collected at 120.0(2)K on an 
Agilent XCalibur 4-circle diffractometer (Sapphire-3 CCD detector, graphite 
monochromator, λMoKα, λ = 0.71073Å, ω-scan, 1.0/frame) equipped with a Cryostream 
(Oxford Cryosystems) open-flow nitrogen cryostat. The structures was solved by direct 
method and refined by full-matrix least squares on F2 for all data using Olex2149 and 
SHELXTL148 software. All non-hydrogen atoms were refined anisotropically, hydrogen 
atoms were found in the difference Fourier maps and refined isotropically. 
Crystallographic data for structure 441 have been deposited with the Cambridge 







General Procedures for Chapter 2.1: 
A) Ortho-substituted carbonylation in flow. 
For a typical reaction, a Vapourtec R2+ Series was used as the platform with a Vapourtec 
Gas / Liquid Membrane Reactor to load the carbon monoxide. The HPLC pumps were 
both set at 0.125 mL/min, the temperature of the reactor at 110 °C, the pressure of CO at 
15 bar with a back pressure regulator of 250 psi (17.24 bar). The system was left running 
for 2 h to reach steady state after which the flow streams were switched to pass from the 
loops where the substrates and catalysts were loaded. The first loop (5 mL) was filled 
with a solution of palladium acetate (20 mg, 0.08 mmol), triphenylphosphine (48 mg, 
0.168 mmol) in 6 mL of 1,4-dioxane while the second loop (5 mL) was filled with a 
solution made from the ortho-substituted iodoarene substrate (1.68 mmol), triethylamine 
(0.272 g, 0.374 mL, 2.69 mmol) and water (0.505 g, 28 mmol) in 5.8 mL of 1,4-dioxane. 
An Omnifit® column filled with 1.71 cm3 (r = 0.33 cm, h = 5.00 cm) of cotton was 
positioned just before the back pressure regulator to trap any particulate matter. This 
avoided blocking of the back pressure regulator. After the substrates were passed through 
the system, the outlet of the flow stream was directed into a receptacle where the excess 
carbon monoxide gas was vented off into the fume cupboard.  The reaction mixture was 
then evaporated to dryness, EtOAc (25 mL) and sodium carbonate solution (2 M, 10 mL) 
were added and transferred to a separating funnel. After collecting the aqueous layer, the 
organic layer was extracted again with sodium carbonate solution (2 M, 2 x 10 mL). The 
combined aqueous layers were acidified (monitored using pH paper) by the addition of 2 
M HCl solution which was then extracted with EtOAc (3 x 25 mL). The organic layer 
was dried over sodium sulfate, and the solvent evaporated under vacuum to give the crude 
product. The crude product was then recrystallised from the appropriate solvent to give 
the pure product. 
B) Ortho-substituted carbonylation in batch (Conventional Lab). 
A solution of palladium acetate (20 mg, 0.08 mmol) and triphenylphosphine (48 mg, 
0.168 mmol) in 11.8 mL of 1,4-dioxane was prepared, to which 2-chloro-iodobenzene 
(0.401g, 1.68 mmol), triethylamine (0.272 g, 0.374 mL, 2.69 mmol) and water (0.505 g, 
28 mmol) were added in a N2 filled 25 mL flask. A balloon (made from two balloons 
inside each other) of carbon monoxide was attached to the flask and the flask was emptied 
through an empty needle. This process was repeated and then the third time the carbon 
monoxide in the balloon was not emptied by removing the empty needle. The reaction 
was heated to reflux, cooled after 2 h or 24 h, solvent evaporated and the same 
extraction/purification for the flow protocol was repeated using MeCN to recrystallise 
the product. 
C) Ortho-substituted carbonylation in batch (High-Pressure Lab). 
A solution of palladium acetate (80 mg, 0.32 mmol) and triphenylphosphine (192 mg, 
0.672 mmol) in 24 mL of 1,4-dioxane was prepared and stirred for 15 min., to which a 
solution of 2-chloro-iodobenzene (1.602 g, 6.72 mmol), triethylamine (1.088 g, 1.50 mL, 
10.76 mmol) and water (2.02 g, 112 mmol) in 24 mL of 1,4-dioxane was added in the 
Parr autoclave (stainless steel, 100 mL capacity, 200 bar maximum pressure). The 
autoclave was tightly sealed and placed in the heating rig. The autoclave was then purged 
with nitrogen (3 x 10 bar) and with carbon monoxide (3 x 10 bar), keeping 10 bar of 
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carbon monoxide in the autoclave at which point it was heated to 110 °C over 15 min. 
The carbon monoxide pressure was adjusted to 15 bar and the reaction was left stirring 
for 2 h and was then cooled down to 30 °C over 2 h. The autoclave was then purged with 
nitrogen (4 x 10 bar) and the reaction mixture removed from the autoclave. The same 
extraction/purification sequence as for the flow protocol was repeated. 
Spectroscopic and experimental data for Chapter 2.1: 
(4-Bromo-3-iodophenyl)methanol, 121: 
 
To a suspension of 4-bromo-3-iodobenzaldehyde (1.24 g, 4.0 mmol) in MeOH (6 mL) at 
0 ºC was added NaBH4 (0.08 g, 2.0 mmol) in small portions over 10 min. The reaction 
mixture was allowed to warm to room temperature and left stirring for 1 h. The solvent 
was then evaporated under vacuum and the residue was dissolved in EtOAc (25 mL) and 
washed with brine solution (3 x 25 mL). The organic layer was dried over sodium sulfate 
and the solvent evaporated under reduced pressure to give the desired product as white 
solid which was used without further purification. 
Isolated yield: 1.17 g (93%, 4.00 mmol scale);  
White crystals (recrystallised from CHCl3);  
1H NMR (400 MHz, CDCl3) δ/ppm δ 7.85 – 7.81 (d, J = 4.0 Hz, 1H), 7.55 (d, J = 8.2 Hz, 
1H), 7.17 – 7.12 (dd, J = 4.0, 8.0 Hz 1H), 4.56 (s, 2H), 2.35 (s, br, 1H);  
13C NMR (101 MHz, CDCl3) δ/ppm 141.5 (C), 138.6 (CH), 132.7 (CH), 128.7 (C), 128.0 
(CH), 101.4 (C), 63.3 (CH2);  
IR (neat) ν = 3293 (br, C-OH), 2921 (w), 1450 (m), 1387 (m), 1195 (w), 1101 (m), 1006 
(s), 808 (s) cm-1;  
LC-MS (MeCN), Rt. 2.14 min, m/z = 295.14 [M-H2O]
+. HR-MS (ESI-TOF) calculated 
for C7H5BrI 294.8619, found 294.8625 (Δ = 2.0 ppm).  






To a solution of (4-bromo-3-iodophenyl)methanol (121) (1.15 g, 3.67 mmol) in THF (4 
mL) was added NaH (60% in hexane, 0.224 g, 5.5 mmol) in small portions over 5 min 
while keeping the reaction mixture at 0 ºC. Iodoethane (0.860 g, 0.44 mL, 5.5 mmol) was 
then added to the reaction mixture after which it was allowed to warm to room 
temperature and left stirring for 2 h.  The reaction solvent was evaporated under vacuum 
and the residue was dissolved in EtOAc (25 mL) and washed with brine (3 x 25 mL). The 
organic layer was dried over sodium sulfate and the solvent evaporated under reduced 
pressure to give the desired product as yellow oil which was purified using flash silica 
chromatography 0.5:9.5 – 2:3 EtOAc/hexane gradient to give the product as a colourless 
liquid. 
Isolated yield: 0.698 g (56%, 3.67 mmol scale);  
Colourless liquid, Rf: 0.32 (2/8, EtOAc/hexane);  
1H NMR (400 MHz, CDCl3) δ/ppm 7.87 (dt, J = 1.9, 0.7 Hz, 1H), 7.60 (d, J = 8.2 Hz, 
1H), 7.20 (ddt, J = 8.2, 2.0, 0.7 Hz, 1H), 4.43 (d, J = 0.8 Hz, 2H), 3.56 (q, J = 7.0 Hz, 
2H), 1.27 (t, J = 7.0 Hz, 3H);  
13C NMR (101 MHz, CDCl3) δ/ppm 139.5 (C), 139.2 (CH), 132.5 (CH), 128.6 (CH), 
128.5 (C), 101.1 (C), 71.0 (CH2), 66.1 (CH2), 15.2 (CH3);  
IR (neat) ν = 2974 (w), 2865 (w), 1454 (m), 1383 (m), 1100 (s), 1009 (m), 811 (m) cm-1;  
GC-MS (MeCN), Rt. 4.72 min, m/z = 340.0 [M]+. LC-MS (MeCN), Rt. 4.31 min, m/z = 
294.86 [M-EtOH]+, HR-MS (ESI-TOF) calculated for C7H5BrI 294.8619, found 
294.8611 (Δ = 2.7 ppm), ASAP (MeCN), Rt. 0.51 min, m/z = 335.9 [M+EtOH+MeCN]+. 
HR-MS (+AP-TOF) calculated for C9H8BrIN 335.8885, found 335.8875 (Δ = 3.0 ppm), 
ASAP (MeCN), Rt. 0.51 min, m/z = 381.9 [M+H+MeCN]+. HR-MS (AP-TOF) 







To a suspension of 4-bromo-3-iodobenzaldehyde (1.24 g, 4.0 mmol) and glycine 
hydrochloride (0.838 g, 6.0 mmol) in MeCN (6 mL), triethylamine (0.836 g, 6.0 mmol) 
was added and reaction mixture was stirred at room temperature for 4 h. The reaction 
solvent was evaporated under vacuum and the residue was dissolved in EtOAc (25 mL) 
and washed with brine solution (3 x 25 mL). The organic layer was dried over sodium 
sulfate and the solvent evaporated under vacuum to give the desired imine intermediate 
which was used in the next step without further purification. The imine intermediate was 
dissolved in THF (6 mL) and tert-butyl methacrylate (1.138 g, 8.0 mmol) was added 
followed by lithium bromide (0.694 g, 8.0 mmol) and triethylamine (1.11 g, 8.0 mmol). 
The reaction mixture was stirred at room temperature for 2 h after which the reaction 
solvent was evaporated under reduced pressure and the residue dissolved in EtOAc (25 
mL) and washed with brine (3 x 25 mL). The organic layer was dried over sodium sulfate 
and the solvent evaporated under vacuum to give the desired crude product as a yellow 
oil which was purified using flash silica chromatography 1:9 EtOAc/hexane. 
Isolated yield: 2.00 g (93%, 4.0 mmol scale);  
Yellow oil, Rf: 0.15 (2/8, EtOAc/hexane);  
1H NMR (600 MHz, CDCl3) δ/ppm; 7.83 (d, J = 2.1 Hz, 1H), 7.52 (d, J = 8.3 Hz, 1H), 
7.22 (dd, J = 8.3, 2.2 Hz, 1H), 4.25 (q, J = 7.1 Hz, 2H), 3.98 – 3.92 (m, 2H), 2.73 (s, br, 
1H), 2.60 (dd, J = 13.2, 8.9 Hz, 1H), 2.04 (dd, J = 13.2, 8.1 Hz, 1H), 1.42 (s, 3H), 1.31 
(t, J = 7.1 Hz, 3H), 1.12 (s, 9H).  
13C NMR (151 MHz, CDCl3) δ/ppm 173.6 (C), 173.0 (C), 141.5 (C), 139.3 (CH), 132.2 
(CH), 128.6 (CH), 128.5 (C), 100.9 (C), 81.2 (C), 71.4 (CH), 61.3 (CH2), 58.8 (CH), 55.1 
(C), 41.3 (CH2), 27.7 (CH3), 24.4 (CH3), 14.4 (CH3);  
IR (neat) ν = 2997 (w), 1933 (w), 1717 (s, C=O), 1449 (m), 1367 (m), 1248 (s), 1149 (s), 
1110 (s), 1033 (m), 1009 (m), 847 (m) cm-1;  
LC-MS (MeCN), Rt. 3.77 min, m/z = 538.4 [M+H]+. HR-MS (ESI-TOF) calculated for 







To a solution of compound 126 (2.0 g, 3.72 mmol) in DCM (4 mL) was added pivolyl 
chloride (0.580 g, 0.594 mL, 4.83 mmol) followed by triethylamine (0.489 g, 0.674 mL, 
4.83 mmol) and the reaction was stirred at room temperature for 2 h. The reaction mixture 
was washed with brine (3 x 25 mL) and the organic layer dried over sodium sulfate and 
the solvent evaporated under vacuum to give the desired product as a yellow oil which 
was purified using flash silica chromatography 1:9 EtOAc/hexane. 
Isolated yield: 1.49 g (65%, 3.72 mmol scale);  
White crystals (recrystallised from CH3Cl), Rf: 0.24 (2/8, EtOAc/hexane);  
1H NMR (600 MHz, CDCl3) δ/ppm 8.04 (s, 1H), 7.83 (d, J = 8.3 Hz, 1H), 7.57 (d, J = 
8.3 Hz, 1H), 4.95 (s, 1H), 4.50 (dd, J = 12.0, 7.1 Hz, 1H), 4.29 (q, J = 7.1 Hz, 2H), 2.46 
(t, J = 12.6 Hz, 1H), 1.96 (dd, J = 13.1, 7.1 Hz, 1H), 1.42 (s, 3H), 1.33 (t, J = 7.1 Hz, 3H), 
1.22 (s, 9H), 1.07 (s, 9H);  
13C NMR (151 MHz, CDCl3) δ/ppm δ 178.5 (C), 172.2 (C), 170.5 (C), 140.8 (C), 140.1 
(CH), 132.4 (CH), 129.5 (CH), 129.0 (C), 100.7 (C), 82.1 (C), 69.0 (CH), 61.2 (CH2), 
60.9 (CH), 56.1 (C), 39.5 (C), 32.6 (CH2), 28.3 (CH3), 27.7 (CH3), 23.5 (CH3), 14.2 
(CH3);  
IR (neat) ν = 2975 (w), 2935 (w), 1743 (s, C=O), 1722 (s, C=O), 1632 (s, amide I band), 
1456 (m), 1394 (m), 1251 (m), 1197 (s), 1167 (s), 1129 (s), 730 (s) cm-1;  
LC-MS (MeCN), Rt. 4.05 min, m/z = 622.5 [M+H]+. HR-MS (ESI-TOF) calculated for 
C24H34BrINO5 622.0665, found 622.0662 (Δ = 0.5 ppm). 
Crystal data: 128, C24H33BrINO5, M=622.32, T=120 K, triclinic, space group P 1  (No. 
2), a=8.8223(5), b=9.7894(5), c= 17.1881(9) Å, α= 94.479(2), β= 101.255(2), γ= 
116.252(2)º, V= 1282.7(1) Å3, Z=2, Dc=1.611 g cm
–3, μ=0.74 mm–1, 34192 reflections 
with 2θ≤71.7º, 10848 unique, Rint=0.031, R(F)=0.027 [9096 data with I≥2σ(I)], 





2-Chlorobenzoic acid,   [CAS Number: 118-91-2], 103: 
 
Prepared using general procedure A: Isolated yield; 0.183 g (90%, 1.30 mmol scale), 
prepared using general procedure B after 2 h: Isolated yield; 0.013 g (5%, 1.68 mmol 
scale) and after 24 h: Isolated yield; 0.024 g (9%, 1.68 mmol scale), prepared using 
general procedure C: Isolated yield: 0.912 g (87%, 6.72 mmol scale); 
Pale yellow crystals (recrystallised from MeCN); 
1H NMR (400 MHz, DMSO-d6) δ/ppm 13.42 (s, br, 1H), 7.78 (d, J = 7.6 Hz, 1H), 7.68 – 
7.17 (m, 3H);  
13C NMR (151 MHz, DMSO-d6) δ/ppm 167.2 (C), 133.0 (CH), 132.0 (C), 131.9 (C), 
131.2 (CH), 131.1 (CH), 127.7 (CH);  
IR (neat) ν = 2820 (w, br), 1683 (s, C=O), 1591 (m), 1473 (m), 1408 (m), 1312 (s), 1267 
(s), 1043 (m), 742 (s) cm-1;  
LC-MS (MeCN), Rt. 2.34 min, m/z = 157.0 [M+H]+. HR-MS (ESI-TOF) calculated for 
C7H6O2Cl 157.0056, found 157.0063 (Δ = 4.5 ppm).  
M.p. 140-141 °C (MeCN) (Literature: 139-140 °C, no solvent specified).151 
2-Bromobenzoic acid, [CAS Number: 88-65-3], 129: 
 
Prepared using general procedure A: Isolated yield; 0.185 g (70%, 1.30 mmol scale); 
White crystals (recrystallised from MeCN); 
1H NMR (400 MHz, DMSO-d6) δ/ppm 13.39 (s, br, 1H), 7.78 – 7.66 (m, 2H), 7.50 – 7.40 
(m, 2H);  
13C NMR (151 MHz, DMSO-d6) δ/ppm 167.4 (C), 133.7 (CH), 132.5 (CH), 130.6 (CH), 
127.7 (CH), 127.5 (C), 119.9 (C);  
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IR (neat) ν = 2646 (w, br), 1675 (s, C=O), 1589 (m), 1473 (m), 1278 (s), 1306 (s). 1265 
(s), 1028 (m), 896 (m) cm-1;  
LC-MS (MeCN), Rt. 2.27 min, m/z = 200.8 [M+H]+. HR-MS (ESI-TOF) calculated for 
C7H6O2Br 200.9551, found 200.9554 (Δ = 1.49 ppm).  
M.p. 147-149 °C (MeCN) (Literature: 147-149 °C, no solvent specified).151 
2-Fluorobenzoic acid, [CAS Number: 445-29-4], 130: 
 
Prepared using general procedure A: Isolated yield; 0.152 g (84%, 1.30 mmol scale); 
Yellow crystals (recrystallised from MeCN);  
1H NMR (400 MHz, DMSO-d6) δ/ppm 13.23 (s, br, 1H), 7.87 (td, J = 7.6, 1.7 Hz, 1H), 
7.64 (m, 1H), 7.35 – 7.26 (m, 2H);  
13C NMR (151 MHz, DMSO-d6) δ/ppm 165.5 (d, J = 3.0 Hz, C), 161.5 (d, J = 256.7 Hz, 
C), 135.1 (d, J = 8.9 Hz, CH), 132.3 (CH), 124.9 (d, J = 3.8 Hz, CH), 119.8 (d, J = 10.3 
Hz, C), 117.4 (d, J = 22.1 Hz, CH);  
19F NMR (376 MHz, DMSO-d6) δ/ppm -110.65 (s);  
IR (neat) ν = 2820 (w, br), 1685 (s, C=O), 1613 (m), 1465 (m), 1414 (m), 1285 (m), 1271 
(m), 1230 (m), 1915 (m), 845 (m), 751 (s) cm-1;  
LC-MS (MeCN), Rt. 2.06 min, m/z = 139.1 [M-H]-. HR-MS (ESI-TOF) calculated for 
C7H4O2F 139.0195, found 139.0189 (Δ = 4.3 ppm).  
M.p. 122-124 °C (MeCN) (Literature: 123-125 °C, no solvent specified).152 
2-(Trifluoromethyl)benzoic acid, [CAS Number: 433-97-6], 131: 
 
Prepared using general procedure A: Isolated yield; 0. 0.176g (71%, 1.30 mmol scale);  
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White crystals (recrystallised from MeCN);  
1H NMR (400 MHz, CDCl3) δ/ppm 11.23 (s, br, 1H), 8.05 – 7.97 (m, 1H), 7.86 – 7.78 
(m, 1H), 7.73 – 7.63 (m, 2H);  
13C NMR (151 MHz, CDCl3) δ/ppm 172.2 (C), 132.4 (CH), 132.0 (CH), 131.3 (CH), 
129.7 (q, J = 2.7 Hz, C), 129.7 (q, J = 49.2 Hz, C), 127.2 (q, J = 8.5 Hz, CH), 123.3 (q, J 
= 274.6 Hz, C);  
19F NMR (376 MHz, DMSO-d6) δ/ppm -59.32 (s);  
IR (neat) ν = 2891 (br), 1700 (s, C=O), 1586 (w), 1416 (w), 1276 (s), 1168 (s), 1127 (s), 
1108 (s), 1058 (s), 1038 (s), 893 (m), 765 (s) cm-1;  
LC-MS (MeCN), Rt. 2.47 min, m/z = 189.4 [M-H]-. HR-MS (ESI-TOF) calculated for 
C8H5F3O2 189.0163, found 189.0171 (Δ = 4.2 ppm).  
M.p. 108-109 °C (MeCN) (Literature: 108-110 °C, EtOAc/Pet Ether).153   
2-Methoxybenzoic acid, [CAS Number: 579-75-9], 132: 
 
Prepared using general procedure A: Isolated yield; 0.125g (63%, 1.30 mmol scale);  
White crystals (recrystallised from MeCN);  
1H NMR (400 MHz,CDCl3) δ/ppm 10.76 (s, br, 1H), 8.18 (dd, J = 7.8, 1.8 Hz, 1H), 7.58 
(ddd, J = 8.4, 7.3, 1.8 Hz, 1H), 7.14 (ddd, J = 7.8, 7.3, 1.1 Hz, 1H), 7.06 (dd, J = 8.4, 1.1 
Hz, 1H), 4.08 (s, 3H);  
13C NMR (151 MHz, CDCl3) δ/ppm 165.6 (C), 158.2 (C), 135.2 (CH), 133.9 (CH), 122.3 
(CH), 117.7 (C), 111.7 (CH), 56.8 (CH3);  
IR (neat) ν = 2950 (w, br), 2648 (w, br), 1668 (s, C=O), 1599 (m), 1578 (m), 1492 (m), 
1464 (m), 1314 (m), 1253 (s), 1168 (m), 1088 (m), 1020 (m), 759 (s) cm-1;  
LC-MS (MeCN), Rt. 2.03 min, m/z = 153.3 [M+H]+. HR-MS (ESI-TOF) calculated for 
C8H9O3 153.0552, found 153.0554 (Δ = 1.3 ppm).  




2-Methylbenzoic acid, [CAS Number: 118-90-1], 133: 
 
Prepared using general procedure A: Isolated yield; 0.106 g (60%, 1.30 mmol scale);  
White crystals (recrystallised from MeCN);  
1H NMR (400 MHz, CDCl3) δ/ppm 11.65 (s, br, 1H), 8.13 – 8.05 (m, 1H), 7.47 (td, J = 
7.5, 1.5 Hz, 1H), 7.30 (t, J = 7.4 Hz, 2H), 2.68 (s, 3H);  
13C NMR (151 MHz, CDCl3) δ/ppm 173.6 (C). 141.5 (C), 133.1 (CH), 132.1 (CH), 131.7 
(CH), 128.4 (C), 126.0 (CH), 22.3 (CH3);  
IR (neat) ν = 2966 (w, br), 2655 (w, br), 1679 (s, C=O), 1577 (m), 1413 (m), 1315 (s), 
1276 (s), 1090 (m), 738 (s) cm-1;  
LC-MS (MeCN), Rt. 2.58 min, m/z = 135.4 [M-H]-. HR-MS (-ESI-TOF) calculated for 
C8H7O3 135.0446, found 135.0448 (Δ = 1.5 ppm).  
M.p. 103-104 °C (MeCN) (Literature: 104-105 °C, no solvent specified).154  
2-Chloronicotinic acid, [CAS Number: 2942-59-8], 134: 
 
Prepared using general procedure A: Isolated yield; 0.116 g (57%, 1.30 mmol scale);  
Yellow crystals (recrystallised from EtOH);  
1H NMR (400 MHz, DMSO-d6) δ/ppm 13.78 (s, br, 1H), 8.56 (dd, J = 4.8, 2.0 Hz, 1H), 
8.23 (dd, J = 7.7, 2.0 Hz, 1H), 7.54 (dd, J = 7.7, 4.8 Hz, 1H);  
13C NMR (151 MHz, DMSO-d6) δ/ppm 165.8 (C), 151.7 (CH), 147.8 (C), 140.0 (CH), 
128.2 (C), 123.2 (CH);  
IR (neat) ν = 2460 (w, br), 1701 (s, C=O), 1577 (s), 1400 (m), 1256 (s), 1231 (s), 1148 
(m), 1058 (s), 1066 (s). 819 (m), 769 (s), 715 (s) cm-1;  
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LC-MS (MeCN), Rt. 1.79 min, m/z = 156.0 [M-H]-. HR-MS (-ESI-TOF) calculated for 
C6H3NO2Cl 155.9852, found 155.9848 (Δ = 2.6 ppm).  
M.p. 183 °C (EtOH, decomposed) (Literature: 190-192 °C, no solvent specified).155   
4-Bromo-2-chlorobenzoic acid, [CAS Number: 59748-90-2], 135: 
 
Prepared using general procedure A: Isolated yield; 0.232 g (76%, 1.30 mmol scale); 
White crystals (recrystallised from MeCN);  
1H NMR (400 MHz, DMSO-d6) δ/ppm 13.55 (s, br, 1H) 7.86 (d, J = 1.9 Hz, 1H), 7.75 
(d, J = 8.3 Hz, 1H), 7.66 (dd, J = 8.3, 1.9 Hz, 1H);  
13C NMR (151 MHz, DMSO-d6) δ/ppm 165.9 (C), 133.0 (C), 132.9 (CH), 132.5 (CH), 
130.5 (C), 130.4 (CH), 125.1 (C);  
IR (neat) ν = 3089 (w, br), 2562 (w, br), 1676 (s, C=O), 1577 (s), 1430 (m), 1366 (m), 
1294 (s), 1254 (s), 1137 (m), 1047 (m), 909 (m), 823 (s) cm-1;  
LC-MS (MeCN), Rt. 2.56 min, m/z = 232.9 [M-H]-. HR-MS (ESI-TOF) calculated for 
C7H3O2ClBr 232.9005, found 232.9013 (Δ = 3.43 ppm).  
M.p. 171-172°C (MeCN) (Literature: 170-172 °C, no solvent specified).156 
2-Chloro-4-(trifluoromethyl)benzoic acid, [CAS Number: 23228-45-7], 136: 
 
Prepared using general procedure A: Isolated yield; 0.128 g (44%, 1.30 mmol scale);  
White crystals (recrystallised from MeCN); 
1H NMR (400 MHz, DMSO-d6) δ/ppm 13.85 (s, br, 1H), 8.01 – 7.94 (m, 2H), 7.82 (dd, 
J = 8.3, 1.7 Hz, 1H);  
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13C NMR (151 MHz, DMSO-d6) δ/ppm 165.9 (C), 135.8 (CH), 132.16 (q, J = 32.3 Hz, 
C), 132.15 (C), 131.4 (C), 127.4 (q, J = 3.8 Hz, CH), 124.2 (q, J = 3.8 Hz, CH), 121.5 (q, 
J = 274.22 Hz, C);  
19F NMR (376 MHz, DMSO-d6) δ/ppm -61.62 (s);  
IR (neat) ν = 2971 (w, br), 1685 (s, C=O), 1299 (m), 1261 (m), 1174 (m), 1161 (s), 1131 
(s), 1079 (m), 920 (w), 895 (m), 854 (s) cm-1;  
LC-MS (MeCN), Rt. 2.68 min, m/z = 223.0 [M-H]-. HR-MS (ESI-TOF) calculated for 
C8H3O2F3Cl 222.9774, found 222.9778 (Δ = 1.8 ppm).  
M.p. 114-115°C (MeCN) (Literature: 114-116 °C, no solvent specified).155 
2-Chloro-4-methylbenzoic acid, [CAS Number: 7697-25-8], 137: 
 
Prepared using general procedure A: Isolated yield; 0.152 g (69%, 1.30 mmol scale); 
Grey crystals (recrystallised from MeCN);  
1H NMR (400 MHz, DMSO-d6) δ/ppm 13.19 (s, br, 1H), 7.72 (d, J = 7.9 Hz, 1H), 7.38 
(dd, J = 1.7, 0.9 Hz, 1H), 7.24 (ddd, J = 7.9, 1.7, 0.9 Hz, 1H), 2.34 (s, 3H); 
13C NMR (151 MHz, DMSO-d6) δ/ppm 166.5 (C), 143.3 (C), 131.9 (C), 131.1 (CH), 
131.0 (CH), 128.1 (C), 127.8 (CH), 20.5 (CH3);  
IR (neat) ν = 2542 (w, br), 1675 (s, C=O), 1606 (m), 1490 (w), 1436 (w), 1302 (s), 1268 
(s), 1047 (m), 915 (w), 835 (s), 767 (s) cm-1;  
LC-MS (MeCN), Rt. 2.41 min, m/z = 171.3 [M+H]+. HR-MS (ESI-TOF) calculated for 
C8H8O2Cl 171.0213, found 171.0207 (Δ = 3.5 ppm).  




2-Chloro-4-fluorobenzoic acid, [CAS Number: 2252-51-9], 138: 
 
Prepared using general procedure A: Isolated yield; 0.154 g (89%, 1.30 mmol scale) or 
2.372 g (85%, 16.00 mmol scale);  
White crystals (recrystallised from MeCN);  
1H NMR (400 MHz, DMSO-d6) δ/ppm 13.45 (s, br, 1H), 7.91 (dd, J = 8.7, 6.3 Hz, 1H), 
7.56 (dd, J = 9.0, 2.6 Hz, 1H), 7.32 (ddd, J = 8.8, 8.2, 2.6 Hz, 1H);  
13C NMR (151 MHz, DMSO-d6) δ/ppm 165.7 (s, C), 163.2 (d, J = 252.6 Hz, C), 133.7 
(d, J = 11.1 Hz, C), 133.3 (d, J = 9.8 Hz, CH), 127.7 (d, J = 3.5 Hz, C), 118.1 (d, J = 25.2 
Hz, CH), 114.60 (d, J = 21.4 Hz, CH);  
19F NMR (376 MHz, DMSO-d6) δ/ppm -106.76 (s);  
IR (neat) ν = 3084 (w, br), 2641 (w, br), 1670 (s, C=O), 1577 (s), 1392 (m), 1410 (m), 
1310 (m), 1258 (s), 1218 (s), 1048 (m), 912 (s), 870 (s), 770 (s) cm-1; 
LC-MS (MeCN), Rt. 2.31 min, m/z = 173.1 [M-H]-. HR-MS (ESI-TOF) calculated for 
C7H3O2FCl 172.9806, found 172.9810 (Δ = 2.3 ppm).  
M.p. 185-186 °C (MeCN) (Literature: 180-181 °C, aq. EtOH).158 
2,4-Dichlorobenzoic acid, [CAS Number: 50-84-0], 139: 
 
Prepared using general procedure A: Isolated yield; 0.171 g (69%, 1.30 mmol scale);  
White crystals (recrystallised from MeCN);  
1H NMR (400 MHz, DMSO-d6) δ/ppm 13.56 (s, br, 1H), 7.83 (d, J = 8.4 Hz, 1H), 7.74 
(d, J = 2.1 Hz, 1H), 7.53 (dd, J = 8.4, 2.1 Hz, 1H);  
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13C NMR (151 MHz, DMSO-d6) δ/ppm 165.8 (C), 136.5 (C), 133.0 (C), 132.4 (CH), 
130.2 (CH), 130.1 (C), 127.5 (CH);  
IR (neat) ν = 2813 (w, br), 1691 (s, C=O), 1580 (m), 1555 (m), 1474 (w), 1412 (m), 1374 
(m), 1302 (s), 1265 (s), 1109 (m), 1052 (s), 914 (m), 872 (s), 837 (s), 771 (s) cm-1;  
LC-MS (MeCN), Rt. 2.85 min, m/z = 189.0 [M-H]-. HR-MS (ESI-TOF) calculated for 
C7H3O2Cl2 188.9510, found 188.9512 (Δ = 1.1 ppm).  
M.p. 162-163 °C (MeCN) (Literature: 162 °C, no solvent specified).159 
1-Naphthoic acid, [CAS Number: 86-55-5], 140: 
 
Prepared using general procedure A: Isolated yield; 0.100 g (43%, 1.30 mmol scale);  
White crystals (recrystallised from MeCN);  
1H NMR (400 MHz, DMSO-d6) δ/ppm 13.16 (s, br, 1H), 8.87 (d, J = 8.5 Hz, 1H), 8.22 – 
8.11 (m, 2H), 8.02 (dd, J = 8.0, 1.5 Hz, 1H), 7.71 – 7.55 (m, 3H);  
13C NMR (151 MHz, DMSO-d6) δ/ppm 169.1 (C), 133.9 (C), 133.4 (CH), 131.1 (C), 
130.3 (CH), 129.1 (CH), 128.2 (C), 128.0 (CH), 126.7 (CH), 125.9 (CH), 125.4 (CH);  
IR (neat) ν = 3046 (br), 1670 (s, C=O), 1593 (m), 1513 (m), 1448 (w), 1413 (m), 1297 
(m), 1250 (m), 1204 (m), 1149 (m), 891 (w), 771 (s) cm-1;  
LC-MS (MeCN), Rt. 2.75 min, m/z = 171.2 [M-H]-. HR-MS (ESI-TOF) calculated for 
C11H7O2 171.0446, found 171.0442 (Δ = 2.3 ppm).  
M.p. 165-167 °C (MeCN) (Literature: 166-167, MeCN.153 
2,5-Dichlorobenzoic acid, [CAS Number: 50-79-3], 141: 
 
Prepared using general procedure A: Isolated yield: 0.118 g (48%, 1.30 mmol scale);  
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White crystals (recrystallised from MeCN);  
1H NMR (400 MHz, DMSO-d6) δ/ppm 13.73 (s, br, 1H), 7.82 (d, J = 2.4 Hz, 1H), 7.66 – 
7.54 (m, 2H);  
13C NMR (151 MHz, DMSO-d6) δ/ppm 165.5 (C), 133.2 (C), 132.34 (CH), 132.25 (CH), 
131.8 (C), 130.3 (C), 130.2 (CH);  
IR (neat) ν = 2801 (w, br), 1675 (s, C=O), 1583 (w), 1558 (m), 1463 (w), 1436 (m), 1290 
(s), 1250 (s), 1107 (m), 1050 (m), 823 (s) cm-1;  
LC-MS (MeCN), Rt. 2.52 min, m/z = 189.0 [M-H]-. HR-MS (ESI-TOF) calculated for 
C7H3O2Cl2 188.9510, found 188.9518 (Δ = 4.2 ppm).  
M.p. 153-155 °C (MeCN) (Literature: 155-156 °C, no solvent specified).160 
2-Chloro-5-(trifluoromethyl)benzoic acid, [CAS Number: 657-06-7], 142: 
 
Prepared using general procedure A: Isolated yield; 0.136 g (47%, 1.30 mmol scale); 
White crystals (recrystallised from CHCl3);  
1H NMR (400 MHz, DMSO-d6) δ/ppm 13.92 (s, br, 1H), 8.09 (d, J = 2.3 Hz, 1H), 7.91 
(dd, J = 8.5, 2.3 Hz, 1H), 7.83 – 7.78 (m, 1H);  
13C NMR (101 MHz, DMSO-d6) δ/ppm 166.0 (C), 136.4 (d, J = 1.3 Hz, C), 133.2 (C), 
132.4 (CH), 129.4 (q, J = 3.4 Hz, CH), 128.3 (q, J = 33.1 Hz, C), 127.9 (q, J = 3.8 Hz, 
CH), 123.9 (q, J = 273.5 Hz, C);  
19F NMR (376 MHz, DMSO-d6) δ/ppm -61.34 (s);  
IR (neat) ν = 2856 (w, br), 2634 (w, br), 1717 (m), 1690 (s, C=O), 1326 (s), 1304 (m), 
1282 (m), 1266 (m), 1248 (m), 1172 (m), 1121 (s), 1080 (s), 1051 (m), 920 (w), 837 (s) 
cm-1;  
LC-MS (MeCN), Rt. 2.99 min, m/z = 223.0 [M-H]-. HR-MS (ESI-TOF) calculated for 
C8H3O2F3Cl 222.9774, found 222.9766 (Δ = 3.6 ppm).  





2-Bromo-5-formylbenzoic acid, [CAS Number: 1289007-84-6], 143: 
 
Prepared using general procedure A: Isolated yield; 0.127 g (43%, 1.30 mmol scale),  
Amorphous solid;  
1H NMR (400 MHz, DMSO-d6) δ/ppm 13.70 (s, br, 1H), 10.03 (s, 1H), 8.24 (d, J = 2.1 
Hz, 1H), 7.98 – 7.86 (m, 2H);  
13C NMR (101 MHz, DMSO-d6) δ/ppm 192.0 (CH), 166.6 (C), 135.2 (C), 135.0 (CH), 
134.5 (C), 132.0 (CH), 131.5 (CH), 126.7 (C);  
IR (neat) ν = 2945 (w, br), 2785 (w, br), 2638 (w, br), 1663 (s, C=O), 1731 (s, C=O), 
1593 (m), 1555 (m), 1368 (m), 1278 (m), 1243 (s), 1190 (s), 1032 (m), 910 (s), 839 (s), 
776 (s) cm-1;  
LC-MS (MeCN), Rt. 2.05 min, m/z = 227.0 [M-H]-. HR-MS (ESI-TOF) calculated for 
C8H4BrO3 226.9344, found 226.9352 (Δ = 3.5 ppm). 
2-Fluoro-5-formylbenzoic acid, [CAS Number: 550363-85-4], 144: 
 
Prepared using general procedure A: Isolated yield; 0.102 g (47%, 1.30 mmol scale);  
Yellow crystals (recrystallised from MeCN);  
1H NMR (400 MHz, DMSO-d6) δ/ppm 13.66 (s, br, 1H), 10.04 (s, 1H), 8.43 (dd, J = 7.2, 
2.3 Hz, 1H), 8.17 (ddd, J = 8.5, 4.7, 2.3 Hz, 1H), 7.56 (dd, J = 10.6, 8.5 Hz, 1H);  
13C NMR (151 MHz, DMSO-d6) δ/ppm 191.8 (s, CH), 164.8 (d, J = 266.0 Hz, C), 164.5 
(d, J = 3.1 Hz, C), 135.5 (d, J = 10.9 Hz, CH), 134.5 (d, J = 2.7 Hz, CH), 133.1 (d, J = 
3.1 Hz, C), 120.6 (d, J = 11.3 Hz, C), 118.7 (d, J = 23.6 Hz, CH);  
19F NMR (376 MHz, DMSO-d6) δ/ppm -101.25 (s);  
IR (neat) ν = 2865 (w, br), 1701 (s, C=O), 1685 (s, C=O), 1610 (m), 1457 (m), 1453 (m), 
1437 (m), 1431 (m), 1290 (m), 1245 (s), 1203 (s), 1087 (m), 923 (m), 841 (s) cm-1;  
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LC-MS (MeCN), Rt. 1.93 min, m/z = 167.1 [M-H]-. HR-MS (ESI-TOF) calculated for 
C8H4FO3 167.0144, found 167.0146 (Δ = 1.2 ppm).  
M.p. 162 °C (MeCN, decomposed). 
2-Bromo-5-(ethoxymethyl)benzoic acid, 145: 
 
 
Prepared using general procedure A: Isolated yield; 0.156 g (36%, 1.00 mmol scale); 
Amorphous solid; 
1H NMR (400 MHz, CDCl3) δ/ppm 10.40 (s, br, 1H), 7.96 (d, J = 2.2 Hz, 1H), 7.67 (d, J 
= 8.3 Hz, 1H), 7.38 (dd, J = 8.2, 2.2 Hz, 1H), 4.51 (s, 2H), 3.57 (q, J = 7.0 Hz, 2H), 1.26 
(t, J = 7.1, 3H); 
13C NMR (101 MHz, CDCl3) δ/ppm 170.9 (C), 138.4 (C), 135.0 (CH), 132.7 (CH), 131.5 
(CH), 130.5 (C), 121.5 (C), 71.4 (CH2), 66.3 (CH2), 15.3 (CH3);  
IR (neat) ν = 2976 (w, br), 2658 (w, br), 1699 (s, C=O), 1471 (w), 1443 (w), 1387 (w), 
1295 (m), 1247 (m), 1195 (m), 1099 (s), 1027 (s), 823 (m) cm-1;  
LC-MS (MeCN), Rt. 2.15 min, m/z = 259.3 [M+H]+. HR-MS (ESI-TOF) calculated for 
C10H12BrO3 258.9970, found 258.9965 (Δ = 1.9 ppm). 
(Rac)-(2-bromo-5-((2R,3S,5S)-3-(tert-butoxycarbonyl)-5-(ethoxycarbonyl)-3-
methyl-1-pivaloylpyrrolidin-2-yl)benzoic acid, 146: 
 
Prepared using general procedure A: Isolated yield; 0.366 g (54%, 1.76 mmol scale); 
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Colourless crystals (recrystallised from hexane/EtOAc);  
1H NMR (700 MHz, CDCl3) δ/ppm 10.02 (s, br, 1H), 8.14 (s, 1H), 8.11 – 8.00 (m, 1H), 
7.69 (d, J = 8.4 Hz, 1H), 5.09 (s, 1H), 4.55 (dd, J = 12.0, 7.1 Hz, 1H), 4.29 (qd, J = 7.1, 
1.7 Hz, 2H), 2.49 (t, J = 12.7 Hz, 1H), 1.99 (dd, J = 13.2, 7.1 Hz, 1H), 1.46 (s, 3H), 1.33 
(t, J = 7.2 Hz, 3H), 1.17 (s, 9H), 1.07 (s, 9H).  
13C NMR (176 MHz, CDCl3) δ/ppm 178.9 (C), 172.4 (C), 170.8 (C), 170.2 (C), 139.8 
(C), 135.1 (CH), 133.5 (CH), 132.7 (CH), 130.1 (C), 122.0 (C), 82.3 (C), 69.7 (CH), 61.5 
(CH2), 61.2 (CH), 56.3 (C), 39.7 (C), 32.8 (CH2), 28.4 (CH3), 27.7 (CH3), 23.7 (CH3), 
14.3 (CH3);  
IR (neat) ν = 2997 (w, br), 1723 (s, C=O), 1627 (m, amide I band), 1597 (m), 1478 (m), 
1369 (m), 1252 (s), 1200 (s), 1130 (s), 1027 (s), 909 (s), 728 (s) cm-1;  
LC-MS (MeCN), Rt. 3.30 min, m/z = 540.5 [M+H]+. HR-MS (+ESI-TOF) calculated for 
C25H24BrNO7 540.1597, found 540.1582 (Δ = 2.8 ppm),  
M.p. 162-165 °C (hexane/EtOAc). 
2,6-Dimethoxybenzoic acid, [CAS Number: 1466-76-8], 147: 
 
Prepared using general procedure A: Isolated yield; 0.042 g (16%, 1.30 mmol scale);  
White crystals (recrystallised from MeCN);  
1H NMR (400 MHz, DMSO-d6) δ/ppm 12.72 (s, br, 1H), 7.32 (t, J = 8.4 Hz, 1H), 6.69 
(d, J = 8.4 Hz, 2H), 3.76 (s, 6H);  
13C NMR (101 MHz, DMSO-d6) δ/ppm 167.2 (C), 156.6 (C), 130.9 (CH), 114.8 (C), 
104.6 (CH), 56.2 (CH3);  
IR (neat) ν = 2944 (w, br), 1695 (m, C=O), 1589 (m), 1478 (m), 1476 (m), 1333 (m), 
1253 (s), 1110 (s), 1076 (m), 1027 (m), 796 (m) cm-1;  
LC-MS (MeCN), Rt. 2.07 min, m/z = 181.1 [M-H]-. HR-MS (ESI-TOF) calculated for 
C9H9O4 181.0501, found 181.0508 (Δ = 3.9 ppm).  




2-Chloro-6-methylbenzoic acid, [CAS Number: 21327-86-6], 148: 
 
Prepared using general procedure A: Isolated yield; 0.054 g (12%, 2.60 mmol scale);  
White crystals (recrystallised from hexane);  
1H NMR (400 MHz, CDCl3) δ/ppm; 10.07 (s, 2H), 7.29 – 7.22 (m, 2H), 7.14 (dd, J = 5.4, 
3.4 Hz, 1H), 2.43 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ/ppm; 172.7 (C), 137.2 (C), 132.8 (C), 130.8 (C), 130.7 
(CH), 128.7 (CH), 127.1 (CH), 19.9 (CH3). 
IR (neat) ν = 2927 (br), 1700 (s, C=O), 1595 (m), 1452 (m), 1282 (m), 1182 (m), 1119 
(m), 1071 (w), 870 (m), 774 (s) cm-1;  
LC-MS (MeCN), Rt. 2.25 min, m/z = 169.5 [M-H]-. HR-MS (ESI-TOF) calculated for 
C8H6O2Cl 169.0056, found 169.0047 (Δ = 5.3 ppm).  
M.p. 100-101 °C (hexane) (Literature: 98-99 °C, hexane).84b  
2-Naphthoic acid, [CAS Number: 93-09-4], 150: 
 
Prepared using general procedure A: Isolated yield; 0.125 g (53%, 1.30 mmol scale);  
White crystals (recrystallised from iPrOH);  
1H NMR (400 MHz, DMSO-d6) δ/ppm; 13.10 (s, br, 1H), 8.62 (s, 1H), 8.17 – 8.09 (m, 
1H), 8.06 – 7.94 (m, 3H), 7.64 (m, 2H). 
13C NMR (101 MHz, DMSO-d6) δ/ppm; 167.9 (C), 135.4 (C), 132.6 (C), 131.0 (CH), 
129.7 (CH), 128.8 (CH), 128.6 (CH), 128.5 (C), 128.1 (CH), 127.3 (CH), 125.6 (CH). 
IR (neat) ν = 2570 (br), 1685 (s, C=O), 1632 (w), 1477 (w), 1424 (m), 1358 (m), 1300 
(s), 1239 (m), 1200 (m), 1135 (m), 833 (m), 906 (m), 868 (m), 778 (s), 759 (s) cm-1;  
133 
 
LC-MS (MeCN), Rt. 2.23 min, m/z = 171.2 [M-H]-. HR-MS (ESI-TOF) calculated for 
C11H7O2 171.0446, found 171.0444 (Δ = 1.2 ppm). 
M.p. 183-186 °C (iPrOH) (Literature: 184-185, EtOAc/Ether).153 
2-(Methylsulfonyl)-4-(trifluoromethyl)benzoic acid, 156: 
 
Procedure 1: To an ice cold solution of 2-(methylsulfonyl)-4-(trifluoromethyl)benzoic 
acid (156, 0.526 g, 2.00 mmol) in MeOH (8 mL) was add Oxone® (KHSO5 · 0.5 KHSO4 
· 0.5 K2SO4, 0.922 g, 3.00 mmol) in water (7 mL) dropwise. The reaction was left to stir 
over night and then was diluted with brine solution (30 mL) and extracted with EtOAc (3 
x 25 mL). The organic layer was dried over sodium sulfate and the solvent evaporated to 
give the product. 
Procedure 2: A suspension of compound 157 (0.526 g, 2.00 mmol) in acetic acid (8 mL) 
and acetic anhydride (0.612 g, 6.0 mmol) was prepared and cooled using an ice bath. 
Hydrogen peroxide (27%, 1.50 g, 6.0 mmol) was added dropwise making sure the 
temperature did not rise above 5 ºC. The reaction was then warmed up to room 
temperature and stirred for 30 min. The reaction was heated to 65 °C for 3 h, cooled 
down, poured over ice and extracted with diethyl ether (3 x 25 mL).  The organic layer 
was washed with brine (9 x 25 mL), dried over sodium sulfate and solvent evaporated 
under vacuum to give the product as a white powder which was recrystallised from 
EtOAc to give the pure product. 
Procedure 3: To a solution of compound 157 (0.236 g, 1.00 mmol) in acetic acid (5.7 
mL) was added QP-SA (0.1 g, 0.22 mmol) and heated at 50 ºC. Hydrogen peroxide 
solution (27%, 0.40 mL, 0.45 g, 3.53 mmol) was added dropwise and reaction left to stir 
for 8 h at 50 ºC. The reaction was then cooled to room temperature, diluted with brine 
(20 mL) and extracted with EtOAc (3 x 25 mL). The organic layer was then washed with 
brine (5 x 25 mL), dried over sodium sulfate and solvent evaporated under vacuum to 
give the product as a white powder which was recrystallised from EtOAc to give the pure 
product. 
Procedure 4: A solution of compound 157 (0.236 g, 1.00 mmol) in acetic acid (6.6 mL) 
was prepared and hydrogen peroxide (27%, 0.40 mL, 0.45 g, 3.53 mmol) was added. The 
pump was set at 0.1 mL/min. which was connected to an Omnifit® column (0.5 cm radius 
x 12 cm height, loaded with 12.5 g QP-SA 2.20 mmol/g loading) and maintained at 50 
ºC, followed by a variable back pressure regulator set at 5 bar (See Scheme 87). The 
output solution was collected and diluted with brine (20 mL) and extracted with EtOAc 
(3 x 25 mL). The organic layer was washed with brine (5 x 25 mL), dried over sodium 
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sulfate and the solvent evaporated under vacuum to give the product as a white powder 
which was recrystallised from EtOAc to give the pure product. 
 
Scheme 87: Oxidation of 156 in flow. 
Procedure 5: A mixture of 4:1 MeCN/H2O (30 mL) was bubbled with F2/N2 (1:9, 40 
mL/min) for 1 h in a Teflon® lined flask (See Figure 24). A suspension of 157 (0.236 g, 
1.00 mmol) in MeCN (10 mL) was added and left stirring for 10 min at room temperature. 
The reaction was then quenched with K2CO3 aqueous solution (1 M, 200 mL) and the 
organic layer was dried over sodium sulfate and the solvent evaporated under vacuum to 
give the product as a white powder which was recrystallised from EtOAc to give the pure 
product. 
 
Figure 24: Fluorination set up including scrubber and mixing tanks. 
Using procedure 1: Isolated yield; 0.27 g (5%, 2.0 mmol scale). Using procedure 2: 
Isolated yield; 0.675 g (63%, 2.0 mmol scale). Using procedure 3: Isolated yield; 0.147 
g (55%, 1.0 mmol scale). Using procedure 4: Isolated yield; 0.228 g (85%, 1.0 mmol 
scale). Using procedure 5: Isolated yield; 0.241 g (90%, 1.0 mmol scale).  
White crystals (recrystallised from EtOAc), Rf: 0.06 (9/1, DCM/MeOH);  
1H NMR (600 MHz, DMSO-d6) δ/ppm 14.26 (s, 1H), 8.25-8.19 (m, 2H), 8.01-7.95 (m, 
1H), 3.47 (s, 3H);  
13C NMR (151 MHz, DMSO-d6) δ/ppm 168.0 (C), 139.5 (C), 138.6 (C), 131.4 (q, J = 
3.28 Hz, CH), 131.1 (q, J = 33.1 Hz, C), 130.8 (CH), 126.7 (q, J = 3.84 Hz, CH), 123.4 
(q, J = 272.98 Hz, CF3), 44.56 (CH3); 
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19F NMR (376 MHz, DMSO-d6) δ/ppm -61.65 (s). 
IR (neat) ν = 3236 (w, br), 1749 (m, C=O), 1401 (w), 1378 (w), 1325 (s), 1287 (s), 1226 
(s), 1187 (s), 1127 (s), 1113 (s), 1079 (s), 971 (m), 937 (m), 860 (m), 845 (w), 789 (m), 
769 (s), 748 (s) cm-1;  
LC-MS (MeCN), Rt. 2.80 min, m/z = 267.1 [M-H]-. HR-MS (ESI-TOF) calculated for 
C9H6O4F3S 266.9939, found 266.9940 (Δ = 0.4 ppm);  
Elemental analysis: calculated for C9H7O4F3S C: 45.76%, H: 2.99%, N: 0.0%; measured 
C: 45.71% (Δ = 0.05), H: 2.92% (Δ = 0.07), N: 0.01% (Δ = 0.01)  
M.p. 154-158 °C (EtOAc). 
2-(Methylthio)-4-(trifluoromethyl)benzoic acid, 157: 
 
Procedure 1: A solution of “turbo-Grignard” (iPrMgCl.LiCl) (1.3 M in THF, 3.0 mmol, 
2.31 mL), was loaded in a 25 mL dry three necked round bottom flask. The (2-bromo-5-
(trifluoromethyl)phenyl)(methyl)sulfane (152, 0.678 g, 2.5 mmol) was dissolved in 3.5 
mL of dry THF and added slowly to the magnesium solution using a syringe. The reaction 
mixture was left stirring at room temperature for 2 h. A small sample was taken, and 
checked by GC-MS which shows complete conversion. The reaction mixture was then 
quenched with 5 pellets of dry ice (solid CO2) and stirred for 10 min before being 
quenched by an aqueous solution of HCl (2 M, addition monitored using pH paper). The 
reaction mixture was diluted with EtOAc (30 mL). The organic layer was extracted with 
a saturated solution of potassium carbonate (3 x 5 mL). The aqueous layer was made 
acidic with dropwise addition of HCl (2 M, addition monitored using pH paper) and the 
solution/suspension extracted with EtOAc (3 x 25 mL). The organic layer was dried over 
magnesium sulfate, filtered and solvent evaporated to give white crystals of the expected 
product (0.221 g, 34% yield). 
Procedure 2: A solution of compound 152 (0.441 g, 1.63 mmol) was prepared in THF 
(2.5 mL) and injected in a 2 mL loop on the Vapourtec R2+. “Turbo-Grignard” 
(iPrMgCl.LiCl) (1.3 M in THF) was injected in a separate 2 mL loop. The reactor pumps 
were set at 0.33 mL/min. with 10 bar CO, 20 mL of PFA reactor set at 70 ºC followed by 
a 15 mL of “tube-in-tube” reactor at room temperature and BPR of 100 psi (See Scheme 
88). The output solution collected was quenched with an aqueous solution of HCl (1 M, 
addition monitored using pH paper). The mixture was extracted using EtOAc (3 x 25 
mL). The organic layer was then extracted with an aqueous solution of NaOH (1 M, 3 x 
5 mL). The combined aqueous layers were acidified (monitored using pH paper) by the 
addition of 2 M HCl solution which was then extracted with EtOAc (3 x 25 mL). The 
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organic layer was dried over sodium sulfate, and the solvent evaporated under reduced 
pressure to give the crude product. 
 
Scheme 88: Grignard hydroxy-carboxylation of 149 using the reverse “tube-in-tube” reactor. 
Procedure 3: To a cooled (-78 ºC) solution of compound 152 (1.36g, 5.00 mmol) in THF 
(25 mL) was added dropwise n-BuLi (2.5 M solution in hexane, 2.20 mL, 5.5 mmol) 
making sure the temperature stays below -70 ºC. After 2 h stirring at -78 ºC, 10 pellets of 
dry ice (solid CO2) were added and the mixture stirred for 10 min. The reaction mixture 
was quenched with an aqueous solution of HCl (1 M, 20 mL, addition monitored using 
pH paper) and stirred at room temperature for 30 min. The mixture was extracted using 
EtOAc (3 x 25 mL). The organic layer was then extracted with an aqueous solution of 
NaOH (1 M, 3 x 5 mL). The combined aqueous layers were acidified (monitored using 
pH paper) by the addition of 2 M HCl solution which was then extracted with EtOAc (3 
x 25 mL). The organic layer was dried over sodium sulfate, and the solvent evaporated 
under reduced pressure to give the crude product which was recrystallised from MeCN 
to give the pure product.  
Procedure 4: A solution of compound 152 (0.564 g, 2.08 mmol) was prepared in THF 
(2.1 mL) and injected in a 2 mL loop on the Vapourtec R2+. A separate 2 mL loop was 
filled with a solution of n-BuLi (1.25 M in hexane). The reactor pumps were set at 0.2 
mL/min. feeding the loops and 0.4 mL/min. for the pump feeding the “tube-in-tube” 
reactor with hexane and 10 bar CO at room temperature. After the two injection loops a 
2 mL residence time loop was placed after each loop which was immersed in a dry 
ice/acetone bath (-78 ºC) which then join together through a T-piece which was also 
immersed in the same cooling bath. After the T-piece the flow stream passed through a 
PFA reactor (2 mL) also immersed in the same cooling bath then joined with a stream of 
hexane loaded with CO coming from the “tube-in-tube” reactor at room temperature. The 
combined stream was passed through another PFA reactor (10 mL) at room temperature 
and BPR of 75 psi (See Scheme 89). The output solution was collected and quenched 
with an aqueous solution of HCl (1 M, addition monitored using pH paper). The mixture 
was extracted using EtOAc (3 x 25 mL). The organic layer was then extracted with an 
aqueous solution of NaOH (1 M, 3 x 5 mL). The combined aqueous layers were acidified 
(monitored using pH paper) by the addition of 2 M HCl solution which was then extracted 
with EtOAc (3 x 25 mL). The organic layer was dried over sodium sulfate, and the solvent 




Scheme 89: Lithiation of 152 followed by hydroxy-carbonylation in continuous flow.  
Using procedure 1: Isolated yield; 0.201 g (34%, 2.5 mmol scale). Using procedure 2: 
Isolated yield; 0.025 g (8%, 1.3 mmol scale). Using procedure 3: Isolated yield; 0.985 g 
(83%, 5.00 mmol scale). Using procedure 4: Isolated yield; 0.280 g (60%, 1.98 mmol 
scale). 
White crystals (recrystallised from MeCN); 
1H NMR (400 MHz, DMSO-d6) δ/ppm 8.06 (d, J = 8.3 Hz, 1H), 7.57-7.52 (m, 2H), 2.49 
(s, 3H). 
13C NMR (101 MHz, DMSO-d6) δ/ppm 166.59 (C), 144.08 (C), 132.22 (q, J = 31.9 Hz, 
C), 131.68 (CH), 131.14 (C), 123.67 (q, J = 273.3 Hz, C), 120.98 (q, J = 3.8 Hz, CH), 
120.25 (q, J = 3.6 Hz, CH), 14.76 (CH3). 
19F NMR (376 MHz, DMSO-d6) δ/ppm -61.69 (s). 
IR (neat) ν = 2932 (w, br), 1695 (m, C=O), 1675 (m), 1481 (w), 1419 (w), 1310 (s), 1254 
(s), 1185 (s), 1119 (s), 1085 (s), 874 (s), 849 (m), 842 (m), 781 (m), 770 (m) cm-1;  
LC-MS (MeOH), Rt. 3.21 min, m/z = 235.0 [M-H]-. HR-MS (ESI-TOF) calculated for 
C9H6O2F3S 235.0041, found 235.0041 (Δ = 0.0 ppm).  
M.p. 192-193 °C (MeCN). 




A solution of compound 152 (0.271 g, 1.0 mmol), triethylamine (0.139 mL, 1.1 equiv.) 
and hydrazine (0.10 mL, 30 mol%) was prepared in 3 mL of a 1:1 mixture of dioxane/ 
MeOH. Another solution was separately prepared with palladium acetate (11.2 mg, 5 
mol%) and Xantphos (34.7 mg, 6 mol%) in 3 mL of dioxane. The respective solutions 
were injected into 2 mL sample loops on the Vapourtec R2+ reactor and the pumps set at 
0.125 mL/min., with 15 bar CO, 30 mL of tube in tube reactor (2 x 15 mL) at 110 °C and 
BPR of 325 psi (Scheme 90). The solution collected was evaporated down, loaded on 
silica and purified using flash chromatography with 1:4 EtOAc/hexanes to give 62 mg 
(22% isolated yield) of pure product as a brown oil. 
 
Scheme 90: Alkoxy-carbonylation of 152 in flow. 
Isolated yield: 0.062 g (22%, 1.0 mmol scale); 
White crystals; Rf: 0.46 (1/4, EtOAc/hexanes); 
1H NMR (400 MHz, CDCl3) δ/ppm 8.09 (d, J = 7.8 Hz, 1H), 7.47 (s, 1H), 7.39 (d, J = 
8.2 Hz, 1H), 3.95 (s, 3H), 2.50 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ/ppm 165.9 (C), 144.9 (C), 136.6 (q, J = 33.0 Hz, C), 131.8 
(CH), 129.7 (C), 123.6 (q, J = 272.9 Hz, C), 121.1 (q, J = 3.7 Hz, CH), 120.1 (q, J = 3.7 
Hz, CH), 52.5 (CH3), 15.6 (CH3). 
19F NMR (376 MHz, CDCl3) δ/ppm -63.29 (s). 
IR (neat) ν = 2999 (w), 2961 (w), 2926 (w), 1723 (s, C=O), 1478 (w), 1437 (m), 1389 
(w), 1314 (s), 1246 (s), 1166 (s), 1110 (s), 1084 (s), 1061 (s), 880 (m), 848 (m), 834 (m), 
774 (s), 698 (s) cm-1; 
ASAP (MeCN), Rt. 0.55 min, m/z = 249.9 [M+H]+. HR-MS (AP-TOF) calculated for 
C10H9O2F3S 250.0275, found 250.0265 (Δ = 4.0 ppm), 




General Procedures for Chapter 2.2: 
A) Catalytic Chan-Lam in flow: 
A solution was prepared from the amine (0.781 mmol) in DCM (5.5 mL) followed by the 
boronic acid (1.25 mmol) and NEt3 (0.039 g, 54 µL, 0.391 mmol). Another solution 
containing Cu(OAc)2·H2O (0.195 mmol, 0.25 equiv.), NEt3 (0.039 g, 54 µL, 0.391 mmol) 
and pyridine (0.062 g, 63 µL, 0.781 mmol) in DCM (5.5 mL) was also prepared. The two 
solutions were separately introduced in 5 mL sample loop as shown in (Scheme 91). The 
pumps were each set at 0.125 mL/min to achieve a residence time of 2 h. Two reverse 
“tube-in-tube” reactors were used in series to achieve a combined reactor volume of 30 
mL which were heated at 40 ºC. The reaction mixture was then passed through an Omnifit 
column (r = 0.33 cm, h = 10.00 cm) filled with QP-DMA followed by a back pressure 
regulator (175 psi). The crude reaction mixture was then passed through a plug of silica 
to remove most of the excess copper present and the organic solvent from eluent 
evaporated under reduced pressure. The resultant crude material was then purified using 
flash chromatography. 
 
Scheme 91: General flow scheme for catalytical Chan Lam reaction. 
 






Ethyl 6-methyl-3-oxo-2,3-dihydropyridazine-4-carboxylate (306, 7.096 g, 39.0 mmol) 
and 3,4-dimethoxyphenylboronic acid (4.439 g, 24.4 mmol) were dissolved in DCM 
(108.1 mL) to which NEt3 (4.93 g, 6.79 mL, 48.8 mmol) was added. Another solution 
was made from Cu(OAc)2·H2O (1.219 g, 6.1 mmol) in DCM (105.8 mL) to which NEt3 
(4.93 g, 6.79 mL, 48.8 mmol) and pyridine (1.94 g, 1.97 mL, 24.4 mmol) were added. 
The stock solutions were separately pumped through two respective HPLC pumps of a 
Vapourtec flow machine equipped with 2 x 15 mL ‘tube in tube’ reactors followed by a 
column reactor filled with cotton as a filter and a 100 psi BPR. The reactors were heated 
at 40 °C and supplied with oxygen gas at 10 bar of pressure (Scheme 92). The reaction 
mixture was collected and washed with 1M HCl (2 x 250 mL), organic layer dried over 
sodium sulfate, filtered and solvent evaporated under reduced pressure. The crude 
material was purified by trituration (MeOH/diethyl ether/n-hexane, 7 mL : 14 mL : 40 
mL) and solid obtained recrystallised from i-PrOH to give the product as yellow crystals. 
(5.52 g, 72% yield).  
 
Scheme 92: Optimised process for the synthesis of 309.  
Isolated yield: 5.52 g (72%, 24.4 mmol scale), 99+% purity; 
Yellow crystals; Rf: 0.33 (8/2, EtOAc/hexanes);  
1H NMR (700 MHz, CDCl3) δ/ppm 7.65 (s, 1H), 7.12 – 7.09 (m, 2H), 6.94 – 6.91 (m, 
1H), 4.40 (q, J = 7.1 Hz, 2H), 3.91 (s, 3H), 3.89 (s, 3H), 2.43 (s, 3H), 1.39 (t, J = 7.1 Hz, 
3H);  
13C NMR (176 MHz, CDCl3) δ/ppm 163.8 (C), 156.5 (C), 149.2 (C), 149.0 (C), 144.0 
(C), 134.8 (C), 134.7 (CH), 131.5 (C), 118.2 (CH), 110.9 (CH), 109.5 (CH), 62.4 (CH2), 
56.3 (CH3), 56.2 (CH3), 21.0 (CH3), 14.3 (CH3);  
IR (neat) ν = 3008 (w), 2992 (w), 1739 (s, C=O), 1656 (m, C=O of lactam), 1609 (s), 




LC-MS (MeCN), Rt. 2.619 min, m/z = 319.2 [M+H]+. HR-MS (ESI-TOF) calculated for 
C16H19N2O5 319.1294, found 319.1287 (Δ = -2.2 ppm);  
Elemental analysis: calculated for C16H18N2O5 C: 60.37%, H: 5.70%, N: 8.80%; 
measured C: 60.60% (Δ = 0.23), H: 5.70% (Δ = 0.00), N: 8.80% (Δ = 0.01);  
M.p. 111-113 °C (iPrOH/Toluene, 1:9). 
1-(4-Methoxyphenyl)-3-phenyl-1H-pyrazole, 311: 
 
Consistent with published data119 
Prepared using general procedure A: Isolated yield; 0.139 g (79%, 0.70 mmol scale); 
Colourless crystals; Rf: 0.36 (8/2, EtOAc/hexanes);  
1H NMR (700 MHz, CDCl3) 7.94 – 7.90 (m, 2H), 7.85 (d, J = 2.5 Hz, 1H), 7.69 – 7.65 
(m, 2H), 7.46 – 7.41 (m, 2H), 7.34 (ddt, J = 7.4, 5.6, 1.3 Hz, 1H), 7.01 – 6.97 (m, 2H), 
6.75 (d, J = 2.4 Hz, 1H), 3.85 (s, 3H);  
13C NMR (176 MHz, CDCl3) δ/ppm 158.3 (C), 152.7 (C), 134.2 (C), 133.4 (C), 128.8 
(CH), 128.2 (CH), 128.0 (CH), 125.9 (CH), 120.9 (CH), 114.7 (CH), 104.7 (CH), 55.7 
(CH3);  
IR (neat) ν = 3003 (w), 1529 (m), 1516 (s), 1458 (m), 1363 (m), 1257 (s), 1234 (m), 1045 
(m), 1025 (m), 956 (m) cm−1;  
LC-MS (MeCN), Rt. 3.63 min, m/z = 251.1 [M+H]+. HR-MS (ESI-TOF) calculated for 
C16H15N2O 251.1184, found 251.1192 (Δ = 3.2 ppm);  




Prepared using general procedure A: Isolated yield; 0.162 g (81%, 0.697 mmol scale);  
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Yellow crystals; Rf: 0.24 (1/1, EtOAc/hexanes); 
1H NMR (400 MHz, CDCl3) δ/ppm 7.65 (s, 1H), 7.52 – 7.45 (m, 2H), 6.99 – 6.92 (m, 
2H), 4.40 (q, J = 7.1 Hz, 2H), 3.83 (s, 3H), 2.42 (s, 3H), 1.38 (t, J = 7.1 Hz, 3H);  
13C NMR (101 MHz, CDCl3) δ/ppm 163.9 (C), 159.5 (C), 156.5 (C), 143.9 (C), 134.74 
(CH), 134.66 (C), 131.4 (C), 126.9 (CH), 114.1 (CH), 62.3 (CH2), 55.7 (CH3), 21.0 
(CH3), 14.3 (CH3);  
IR (neat) ν = 3022 (w), 2971 (w), 1739 (s, C=O), 1658 (m, C=O of lactam), 1604 (m), 
1510 (m), 1314 (m), 1250 (m), 1229 (s), 1150 (m), 1025 (m), 841 (s) cm−1;  
LC-MS (MeCN), Rt. 2.64 min, m/z = 289.4 [M+H]+. HR-MS (ESI-TOF) calculated for 
C15H17N2O4 289.1188, found 289.1198 (Δ = 3.5 ppm);  
Elemental analysis: calculated for C15H16N2O4 C: 62.49%, H: 5.59%, N: 9.72%; 
measured C: 62.63% (Δ = 0.14), H: 5.59% (Δ = 0.00), N: 9.73% (Δ = 0.01);  
M.p. 80-81 °C (iPrOH).  
4-Methoxy-N-phenylaniline, 313: 
 
Consistent with published data.163 
Prepared using general procedure A: Isolated yield; 0.125 g (90%, 0.69 mmol scale);  
Colourless crystals; Rf: 0.36 (8/2, EtOAc/hexanes);  
1H NMR (400 MHz, CDCl3) δ/ppm 7.28 – 7.22 (m, 2H), 7.14 – 7.08 (m, 2H), 6.98 – 6.83 
(m, 5H), 5.54 (s, br, 1H), 3.83 (s, 3H);  
13C NMR (101 MHz, CDCl3) δ/ppm 155.4 (C), 145.3 (C), 135.9 (C), 129.4 (CH), 122.4 
(CH), 119.7 (CH), 115.8 (CH), 114.8 (CH), 55.7 (CH3);  
IR (neat) ν = 3387 (m), 3010 (w), 2958 (w), 2839 (w), 1595 (m), 1507 (s), 1499 (s), 1462 
(w), 1443 (m), 1316 (m), 1298 (m), 1248 (s), 1236 (s), 1182 (m), 1169 (m), 1033 (w), 
812 (m), 750 (s), 694 (s)  cm−1;  
LC-MS (MeCN), Rt. 3.15 min, m/z = 200.6 [M+H]+. HR-MS (ESI-TOF) calculated for 
C13H14NO 200.1075, found 200.1072 (Δ = 1.5 ppm);  






Consistent with published data.164 
Prepared using general procedure A: Isolated yield; 0.108 g (92%, 0.69 mmol scale);  
Colourless crystals; Rf: 0.47 (8/2, EtOAc/hexanes);  
1H NMR (400 MHz, CDCl3) δ/ppm 7.33 – 7.26 (m, 4H), 7.13 – 7.07 (m, 4H), 6.96 (tt, J 
= 7.3, 1.1 Hz, 2H), 5.82 (s, br, 1H);  
13C NMR (101 MHz, CDCl3) δ/ppm 143.2 (C), 129.5 (CH), 121.2 (CH), 118.0 (CH);  
IR (neat) ν = 3408 (w), 3384 (m), 3042 (w), 1739 (w, br), 1596 (s), 1519 s), 1496 (s), 
1459 (m), 1419 (m), 1319 (m), 1173 (m), 749 (s), 744 (s), 690 (s) cm−1;  
LC-MS (MeCN), Rt. 3.22 min, m/z = 170.1 [M+H]+. HR-MS (ESI-TOF) calculated for 
C12H12N 170.0970, found 170.0966 (Δ = 2.4 ppm);  
M.p. 53-54 °C (95% EtOH) (Literature: 54-55 °C, no solvent reported).164 
5-Bromo-N-phenylpyridin-3-amine, 314: 
 
Prepared using general procedure A: Isolated yield; 0.085 g (50%, 0.69 mmol scale);  
Colourless crystals; Rf: 0.20 (8/2, EtOAc/hexanes);  
1H NMR (400 MHz, CDCl3) δ/ppm 8.24 (d, J = 2.5 Hz, 1H), 8.16 (d, J = 2.0 Hz, 1H), 
7.52 (t, J = 2.2 Hz, 1H), 7.38 – 7.30 (m, 2H), 7.15 – 7.03 (m, 3H), 6.02 (s, br, 1H);  
13C NMR (101 MHz, CDCl3) δ/ppm 141.9 (CH), 141.5 (C), 140.7 (C), 137.5 (CH), 130.0 
(CH), 124.6 (CH), 123.4 (CH), 121.0 (C), 119.7 (CH);  
IR (neat) ν = 3257 (w), 3083 (w), 3047 (w), 2992 (w), 2365 (w), 1739 (w, br), 1614 (w), 
1578 (s), 1570 (s), 1497 (s), 1444 (s), 1343 (m), 1331 (m), 1219 (m), 1096 (m), 1005 (m), 
854 (s), 750 (s), 693 (s) cm−1;  
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LC-MS (MeCN), Rt. 3.09 min, m/z = 249.0 [M+H]+. HR-MS (ESI-TOF) calculated for 
C11H10N2Br 249.0027, found 249.0023 (Δ = 1.6 ppm);  
M.p.  160 °C (DCM). 
4-Chloro-N-phenylaniline, 205c: 
 
Consistent with published data.163 
Prepared using general procedure A: Isolated yield; 0.201 g (71%, 1.39 mmol scale);  
Yellow oil; Rf: 0.44 (8/2, EtOAc/hexanes);  
1H NMR (400 MHz, CDCl3) δ/ppm 7.32 – 7.25 (m, 3H), 7.24 – 7.19 (m, 2H), 7.08 – 7.03 
(m, 2H), 7.02 – 6.93 (m, 3H), 5.79 (s, br, 1H);  
13C NMR (101 MHz, CDCl3) δ/ppm 142.7 (C), 141.9 (C), 129.6 (CH), 129.4 (CH), 125.7 
(C), 121.7 (CH), 119.0 (CH), 118.3 (CH).  
IR (neat) ν = 3400 (w, br), 3062 (w), 3029 (w), 1588 (s), 1501 (s), 1499 (s), 1496 (s), 
1486 (s), 1310 (s), 1173 (m), 1091 (m), 816 (m), 748 (s), 693 (s) cm−1;  
LC-MS (MeCN), Rt. 3.29 min, m/z = 204.11 [M+H]+. HR-MS (ESI-TOF) calculated for 
C12H11NCl 204.0580, found 204.0579 (Δ = 0.5 ppm).  
(Rac)-methyl 3-(4-hydroxyphenyl)-2-(phenylamino)propanoate, 315: 
 
Prepared using general procedure A: Isolated yield; 0.049 g (26%, 0.69 mmol scale);  
Colourless crystals; Rf: 0.12 (8/2, EtOAc/hexanes);  
1H NMR (400 MHz, CDCl3) δ/ppm 7.18 (dd, J = 7.3, Hz, 2H), 7.02 (d, J = 8.4 Hz, 2H), 
6.76 (t, J = 7.3 Hz, 1H), 6.74 (d, J = 8,4 Hz, 2H),  6.63 (d, J = 7.7 Hz, 2H), 5.08 (s, 1H), 
4.33 (t, J = 6.1 Hz, 1H), 4.15 (s, br, 1H), 3.68 (s, 3H), 3.14 – 3.00 (m, 2H);  
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13C NMR (101 MHz, CDCl3) δ/ppm 174.0 (C), 154.8 (C), 146.4 (C), 130.6 (CH), 129.5 
(CH), 128.3 (C), 118.7 (CH), 115.6 (CH), 113.8 (CH), 58.0 (CH), 52.3 (CH3), 37.9 (CH2);  
IR (neat) ν = 3391 (m, br), 3028 (w). 2954 (w), 1727 (m, C=O), 1603 (s), 1515 (s), 1437 
(w), 1221 (m, br) cm−1;  
LC-MS (MeCN), Rt. 2.61 min m/z = 272.4 [M+H]+. HR-MS (ESI-TOF) calculated for 
C16H18NO3 272.1287, found 272.1281 (Δ = 2.2 ppm). 
(Rac)-methyl 3-(4-phenoxyphenyl)-2-(phenylamino)propanoate, 316: 
 
The results from the 2D NMR spectra (2D-NOESY) are consistent with the second 
alkylation on the phenol rather than the secondary amine. The fact that correlation is 
present with the ortho-protons on the phenol attached to the amine with the methane and 
methylene protons but no other correlation of other aromatic protons with the same 
methane and methylene protons, indicates that the other phenyl ring is not in the same 
environment. Unfortunately no correlation with the ortho-protons of the phenyl rings 
separated by the ether bond is present, but this could be due to the conformation of the 
molecule with the phenyl rings perpendicular to each other.   
Prepared using general procedure A: Isolated yield; 8 mg (3%, 0.69 mmol scale);  
Colourless crystals; Rf: 0.40 (8/2, EtOAc/hexanes);  
1H NMR (700 MHz, CDCl3) δ/ppm 7.35 – 7.31 (m, 2H), 7.20 – 7.16 (m, 2H), 7.14 – 7.08 
(m, 3H), 7.00 – 6.97 (m, 2H), 6.95 – 6.92 (m, 2H), 6.76 (tt, J = 7.3, 1.1 Hz, 1H), 6.64 – 
6.60 (m, 2H), 4.35 (t, J = 6.2 Hz, 1H), 3.69 (s, 3H), 3.18 – 3.06 (m, 2H);  
13C NMR (176 MHz, CDCl3) δ/ppm 173.6 (C), 157.3 (C), 156.5 (C), 146.3 (C), 131.2 
(C), 130.7 (CH), 129.9 (CH), 129.5 (CH), 123.4 (CH), 119.04 (CH), 119.01 (CH), 118.8 
(CH), 113.9 (CH), 58.1 (CH), 52.3 (CH3), 38.1 (CH2);  
IR (neat) ν = 3404 (w), 3030 (w), 2954 (w), 1739 (m, C=O), 1603 (m), 1591 (m), 1506 
(s), 1489 (s), 1239 (s) cm−1;  
LC-MS (MeCN), Rt. 3.67 min, m/z = 348.2 [M+H]+. HR-MS (ESI-TOF) calculated for 




Methyl 4-methyl-2-(phenylamino)pentanoate, 317: 
 
Prepared using general procedure A: Isolated yield; 0.153 g (60%, 0.69 mmol scale);  
Amorphous solid; Rf: 0.52 (8/2, EtOAc/hexanes);  
1H NMR (400 MHz, CDCl3) δ/ppm 7.22 – 7.14 (m, 2H), 6.75 (tt, J = 7.4, 1.1 Hz, 1H), 
6.65 – 6.60 (m, 2H), 4.11 (dd, J = 7.8, 6.6 Hz, 1H), 4.00 (s, br, 1H), 3.71 (s, 3H), 1.81 
(dh, J = 13.3, 6.6 Hz, 1H), 1.72 – 1.59 (m, 2H), 1.00 (d, J = 6.6 Hz, 3H), 0.95 (d, J = 6.6 
Hz, 3H);  
13C NMR (101 MHz, CDCl3) δ/ppm 175.3 (C), 147.1 (C), 129.5 (CH), 118.5 (CH), 113.5 
(CH), 55.2 (CH), 52.2 (CH3), 42.5 (CH2), 25.0 (CH), 22.9 (CH3), 22.32 (CH3);  
IR (neat) ν = 3384 (w, br), 3028 (w), 2955 (m), 2870 (w), 1734 (s), 1602 (s), 1507 (m), 
1433 (w), 1198 (m), 1155 (s), 748 (s), 691 (s) cm−1;  
LC-MS (MeCN), Rt. 3.39 min, m/z = 222.2 [M+H]+. HR-MS (ESI-TOF) calculated for 
C13H20NO2 222.1494, found 222.1496 (Δ = 0.9 ppm). 
1-(3,4-Dimethoxyphenyl)-3,4-dimethyl-1H-1,2,4-triazol-5(4H)-one, 318: 
 
Prepared using general procedure A: Isolated yield; 0.045g (26%, 0.702 mmol scale);  
Off-white crystals (recrystallised using iPrOH); Rf: 0.12 (8/2, EtOAc/hexanes);  
1H NMR (600 MHz, CDCl3) δ/ppm 7.56 (d, J = 2.4 Hz, 1H), 7.45 (dd, J = 8.8, 2.4 Hz, 
1H), 6.89 (d, J = 8.8 Hz, 1H), 3.93 (s, 3H), 3.89 (s, 3H), 3.29 (s, 3H), 2.30 (s, 3H);  
13C NMR (151 MHz, CDCl3) δ/ppm 152.3 (C), 149.0 (C), 146.5 (C), 143.8 (C), 131.6 




IR (neat) ν = 2943 (w), 2842 (w), 1701 (s), 1604 (w). 1590 (w), 1515 (s), 1466 (m), 1250 
(s), 1220 (m), 1027 (m) cm−1;  
LC-MS (MeCN), Rt. 2.48 min, m/z = 250.1 [M+H]+. HR-MS (ESI-TOF) calculated for 
C12H16N3O3 250.1192, found 250.1196 (Δ = 1.6 ppm);  
Elemental analysis: calculated for C12H15N3O3 C: 57.82%, H: 6.07%, N: 16.86%; 
measured C: 57.60% (Δ = 0.22), H: 6.08% (Δ = 0.01), N: 16.51% (Δ = 0.35);  
M.p. 145-146 °C (iPrOH).  
1,3-Diphenyl-1H-pyrazole, 319: 
 
Consistent with published data119 
Prepared using general procedure A: Isolated yield; 0.249 g (81%, 0.70 mmol scale);  
Colourless crystals (recrystallised using iPrOH); Rf: 0.40 (8/2, EtOAc/hexanes);  
1H NMR (700 MHz, CDCl3) 7.99 – 7.95 (m, 1H), 7.93 (dd, J = 7.8, 1.5 Hz, 2H), 7.80 – 
7.76 (m, 2H), 7.50 – 7.46 (m, 2H), 7.44 (t, J = 7.6 Hz, 2H), 7.37 – 7.33 (m, 1H), 7.32 – 
7.28 (m, 1H), 6.80 – 6.77 (m, 1H);  
13C NMR (176 MHz, CDCl3) δ/ppm 153.1 (C), 140.4 (C), 133.2 (C), 129.6 (CH), 128.8 
(CH), 128.2 (CH), 128.1 (CH), 126.5 (CH), 126.0 (CH), 119.2 (CH), 105.2 (CH);  
IR (neat) ν = 3137 (w), 3065 (w), 1599 (m), 1526 (m), 1506 (m), 1457 (m), 1360 (m), 
1303 (w), 1265 (m), 1045 (m), 954 (m), 940 (m) cm−1;  
LC-MS (MeCN), Rt. 3.53 min, m/z = 221.2 [M+H]+. HR-MS (ESI-TOF) calculated for 
C15H13N2 221.1079, found 221.1090 (Δ = 5.0 ppm);  
M.p. 84-85 °C (iPrOH) (Literature: 83-84 °C, no solvent reported).165 




Prepared using general procedure A: Isolated yield; 0.286 g (77%, 1.4 mmol scale);  
Colourless oil; Rf: 0.50 (8/2, EtOAc/hexanes);  
1H NMR (600 MHz, CDCl3) δ/ppm 7.95 (d, J = 1.4 Hz, 1H), 7.94 – 7.92 (m, 2H), 7.73 
(t, J = 2.1 Hz, 1H), 7.49 (ddd, J = 8.1, 2.2, 0.9 Hz, 1H), 7.45 (dd, J = 8.2, 7.1 Hz, 2H), 
7.36 (t, J = 7.7 Hz, 2H), 7.19 – 7.15 (m, 1H), 6.78 (d, J = 2.4 Hz, 1H), 2.56 (s, 3H);  
13C NMR (151 MHz, CDCl3) δ/ppm 153.1 (C), 140.7 (C), 140.5 (C), 133.1 (C), 129.7 
(CH), 128.8 (CH), 128.2 (CH), 128.2 (CH), 126.0 (CH), 124.2 (CH), 117.0 (CH), 115.5 
(CH), 105.3 (CH), 15.8 (CH3);  
IR (neat) ν = 3062 (w), 2920 (w), 1591 (s), 1583 (s), 1530 (w), 1502 (s), 1479 (m), 1454 
(s), 1360 (s), 1045 (s), 963 (m), 945 (m) cm−1;  
LC-MS (MeCN), Rt.  4.409 min, m/z = 267.1 [M+H]+. HR-MS (ESI-TOF) calculated for 
267.0956 C16H15N2S, found 267.0966 (Δ = 3.7 ppm).  
1-(2-Methoxyphenyl)-3-phenyl-1H-pyrazole, 321:  
 
Consistent with published data119 
Prepared using general procedure A: Isolated yield; 0.227 g (65%, 1.4 mmol scale);  
Colourless oil; Rf: 0.43 (8/2, EtOAc/hexanes);  
1H NMR (400 MHz, CDCl3) δ/ppm 8.09 (d, J = 2.5 Hz, 1H), 7.94 – 7.90 (m, 2H), 7.87 
(dd, J = 7.9, 1.7 Hz, 1H), 7.44 – 7.40 (m, 2H), 7.35 – 7.29 (m, 2H), 7.09 (td, J = 7.7, 1.3 
Hz, 1H), 7.06 (dd, J = 8.3, 1.2 Hz, 1H), 6.74 (d, J = 2.5 Hz, 1H), 3.91 (s, 3H);  
13C NMR (151 MHz, CDCl3) δ/ppm 151.8 (C), 151.2 (C), 133.3 (C), 133.0 (CH), 129.8 
(C), 128.5 (CH), 127.8 (CH), 127.8 (CH), 125.9 (CH), 125.2 (CH), 121.3 (CH), 112.3 
(CH), 103.7 (CH), 56.0 (CH3);  
IR (neat) ν = 3060 (w), 2940 (w), 2839 (w), 1597 (m), 1530 (m), 1508 (s), 1455 (s), 1286 
(m), 1259 (m), 1242 (s), 1127 (m), 1022 (s), 954 (m), 942 (m) cm−1;  
LC-MS (MeCN), Rt. 3.53 min, m/z = 251.2 [M+H]+. HR-MS (ESI-TOF) calculated for 




1-(3-Methoxyphenyl)-3-phenyl-1H-pyrazole, 322:  
 
Consistent with published data119 
Prepared using general procedure A: Isolated yield; 0.287 g (82%, 1.4 mmol scale);  
Colourless oil; Rf: 0.36 (8/2, EtOAc/hexanes);  
1H NMR (400 MHz, CDCl3) δ/ppm 8.01 – 7.97 (m, 2H), 7.96 (d, J = 2.5 Hz, 1H), 7.52 – 
7.44 (m, 3H), 7.43 – 7.32 (m, 3H), 6.88 (ddd, J = 8.0, 2.5, 1.2 Hz, 1H), 6.80 (d, J = 2.5 
Hz, 1H), 3.92 (s, 3H);  
13C NMR (151 MHz, CDCl3) δ/ppm 160.6 (C), 152.9 (C), 141.4 (C), 133.2 (C), 130.2 
(CH), 128.7 (CH), 128.2 (CH), 128.1 (CH), 125.9 (CH), 112.1 (CH), 111.1 (CH), 105.2 
(CH), 105.1 (CH), 55.6 (CH3);  
IR (neat) ν = 3065 (w), 2961 (w), 1606 (s), 1593 (s), 1530 (m), 1504 (s), 1362 (m), 1246 
(m), 1217 (s), 1170 (m), 1045 (s), 966 (m) cm−1;  
LC-MS (MeCN), Rt. 3.35 min, m/z = 251.1 [M+H]+. HR-MS (ESI-TOF) calculated for 
C16H15N2O 251.1184, found 251.1194 (Δ = 4.0 ppm). 
4-(3-Phenyl-1H-pyrazol-1-yl)benzonitrile, 323: 
 
Prepared using general procedure A: Isolated yield; 0.264 g (76%, 1.4 mmol scale);  
Colourless crystals (recrystallised using iPrOH); Rf: 0.26 (8/2, EtOAc/hexanes);  
1H NMR (600 MHz, CDCl3) 8.02 (d, J = 2.6 Hz, 1H), 7.94 – 7.88 (m, 4H), 7.78 – 7.73 
(m, 2H), 7.45 (dd, J = 8.3, 7.0 Hz, 2H), 7.41 – 7.36 (m, 1H), 6.84 (d, J = 2.6 Hz, 1H);  
13C NMR (151 MHz, CDCl3) δ/ppm 154.2 (C), 142.9 (C), 133.6 (CH), 132.3 (C), 128.8 




IR (neat) ν = 3138 (w), 3123 (w), 2228 (m, CN), 1604 (m), 1533 (m), 1520 (m), 1517 
(m), 1457 (m), 1394 (w), 1363 (m), 1183 (m), 953 (m), 939 (m) cm−1;  
LC-MS (MeCN), Rt. 3.36 min, m/z = 246.1 [M+H]+. HR-MS (ESI-TOF) calculated for 
C16H12N3 246.1031, found 246.1032 (Δ = 0.4 ppm); 
M.p. 126-131 °C (iPrOH). 
Crystal Data: 323, C16H11N3 (M =245.28 g/mol): monoclinic, space group P21/c (no. 
14), a = 10.9809(6) Å, b = 11.0294(6) Å, c = 11.0655(6) Å, β = 113.0712(17)°, V = 
1232.98(12) Å3, Z = 4, T = 120 K, μ(MoKα) = 0.081 mm-1, Dcalc = 1.321 g/cm3, 26247 
reflections measured (5.446° ≤ 2Θ ≤ 60.176°), 3621 unique (Rint = 0.0290, Rsigma = 
0.0186) which were used in all calculations. The final R1 was 0.0457 (I > 2σ(I)) 
and wR2 was 0.1236 (all data). 
3-(3-Phenyl-1H-pyrazol-1-yl)benzonitrile, 324:  
 
Consistent with published data119 
Prepared using general procedure A but using 2 equiv. of NEt3 to aid solubility: Isolated 
yield; 0.067 g (40%, 0.69 mmol scale);  
Colourless oil; Rf: 0.30 (8/2, EtOAc/hexanes);  
1H NMR (400 MHz, CDCl3) δ/ppm 8.16 – 8.11 (m, 1H), 8.04 – 7.97 (m, 2H), 7.96 – 7.91 
(m, 2H), 7.63 – 7.55 (m, 2H), 7.52 – 7.45 (m, 2H), 7.43 – 7.37 (m, 1H), 6.85 (d, J = 2.6 
Hz, 1H);  
13C NMR (151 MHz, CDCl3) δ/ppm 153.9 (C), 140.7 (C), 132.5 (C), 130.5 (CH), 129.5 
(CH), 128.9 (CH), 128.6 (CH), 127.9 (CH), 126.0 (CH), 122.6 (CH), 122.1 (CH), 118.3 
(C), 113.7 (C), 106.3 (CH);  
IR (neat) ν = 3148 (w), 3064 (w), 2232 (m, CN), 1604 (s), 1587 (s), 1533 (m), 1506 (s), 
1455 (s), 1437 (m), 1398 (m), 1368 (s), 1388 (w), 1051 (m), 967 (m) cm−1;  
LC-MS (MeCN) Rt. 3.18 min, m/z = 246.4 [M+H]+. HR-MS (ESI-TOF) calculated for 




2-(3-Phenyl-1H-pyrazol-1-yl)benzonitrile: 325;  
 
Consistent with published data166 
Prepared using general procedure A but using 2 equiv. of NEt3 to aid solubility: Isolated 
yield; 0.064 g (38%, 0.69 mmol scale);  
Colourless oil; Rf: 0.22 (8/2, EtOAc/hexanes);  
1H NMR (700 MHz, CDCl3) δ/ppm 8.19 (d, J = 2.6 Hz, 1H), 7.96 – 7.91 (m, 2H), 7.88 
(dd, J = 8.3, 1.1 Hz, 1H), 7.79 (dd, J = 7.8, 1.5 Hz, 1H), 7.71 (ddd, J = 8.3, 7.5, 1.5 Hz, 
1H), 7.47 – 7.43 (m, 2H), 7.41 (td, J = 7.6, 1.1 Hz, 1H), 7.37 (ddt, J = 8.0, 6.8, 1.3 Hz, 
1H), 6.86 (d, J = 2.6 Hz, 1H);  
13C NMR (176 MHz, CDCl3) 154.2 (C), 142.0 (C), 134.8 (CH), 134.1 (CH), 132.6 (C), 
130.7 (CH), 128.9 (CH), 128.6 (CH), 127.0 (CH), 126.2 (CH), 123.8 (CH), 117.4 (C), 
106.2 (CH), 104.9 (C);  
IR (neat) ν = 3143 (w), 3065 (w), 2226 (w, CN), 1601 (m), 1580 (m), 1532 (m), 1505 (s), 
1455 (s), 1392 (w), 1364 (m), 1310 (w), 1259 (w), 1046 (m), 955 (m), 941 (m) cm−1;  
LC-MS (MeCN) Rt. 3.11 min, m/z = 246.4 [M+H]+. HR-MS (ESI-TOF) calculated for 
C16H12N3 246.1031, found 246.1036 (Δ = 2.0 ppm). 
(E/Z)-ethyl 2-(1-ethoxyethylidene)hydrazinecarboxylate, 328: 
 
Literature procedure.167  
Ethyl acetimidate hydrochloride (4.96 g, 10 mmol) was dissolved in absolute EtOH (200 
mL) and cooled using an ice bath. Ethyl hydrazine carboxylate (4.16 g, 10 mmol) was 
dissolved in absolute EtOH (80 mL) and added dropwise and reaction left to stir for 6 h 
at 0 °C. The solvent was evaporated under reduced pressure and the residue was purified 
using a flash chromatography (9:1, DCM/MeOH) to give the pure product as white 
crystals (5.27 g, 76% yield) as a mixture of two E/Z isomers (45:55). 
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Isolated yield: 5.27 g (76%, 10 mmol scale);  
White crystals; Rf: 0.72 (1/9, DCM/MeOH);  
Isomer 1: 1NMR (700 MHz, CDCl3) δ/ppm 8.06 (s, br, 1H), 4.08 (q, J = 7.0 Hz, 4H), 2.09 
(s, 3H), 1.33 (t, J = 7 Hz, 6H). 
Isomer 2: 1NMR (700 MHz, CDCl3) δ/ppm 6.79 (s, br, 1H), 4.14 (q, J = 7.0 Hz, 4H), 1.94 
(s, 3H), 1.27 (t, J = 7 Hz, 6H). 
IR (neat) ν = 3408 (w), 3274 (w, br), 2986 (w), 2938 (w), 1713 (s), 1657 (s), 1500 (br), 
1447 (m), 1379 (m), 1338 (w), 1243 (br), 1047 (s), 1017 (w) cm−1;  
LC-MS (MeCN), Rt. 2.63 min, m/z = 174.8 [M+H]+. HR-MS (+ESI-TOF) calculated for 
C7H14N2O3 175.1083, found 175.1078 (Δ = 4.6 ppm). 
M.p. 60-65 °C (MeOH) (Literature: 68 °C, Pet. Ether).168 
3,4-Dimethyl-1H-1,2,4-triazol-5(4H)-one, 329: 
 
Literature procedure.169  
Methylamine hydrochloride (2.70 g, 40 mmol) was dissolved in absolute EtOH (200 mL) 
to which a suspension of sodium ethoxide (2.72 g, 40 mmol) in absolute EtOH (70 mL) 
was added and reaction was stirred for 5 min at room temperature. A solution of (E)-ethyl 
2-(1-ethoxyethylidene)hydrazine carboxylate (328, 3.48 g, 20 mmol) in absolute EtOH 
(50 mL) was added dropwise and reaction refluxed for 4 h. The reaction was then cooled 
to room temperature and filtered over a celite pad. The eluant was dried under reduced 
pressure and the resultant residue was recrystallised (through a hot filtration) from EtOAc 
to give the pure product. 
Isolated yield: 0.904 g (40%, 20 mmol scale);  
White crystals (recrystallised from EtOAc); Rf: 0.31 (1/9, DCM/MeOH);  
1H NMR (600 MHz, DMSO-d6) δ/ppm 11.28 (s, br, 1H), 3.06 (s, 3H), 2.12 (s, 3H);  
13C NMR (151 MHz, DMSO-d6) δ/ppm 155.1 (C), 144.8 (C), 26.3 (CH3), 11.4 (CH3);  
IR (neat) ν = 3139 (w, br), 3057 (w, br), 3001 (w, br), 2815 (w, br), 1701 (s), 1663 (s), 
1590 (m), 1477 (m), 1474 (m), 1437 (m), 1400 (m), 1376 (m), 976 (m), 797 (m). 736 (s), 
609 (s) cm−1;  
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LC-MS (MeCN), Rt. 0.77 min, m/z = 114.4 [M+H]+. HR-MS (ESI-TOF) calculated for 
C4H7N3O 114.0667, found 114.0647 (Δ = 17.5 ppm or -2.0 mDa).  





General Procedures for Chapter 2.3: 
A) Microwave synthesis of thiazoles and 2-aminothiophenes: 
In a 2-5 mL microwave vial was placed the nitrile (0.22 mmol, 1 equiv.) and 
dissolved in trifluoroethanol (2 mL) which was stirred for 2 min at room 
temperature. Next, 1,4-dithian-2,5-diol (0.11 mmol, 0.5 equiv.) was added and the 
mixture stirred for 5 min before triethylamine (0.242 mmol, 1.1 equiv.) was added 
and the mixture further stirred for 2 min. The vial was then sealed and heated in a 
microwave reactor for 390 min at 60 °C. The solvent was evaporated under reduced 
pressure and the crude residue was then purified using flash chromatography on 
silica (EtOAc/hexanes). 
 
Spectroscopic and experimental data for Chapter 2.3: 
Ethyl-2-phenyl-2(thiazol-2-yl)acetate, 362: 
 
Prepared using general procedure A: Isolated yield; 45 mg (83%, 0.22 mmol scale);  
Pale yellow oil; Rf: 0.37 (1:4, EtOAc/hexane);  
1H NMR (700 MHz, CDCl3): δ/ppm 7.75 (d, J = 3.3 Hz, 1H), 7.45 (d, J = 7.4 Hz, 2H), 
7.39 – 7.35 (m, 2H), 7.34 – 7.30 (m, 1H), 7.29 (d, J = 3.3 Hz, 1H), 5.42 (s, 1H), 4.30 – 
4.19 (m, 2H), 1.26 (t, J = 7.1 Hz, 3H);  
13C NMR (176 MHz, CDCl3) δ/ppm 170.6 (C), 167.6 (C), 142.5 (CH), 136.7 (C), 129.1 
(CH), 128.6 (CH), 128.3 (CH), 120.1 (CH), 62.0 (CH2), 55.6 (CH), 14.2 (CH3);  
IR (neat) ν = 3064 (s), 3031 (s), 2980 (s), 2935 (s), 1730 (w), 1644 (s), 1600 (s), 1494 
(m), 1454 (m), 1421 (s), 1390 (s), 1367 (m), 1308 (m), 1231 (m), 1185 (w), 1153 (w), 
1130 (m), 1094 (m), 1056 (m), 1021 (w), 916 (s), 863 (m), 789 (m), 724 (w), 698 (w), 
644 (s), 610 (m) cm−1; 
LC-MS (MeCN), Rt. 2.79 min, m/z = 248.8 [M+H]+. HR-MS (ESI-TOF) calculated for 






Prepared using general procedure A: Isolated yield; 40 mg (60%, 0.22 mmol scale);  
Pale yellow oil; Rf: 0.1 (1/9, EtOAc/hexane);  
1H NMR (700 MHz, CDCl3) δ/ppm 7.79–7.75 (m, 1H), 7.46 (d, J = 8.3 Hz, 2H), 7.40–
7.32 (m, 3H), 7.32–7.29 (m, 1H), 5.46 (s, 1H), 3.79 (s, 3H);  
13C NMR (176 MHz, CDCl3) δ/ppm 170.9 (C), 167.5 (C), 142.2 (CH), 136.4 (C), 128.9 
(CH), 128.5 (CH), 128.3 (CH), 120.1 (CH), 55.2 (CH), 52.9 (CH3);  
IR (neat) ν = 3088 (w), 2952 (w), 1968 (w), 1732 (s), 1644 (w), 1599 (w), 1494 (w), 1448 
(w), 1434 (w), 1388 (w), 1368 (w), 1313 (w), 1241 (m), 1199 (m), 1156 (m), 1133 (m), 
1098 (w), 1058 (w), 1005 (m), 892 (w), 863 (w), 795 (w), 728 (s), 697 (s), 654 (w), 612 
(m) cm−1;  
LC-MS (MeCN), Rt. 2.63 min, m/z = 233.9 [M+H]+. HR-MS (ESI-TOF) calculated for 
C12H12NO2S 234.0589, found 234.0592 (Δ = 1.3 ppm). 
Isopropyl 2-cyano-2-phenylacetate, 367: 
 
Ethyl phenylcyanoacetate (362, 0.473 g, 2.5 mmol) was dissolved in iPrOH (10 mL) and 
was stirred for 1 min. Polymer bound sulfonic acid (QP-SA) (200 mg, 2.2 mmol/g 
loading) was added and reaction was stirred for 3 days at 70 °C. The QP-SA resin was 
filtered, and the solvent evaporated to give the product as a colourless oil which was used 
without further purification. 
Isolated yield: 0.322 g (64% 2.5 mmol),  
Colourless oil; Rf: 0.40 (1/4, EtOAc/hexane);   
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1H NMR (400 MHz, CDCl3) δ/ppm 7.51 – 7.40 (m, 5H), 5.07 (hept, J = 6.3 Hz, 1H), 4.70 
(s, 1H), 1.28 (dd, J = 7.6, 6.3 Hz, 6H);  
13C NMR (101 MHz, CDCl3) δ/ppm 164.6 (C), 130.3 (C), 129.4 (CH), 129.3 (CH), 128.0 
(CH), 116.0 (C), 71.6 (CH), 44.2 (CH), 21.6 (CH3), 21.5 (CH3);  
IR (neat) ν = 3069 (w), 3038 (w), 2986 (w), 2937 (w), 2253 (w), 1739 (s), 1601 (w), 1498 
(w), 1467 (w), 1456 (m), 1377(w), 1353 (w), 1256 (m), 1235 (m), 1199 (m), 1101 (s), 
1032 (w), 1016 (w), 1004 (w), 956 (w), 917 (w), 901 (w), 83 (w), 732 (m), 695 (s) cm-1; 
LC-MS (MeCN), Rt. 2.93 min, m/z = 204.0 [M+H]+. HR-MS (ESI-TOF) calculated for 
C12H14NO 204.1025, found 204.1032 (Δ = 3.4 ppm). 
Ethyl 2-cyano-2-(4-methoxyphenyl)-acetate, 370:  
 
Literature procedure:170 
A solution of 4-methoxyphenylacetonitrile (0.70 g, 4.76 mmol, 1.00 equiv.) was 
dissolved in dry THF (4.7 mL) and cooled to -78 °C. To the solution was added 
drowpwise n-butyllithium (6.0 mL, 9.52 mmol, 2.00 equiv.) and the colour of the solution 
immediately changed to yellow. After stirring for 20 min at -78 °C, a solution of ethyl 
chloroformate (369) (0.52 g, 4.76 mmol, 1.00 equiv.) in THF (1 mL) was added slowly 
to the stirred solution. The reaction mixture was stirred for 30 min and then allowed to 
warm to room temperature with stirring for over 1 h. The reaction was quenched with 
water (10 mL) and EtOAc (25 mL) was added. The layers were separated and the aqueous 
phase was extracted three times with EtOAc. The combined organic layer was washed 
with brine (2 x 25 mL), dried over sodium sulfate and the solvent was removed under 
reduced pressure. The crude material was further purified on a silica column 1:9 – 4:6 
EtOAc/hexane gradient to give the product.   
Isolated yield: 0.54 g (52%, 4.76 mmol scale); 
Colourless oil; Rf: 0.32 (1/4, EtOAc/hexane); 
1H NMR (400 MHz, DMSO-d6) δ/ppm 7.40 – 7.34 (m, 2H), 6.95 – 6.89 (m, 2H), 4.66 (s, 
1H), 4.23 (qd, J = 7.1, 2.1 Hz, 2H), 3.81 (s, 3H), 1.27 (t, J = 7.1 Hz, 3H);  
13C NMR (101 MHz, DMSO-d6) δ/ppm 165.4 (C), 160.3 (C), 129.2 (CH), 122.0 (C), 
116.0 (C), 114.8 (CH), 63.3 (CH2), 55.5 (CH), 43.1 (CH3), 14.0 (CH3);  
IR (neat) ν = 3744 (w), 2984 (w), 2940 (w), 2910 (w), 2839 (w), 2248 (w), 2001 (w), 
1741 (m), 1611 (m), 1586 (w), 1510 (s), 1464 (w), 1443 (w), 1423 (w), 1369 (w), 1304 
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(m), 1247 (s), 1199 (m), 1179 (m), 1112 (w), 1095 (w), 1027 (m), 942 (w), 833 (m), 811 
(m), 793 (w), 753 (w), 634 (w) cm−1;  
LC-MS (MeCN), Rt. 2.69 min, m/z = 218.2 [M-H]−. HR-MS (ESI-TOF) calculated for 
C12H14NO3 220.0974, found 220.0970 (Δ = 1.8 ppm). 
Ethyl 2-(benzo[d][1,3]dioxol-5-yl)-2-cyanoacetate, 373: 
 
Literature procedure:171 
Sodium hydride (0.799 g, 20.0 mmol) was slowly added to a solution of 3,4-
(methylenedioxy)phenylacetonitrile (1.61 g, 10.0 mmol) in THF (20 mL) at 0 °C. Diethyl 
carbonate (2.36 g, 20.0 mmol) was added dropwise at room temperature and the reaction 
was refluxed for 4 h. The reaction was quenched with 2 M HCl (20 mL) and most of the 
THF was removed using a rotatory evaporator. The residue was then extracted with 
EtOAc (3 × 20 mL), the organic layer was dried over sodium sulfate, filtered and solvent 
evaporated under reduced pressure to obtain an orange oil which was purified using 
column chromatography (4:1, hexanes/EtOAc).  
Isolated yield: 1.74 g (75%, 10.0 mmol scale);  
Colourless oil; Rf: 0.61 (1/1, EtOAc/hexane); 
1H NMR (400 MHz, CDCl3) δ/ppm 6.94 – 6.89 (m, 2H), 6.82 (dd, J = 7.7, 0.7 Hz, 1H), 
6.01 (s, 2H), 4.61 (s, 1H), 4.25 (qd, J = 7.1, 2.2 Hz, 2H), 1.29 (t, J = 7.1 Hz, 3H);  
13C NMR (101 MHz, CDCl3) δ/ppm 165.2 (C), 148.6 (C), 148.6 (C), 123.5 (C), 121.9 
(CH), 115.8 (C), 108.9 (CH), 108.4 (CH), 101.8 (CH2), 63.5 (CH2), 43.5 (CH), 14.1 
(CH3);  
IR (neat) ν = 2986 (w), 2941 (w), 2906 (w), 1744 (s), 1504 (s), 1491 (s), 1447 (m), 1369 
(w), 1251 (s), 1105 (w), 1038 (s), 934 (w) cm-1;  
LC-MS (MeCN), Rt. 2.67 min, m/z = 233.9 [M+H]+. HR-MS (ESI-TOF) calculated for 




Methyl 2-cyano-2-(4-nitrophenyl)-acetate, 377: 
 
Consistent with published data172 
Potassium hydroxide (0.40 g, 7.09 mmol, 1.00 equiv.) was stirred in DMSO (5 mL) to 
form a homogeneous solution in a sealed microwave vial. After 10 min of stirring in a 
water bath at 85 °C, methyl 2-cyanoacetate 375 (1.51 mL, 7.09 mmol, 1.00 equiv.) was 
added by means of a syringe and the solution stirred for a further 30 min. A solution of 
1-fluoro-4-nitrobenzene 374 (2.00 g, 7.09 mmol, 1.00 equiv.) in DMSO (2 mL) was 
added dropwise at 85 °C. After 4 h the reaction mixture was poured in a beaker filled 
with ice and HCl (1 M, 5 mL). The vial was washed with EtOAc (20 mL) and the resulting 
solution was allowed to stir for 2 h. The two layers were separated and the aqueous layer 
was extracted with EtOAc (3 × 25 mL). The combined organic layers were washed with 
brine (2 x 25 mL), dried over sodium sulfate and the solvent was removed under reduced 
pressure. The crude material was purified via a silica column with pure hexanes to elute 
374. Methyl 2-cyanoacetate was removed on a high vacuum.  
Isolated yield: 0.834 g (53% 7.09 mmol scale);  
Red solid; Rf: 0.05 (2/8, EtOAc/hexane);  
1H NMR (700 MHz, CDCl3) δ/ppm 8.28 (d, J = 8.8 Hz, 2H), 7.67 (d, J = 8.7 Hz, 2H), 
4.87 (s, 1H), 3.83 (s, 3H);  
13C NMR (176 MHz, CDCl3) δ/ppm 164.2 (C), 148.5 (C), 136.3 (C), 129.2 (CH), 124.5 
(CH), 114.4 (C), 54.4 (CH), 43.1 (CH3);  
IR (neat) ν = 3133 (w), 3086 (w), 2973 (w), 2937 (w), 1740 (s), 1735 (s), 1610 (w), 1597 
(w), 1523 (s), 1437 (m), 1348 (s), 1313 (m), 1289 (s), 1234 (s), 1165 (m), 1107 (m), 857 
(m), 779 (m), 736 (s) cm−1;  
LC-MS (MeCN), Rt. 2.44 min, m/z = 218.92 [M-H]−. HR-MS (ESI-TOF) calculated for 
C10H7N2O4 219.0406, found 219.0409 (Δ = 1.4 ppm);  




Ethyl 2-cyano-2-(4-nitrophenyl)-acetate, 378: 
  
Consistent with published data173 
Potassium hydroxide (0.80 g, 14.18 mmol, 1.00 equiv.) was stirred in DMSO (10 mL) to 
prepare a homogeneous solution in a sealed microwave vial. After 10 min of stirring in a 
water bath at 85 °C ethyl 2-cyanoacetate 376 (1.51 mL, 14.18 mmol, 1.00 equiv.) was 
added by means of a syringe and the solution was stirred for further 30 min. Then a 
solution of 1-fluoro-4-nitrobenzene 374 (2.00 g, 14.18 mmol, 1.00 equiv.) in DMSO (4 
mL) was added dropwise at 85 °C. After 4 h the mixture was transferred in a beaker 
containing ice and HCl (1 M, 10 mL). The vial was washed with EtOAc (40 mL) and the 
resulting solution was allowed to stir for 2 h. The two layers were separated and the 
aqueous layer was extracted with EtOAc (3 x 25 mL). The combined organic layers were 
washed with brine (2 x 25 mL), dried over sodium sulfate and the solvent was removed 
under reduced pressure. The compound was purified by silica column chromatography 
with pure hexane to elute 374. Ethyl 2-cyanoacetate was removed on a high vacuum.  
Isolated yield: 1.89 g (57% 14.18 mmol scale);  
Red oil; Rf: 0.17 (1/1, EtOAc/hexane);  
1H NMR (700 MHz, CDCl3) δ/ppm 8.28 – 8.32 (m, 2H), 7.66 – 7.70 (m, 2H), 4.84 (s, 
1H), 4.29 (qd, J = 7.1, 1.4 Hz, 2H), 1.31 (t, J = 7.1 Hz, 3H);  
13C NMR (176 MHz, CDCl3) δ/ppm 163.8 (C), 148.6 (C), 136.6 (C), 129.3 (CH), 124.6 
(CH), 114.6 (C), 64.2 (CH2), 43.5 (CH), 14.0 (CH3);  
IR (neat) ν = 3733 (w), 3588 (w), 2988 (w), 2205 (w), 2059 (w), 2032 (w), 2016 (w), 
1999 (w), 1967 (w), 1742 (s), 1608 (w), 1522 (s), 1494 (w), 1468 (w), 1446 (w), 1346 
(s), 1318 (m), 1297 (m), 1241 (m), 1199 (m), 1157 (m), 1109 (m), 1016 (m), 855 (m), 
828 (m), 770 (w), 734 (m), 692 (m) cm−1;  
LC-MS (MeCN), Rt. 2.69 min, m/z = 233.2 [M-H]−. HR-MS (ESI-TOF) calculated for 




Ethyl 2-cyano-2-(4-nitrophenyl)acetate, 380: 
 
Literature procedure:174  
Malonitrile 379 (1.06 g, 16.00 mmol, 2.00 equiv.) and iodobenzne 1a (1.63 g, 8.00 mmol, 
1.00 equiv.) were stirred in DMSO (20 mL) with copper iodide (0.152 g, 0.8 mmol, 0.1 
equiv.) and potassium carbonate (4.40 g, 32.00 mmol, 4 equiv.). The reaction mixture 
was heated to 120 °C. After 20 h the reaction mixture was poured in a beaker with HCl 
(1 M, 15 mL). The resulting mixture was filtered through silica and extracted with EtOAc 
(50 mL). The two layers were separated and the organic layer was washed with brine (5 
x 250 mL). The combined organic layers were dried over sodium sulfate and the solvent 
was removed under reduced pressure. The crude product was purified by silica column 
chromatography with EtOAc/hexane (1:9) to give the pure product.  
Isolated yield: 0.455 g (40% 8.00 mmol scale);  
White solid; Rf: 0.26 (2/8, EtOAc/hexane);  
1H NMR (600 MHz, CDCl3) δ/ppm 7.54–7.47 (m, 5H), 5.08 (s, 1H);  
13C NMR (151 MHz, CDCl3) δ/ppm 130.4 (CH), 130.0 (CH), 127.2 (CH), 126.2 (C), 
111.7 (C), 28.1 (CH);  
IR (neat) ν = 3656 (w), 2982 (br), 2889 (br), 2257 (w), 1495 (s), 1455 (m), 1134 (br), 
1014 (w), 1004 (w), 752 (m), 734 (s), 694 (s) cm−1;  
LC-MS (MeOH), Rt. 2.57 min, m/z = 140.1 [M-H]−. HR-MS (ESI-TOF) calculated for 
C9H5N2 141.0453, found 141.0458 (Δ = 3.5 ppm);  
Melting point: 67-68 °C (EtOH). 
(E)-Methyl-2-cyano-3-phenylacrylate, 382: 
 
Consistent with published data175 
161 
 
Benzaldehyde 281 (1.59 g, 15 mmol, 1.0 equiv.) and methyl-2-cyanoacetate 375 (1.59 g, 
16 mmol 1.10 equiv.) were dissolved in MeCN (50 mL) and polymer bound dimethyl 
benzylamine (QP-DMA, 10 g, 2.2 mmol/g loading) was added. The mixture was stirred 
under N2 at 80 °C for 18 h. The solvent was removed under reduced pressure and the 
crude solid was recrystallised from EtOH to give the product.  
Isolated yield: 1.64 g (58%, 15 mmol);  
White crystals (recrystallised from EtOH); Rf: 0.33 (2/8, EtOAc/hexane);  
1H NMR (700 MHz, CDCl3) δ/ppm 8.27 (s, 1H), 8.01–7.98 (m, 2H), 7.59–7.55 (m, 1H), 
7.53–7.49 (m, 2H), 3.94 (s, 3H);  
13C NMR (176 MHz, CDCl3) δ/ppm 163.3 (C), 155.6 (CH), 133.7 (CH), 131.7 (C), 131.4 
(CH), 129.5 (CH), 115.7 (C), 102.8 (C), 53.7 (CH3);  
IR (neat) ν = 2358 (s), 2341 (s), 1654 (w), 668 (s) cm−1;  
LC-MS (MeCN), Rt. 2.84 min, m/z = 188.1 [M+H]+. HR-MS (ESI-TOF) calculated for 
C11H10NO2 188.0712, found 188.0716 (Δ = 2.1 ppm);  
Melting point: 89-90 °C (EtOH). Lit.: 89 °C (EtOH).176 
Methyl-2-cyano-3-phenylpropanoate, 384: 
 
Consistent with published data177 
(E)-methyl-2-cyano-3-phenylacrylate 382 (1.40 g, 7.48 mmol, 1.0 equiv.) and zinc 
powder (7.83 g, 119.7 mmol, 16.0 equiv.) were dissolved in glacial acetic acid (50 mL) 
and the solution was stirred for 2.5 h at 100 °C. The reaction mixture was filtered through 
a celite pad and washed with EtOAc (100 mL). The filtrate was neutralised with aqueous 
NaHCO3 solution and the organic layer was separated, washed with brine (2 × 25 mL), 
dried over sodium sulfate and the solvent removed under reduced pressure. The crude 
product was purified via silica column chromatography with a solvent mixture of 1:9 
(EtOAc/hexane) with the desired nitrile isolated as a colourless oil.177 
Isolated yield: 0.583 g (41%, 7.48 mmol);  
Colourless oil; Rf: 0.44 (1/9, EtOAc/hexane);  
1H NMR (700 MHz, CDCl3) δ/ppm 7.36 – 7.32 (m, 2H), 7.31–7.28 (m, 1H), 7.26 (dd, J 
= 7.0, 1.6 Hz, 2H), 3.78 (s, 3H), 3.73 (ddd, J = 8.5, 5.7, 0.9 Hz, 1H), 3.27 (dd, J = 13.9, 
5.7 Hz, 1H), 3.19 (dd, J = 13.9, 8.5 Hz, 1H);  
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13C NMR (176 MHz, CDCl3) δ/ppm 166.1 (C), 135.3 (C), 129.1 (CH), 128.9 (CH), 127.9 
(CH), 116.1 (C), 53.6 (CH3), 39.6 (CH), 35.8 (CH2);  
IR (neat) ν = 3032 (w), 2956 (w), 2360 (w), 2250 (w), 1743 (s), 1604 (w), 1585 (w), 1497 
(m), 1455 (s), 1435 (s), 1340 (m), 1310 (m), 1263 (s), 1210 (s), 1190 (s), 1166 (s), 1081 
(m), 1028 (s), 964 (w), 910 (w), 860 (w), 819 (w), 799 (w), 747 (s), 699 (s), 641 (m) 
cm−1;  
LC-MS (MeCN), Rt. 2.60 min, m/z = 189.9 [M+H]+. HR-MS (ESI-TOF) calculated for 
C11H12NO2 190.0868, found 190.0877 (Δ = 4.7 ppm). 
(E)-Ethyl-2-cyano-3-phenylacrylate, 383: 
 
Consistent with published data178 
Freshly distilled benzaldehyde 281 (1.59 g, 15 mmol, 1.0 equiv.) and ethyl 2-
cyanoacetate 376 (1.81 g, 16 mmol 1.1 equiv.) were dissolved in MeCN (50 mL) and QP-
DMA (10 g, 2.2 mmol/g loading) was added. The mixture was stirred under N2 at 80 °C 
for 18 h; the QP-DMA was filtered off and the solvent removed under reduced pressure 
to give the crude solid which was recrystallised from EtOH. 
Isolated yield: 1.166 g (39%, 15 mmol scale);  
White crystals (recrystallised from EtOH); Rf: 0.35 (1/9, EtOAc/hexane);  
1H NMR (700 MHz, CDCl3) δ/ppm 8.25 (s, 1H), 7.99 (dd, J = 7.4, 1.7 Hz, 2H), 7.54 – 
7.58 (m, 1H), 7.48 – 7.53 (m, 2H), 4.39 (q, J = 7.2 Hz, 2H), 1.40 (t, J = 7.2 Hz, 3H);  
13C NMR (176 MHz, CDCl3) δ/ppm 162.6 (C), 155.2 (CH), 133.4 (CH), 131.6 (C), 131.2 
(CH), 129.4 (CH), 115.6 (C), 103.2 (C), 62.9 (CH2), 14.3 (CH3);  
IR (neat) ν = 3924 (w), 3869 (w), 3734 (w), 2568 (w), 2366 (s), 2203 (w), 2165 (w), 2033 
(w), 1993 (w), 1963 (w) cm−1;  
LC-MS (MeCN), Rt. 2.88 min, m/z = 202.1 [M+H]+. HR-MS (ESI-TOF) calculated for 
C12H12NO2 202.0868, found 202.0865 (Δ = 1.5 ppm);  




Ethyl 2-cyano-3-phenylpropanoate, 385: 
 
Consistent with published data179 
(E)-Ethyl-2-cyano-3-phenylacrylate 382 (0.80 g, 3.98 mmol) and zinc powder (3.98 g, 
60.8 mmol, 16.0 equiv.) were dissolved in glacial acetic acid (25 mL) and the solution 
was stirred for 2.5 h at 100 °C. The reaction mixture was filtered through a celite pad and 
washed with EtOAc (50 mL). The filtrate was neutralised with aqueous NaHCO3 solution 
and the organic layer was separated, washed with brine (2 × 25 mL), dried over sodium 
sulfate and the solvent removed under reduced pressure to obtain the an oil which was 
purified via short silica column with a solvent mixture of 1:9 (EtOAc/hexane).  
Isolated yield: 0.53 g (56%, 3.98 mmol scale);  
Pale yellow oil;  
1H NMR (700 MHz, CDCl3) δ/ppm 7.32 – 7.37 (m, 2H), 7.30–7.32 (m, 1H), 7.26 – 7.29 
(m, 2H), 4.24 (qd, J = 7.1, 1.8 Hz, 2H), 3.72 (ddd, J = 8.4, 5.8, 1.1 Hz, 1H), 3.28 (dd, J 
= 13.9, 5.8 Hz, 1H), 3.20 (dd, J = 13.9, 8.5 Hz, 1H), 1.27 (t, J = 7.2 Hz, 3H);  
13C NMR (176 MHz, CDCl3) δ/ppm 165.6 (C), 135.4 (C), 129.1 (CH), 128.9 (CH), 127.9 
(CH), 116.3 (C), 63.1 (CH2), 39.8 (CH), 35.9 (CH2), 14.1 (CH3);  
IR (neat) ν = 3837 (w), 3815 (w), 3768 (w), 2746 (w), 3677 (w), 3648 (w), 2982 (w), 
2936 (w), 2248 (w), 1995 (w), 1974 (w), 1739 (s), 1604 (w), 1496 (w), 1454 (w), 1392 
(w), 1369 (w), 1256 (m), 1196 (m), 1163 (m), 1095 (w), 1080 (w), 1028 (m), 856 (w), 
746 (m), 698 (s) cm−1;  
LC-MS (MeCN), Rt. 2.78 min, m/z = 204.1 [M+H]+. HR-MS (ESI-TOF) calculated for 
C12H14NO2 204.1025, found 204.1019 (Δ = 2.9 ppm). 
(E)-2-Cyano-3-phenylacrylamide, 389: 
 
Consistent with published data180 
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Benzaldehyde 386 (1.06 g, 10.0 mmol) and cyanoacetamide (0.84 g, 10.0 mmol) were 
dissolved in EtOH (28 mL) to which 3 drops of piperidine were added and the solution 
was stirred for 24 h at room temperature. The solvent was then evaporated under reduced 
pressure to give a yellow solid which was recrystallised from EtOH.  
Isolated yield: 1.54 g (89%, 10.0 mmol scale),  
White amorphous solid (recrystallised from EtOH); Rf: 0.53 (1/4, EtOAc/hexane); 
1H NMR (400 MHz, DMSO-d6) δ/ppm 8.19 (s, 1H), 8.02 – 7.86 (m, 3H), 7.79 (s, 1H), 
7.62 – 7.52 (m, 3H);  
13C NMR (101 MHz, CDCl3) δ/ppm 163.1 (C), 151.0 (CH), 132.8 (CH), 132.4 (C), 130.5 
(CH), 129.7 (CH), 116.9 (C), 107.2 (C);  
IR (neat) ν = 3395 (w, br), 3315 (w), 3151 (w, br), 2218 (w), 1685 (s), 1595 (m), 1573 
(m), 1496 (w), 1494 (w), 1369 (m), 1355 (m), 1314 (w), 1290 (w), 1184 (m), 1104 (w), 
765 (m), 741 (m), 683 (s), 677 (s), 595 (s), 582 (s) cm-1;  
LC-MS (MeOH), Rt. 2.15 min, m/z = 173.0 [M+H]+. HR-MS (ESI-TOF) calculated for 
C10H9N2O 173.0715, found 173.0717 (Δ = 1.2 ppm);  
Melting point: 120-121 °C (EtOH). (Literature: 123-124 °C, EtOH).180 
2-Cyano-3-phenylpropanamide, 391: 
 
Consistent with published data181 
(E)-2-Cyano-3-phenylacrylamide 389 (0.50 g, 2.9 mmol) and zinc powder (3.03 g, 46.4 
mmol, 16.0 equiv.) were suspended in glacial acetic acid (12.5 mL) and the suspension 
was stirred for 2.5 h at 100 °C. The reaction mixture was filtered through a celite pad and 
washed with EtOAc (50 mL). The filtrate was neutralised with aqueous solution of 
NaHCO3 and the organic layer was separated, washed with brine (2 × 25 mL), dried over 
sodium sulfate and the solvent removed under reduced pressure to obtain a white powder 
which was recrystallised from EtOH to give the product as a white solid.  
Isolated yield: 0.432 g (86%, 2.9 mmol scale);  
White amorphous solid (recrystallised from EtOH); Rf: 0.53 (1/4, EtOAc/hexane); 
1H NMR (400 MHz, DMSO-d6) δ/ppm 7.79 (s, 1H), 7.50 (s, 1H), 7.40 – 7.20 (m, 5H), 




13C NMR (101 MHz, DMSO-d6) δ/ppm 166.7 (C), 137.3 (C), 129.4 (CH), 128.9 (CH), 
127.5 (CH), 118.9 (C), 40.0 (CH), 35.7 (CH2);  
IR (neat) ν = 3379 (w, br), 3314 (w), 3239 (w), 3196 (w, br), 3055 (w), 3032 (w), 2946 
(w), 2920 (w), 2257 (w), 1663 (s), 1653 (s), 1622 (m), 1497 (m), 1457 (m), 1415 (m), 
1349 (w), 1332 (w), 1283 (m), 1179 (m), 1133 (m), 1081 (w), 775 (m), 711 (s), 630 (s), 
617 (s), 593 (s) cm-1;   
LC-MS (MeCN), Rt. 2.10 min, m/z = 175.2 [M+H]+. HR-MS (ESI-TOF) calculated for 
C10H11N2O 175.0871, found 175.0874 (Δ = 1.7 ppm);  




To a solution of 4-bromo benzaldehyde 387 (1.85 g, 10 mmol,) and cyanoacetamide 388 
(0.81 g, 10 mmol) in MeCN (100 mL), QP-DMA (10 g. 0.22 mmol/g loading) was added. 
The mixture was stirred under N2 at 70 °C for 12 h.  The QP-DMA was filtered off and 
the solvent was removed under reduced pressure to give a yellow solid which was 
recrystallised from iPrOH. 
Isolated yield: 3.75 g, (60%, 10.0 mmol scale);  
Yellow amorphous solid (recrystallised form iPrOH); Rf: 0.51 (1/4, EtOAc/hexane); 
1H NMR (400 MHz, CDCl3) δ/ppm 8.28 (s, 1H), 7.85 – 7.77 (m, 2H), 7.68 – 7.61 (m, 
2H), 6.33 (s, 1H), 5.78 (s, 1H);  
13C NMR (101 MHz, CDCl3) δ/ppm 161.5 (C), 152.8 (CH), 132.9 (CH), 132.1 (CH), 
130.5 (C), 128.2 (C), 116.9 (C), 103.7 (C);  
IR (neat) ν = 3437 (m), 3302 (w), 3142 (m), 3056 (w), 2216 (w), 1696 (s), 1580 (s), 1601 
(s), 1559 (m), 1489 (s), 1374 (s), 1309 (s), 1281 (m), 1206 (m), 1186 (m), 1125 (w), 1115 
(m), 1006 (m), 828 (s), 809 (s), 777 (m), 697 (m), 577 (s) cm-1;  
LC-MS (MeCN), Rt. 2.58 min, m/z = 251.0[M+H]+. HR-MS (ESI-TOF) calculated for 
C10H8BrN2O 250.9820, found 250.9826 (Δ = 2.4 ppm);  






A mixture of (E)-3-(4-bromophenyl)-2-cyanoacrylamide 390 (0.377 g, 1.50 mmol) and 
zinc powder (1.56 g, 24.0 mmol, 16.0 equiv.) were suspended in glacial acetic acid (8 
mL) and the solution was stirred for 2.5 h at 100 °C. The reaction mixture was filtered 
through a celite pad and washed with EtOAc (30 mL). The filtrate was neutralised with 
a saturated aqueous solution of NaHCO3 and the organic layer was separated, washed 
with brine (2 × 15 mL), dried over sodium sulfate and the solvent removed under reduced 
pressure to obtain the crude product as an off white solid which was recrystallised from 
iPrOH.  
Isolated yield: 0.314 g (83%, 1.5 mmol scale);  
White amorphous solid (recrystallised from iPrOH); Rf: 0.41 (1/4, EtOAc/hexane); 
1H NMR (400 MHz, CDCl3) δ/ppm 7.79 (s, 1H), 7.60 – 7.47 (m, 3H), 7.30 – 7.23 (m, 
2H), 3.95 (dd, J = 8.7, 6.7 Hz, 1H), 3.13 (dd, J = 13.7, 6.7 Hz, 1H), 3.05 (dd, J = 13.7, 
8.7 Hz, 1H);  
13C NMR (101 MHz, CDCl3) δ/ppm 166.5 (C), 136.8 (C), 131.8 (CH), 131.7 (CH), 120.8 
(C), 118.7 (C), 39.7 (CH), 34.9 (CH2);  
IR (neat) ν = 3391 (w), 3307 (w), 3192 (w), 2257 (w), 1685 (s), 1619 (w), 1493 (m), 1442 
(w), 1401 (m), 1242 (w), 1197 (w), 1179 (w), 1074 (m), 1013 (m), 946 (w), 917 (w), 785 
(s), 717 (w), 616 (s), 604 (s) cm-1;  
LC-MS (MeCN), Rt. 2.72 min, m/z = 252.9 [M+H]+. HR-MS (ESI-TOF) calculated for 
C10H10BrN2O 252.9976, found 252.9987 (Δ = 4.4 ppm);  
Melting point: 176 °C (decomposed, iPrOH). 





Sodium hydride (58 mg, 1.46 mmol, 0.33 equiv., 60% in paraffin) was suspended in dry 
THF (1.46 mL) and stirred under N2 at 0 °C. A solution of ethyl-2-cyano-acetate (500 
mg, 4.42 mmol, 1.0 equiv.) in THF (0.74 mL) was added using a syringe. After 15 min 
stirring at 0 °C, iodomethane (90.8 μL, 207 mg, 1.46 mmol, 0.33 equiv.) was added and 
the reaction stirred for 3 h. The reaction mixture was quenched with water (10 mL), 
diethyl ether (10 mL) was added and the separated organic layer was washed with brine 
(3 × 25 mL). The organic layer was dried over sodium sulfate and the solvent was 
removed under reduced pressure. The product was purified using silica column 
chromatography with a solvent mixture of 0.5/9.5 (EtOAc/hexane) and the desired nitrile 
was recovered as a colourless liquid.  
Isolated yield: 51 mg (83%, 1.46 mmol);  
Colorless oil; Rf: 0.55 (1/1, EtOAc/hexane).  
1H NMR (700 MHz, CDCl3) δ/ppm 4.25 (q, J = 7.2 Hz, 2H), 3.52 (q, J = 7.4 Hz, 1H), 
1.60 – 1.59 (d, J = 7.4 Hz, 3H), 1.31 (t, J = 7.2 Hz, 3H);  
13C NMR (176 MHz, CDCl3) δ/ppm 166.6 (C), 117.5 (C), 62.9 (CH2), 31.6 (CH), 15.4 
(CH3), 14.1 (CH3);  
IR (neat) ν = 3116 (w), 2983 (w), 2937 (w), 1732 (s), 1499 (w), 1446 (w), 1370 (w), 1254 
(m), 1173 (m), 1096 (m), 1047 (m), 1017 (m), 939 (w), 859 (w), 730 (m), 624 (w) cm−1; 
LC-MS (MeCN), Rt. 1.99 min, m/z = 227.8 [M+H]+. HR-MS (ESI-TOF) calculated for 
C6H10NO2 128.0713, found 128.0713 (Δ = 0.8 ppm). 
Ethyl 2-cyanobutanoate, 397: 
 
A solution of cyanoethyl acetate (2.172 g, 19.2 mmol) in dry THF (3 mL) was slowly 
added to a suspension of sodium hydride (0.256 g, 6.4 mmol, 60% in paraffin) and THF 
(5 mL) under N2 at 0 °C. After 15 min, a solution of iodoethane (0.998 g, 6.4 mmol) in 
THF (3 mL) was added dropwise and after stirring the suspension for 15 min at 0 °C, the 
reaction mixture was allowed to warm to room temperature and stirred for 8 h. The 
reaction was quenched with HCl solution (1 M, 10 mL) and extracted with EtOAc (2 × 
25 mL). The organic layer was dried over sodium sulfate and the solvent evaporated 
under reduced pressure to give the crude as an orange oil. The crude material was purified 
via silica column chromatography (1:4, EtOAc/hexanes) to give the desired product.  
Isolated yield: 0.740 g (82%, 6.4 mmol);  
Colourless oil; Rf: 0.29 (1/1, EtOAc/hexane).  
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1H NMR (400 MHz, CDCl3) δ/ppm 4.27 (q, J = 7.1 Hz, 2H), 3.46 (dd, J = 7.4, 6.1 Hz, 
1H), 2.07–1.92 (m, 2H), 1.33 (t, J = 7.1 Hz, 3H), 1.13 (t, J = 7.4 Hz, 3H);  
13C NMR (101 MHz, CDCl3) δ/ppm 166.2 (C), 116.6 (C), 62.9 (CH2), 39.2 (CH), 23.8 
(CH2), 14.2 (CH3), 11.4 (CH3);  
IR (neat) ν = 2981 (w), 2941 (w), 2884 (w), 2249 (w), 1741 (s), 1462 (w), 1389 (w), 1370 
(w), 1247 (m), 1189 (m), 1110 (w), 1021 (m), 955 (w), 854 (w), 811 (w) cm-1;  
ASAP-MS (MeCN), Rt. 0.41 min, m/z = 142.1 [M+H]+. HR-MS (ASAP) calculated for 
C7H12NO2 141.0862, found 141.0868 (Δ = 4.2 ppm). 
Ethyl 2-cyano-2-phenylpropanoate, 398: 
 
Consistent with published data182 
Ethyl-2-cyano-2-phenylacetate 362 (300 mg, 1.60 mmol, 1.00 equiv.) was dissolved in 
dry DMF (1.55 mL) and cooled to 0 °C under a N2 atmosphere. Sodium hydride (70 mg, 
1.76 mmol, 1.1 equiv., 60% in paraffin) was added and mixture stirred for 15 min at 0 
°C. After the dropwise addition of iodomethane (227 mg, 1.60 mmol, 1.00 equiv.) the 
mixture was allowed to warm to room temperature. After 1.5 h, EtOAc amount was added 
to the solution and the organic layer was washed with brine (3 × 25 mL), dried over 
sodium sulfate and the solvent was removed under reduced pressure. The crude material 
was purified using silica column chromatography with a solvent gradient 5:95-20:80  
(EtOAc /hexane) to obtain the product as a colourless oil (57% yield).  
Isolated yield: 0.186 g (57%, 1.6 mmol);  
Colorless oil; Rf: 0.25 (1/9, EtOAc/hexane);  
1H NMR (700 MHz, CDCl3) δ/ppm 7.56 – 7.51 (m, 2H), 7.41 (tt, J = 6.7, 0.9 Hz, 2H), 
7.39 – 7.35 (m, 1H), 4.29 – 4.19 (m, 2H), 1.95 (s, 3H), 1.25 (t, J = 7.1, 3H);  
13C NMR (176 MHz, CDCl3) δ/ppm 167.9 (C), 135.8 (C), 129.1 (CH), 128.8 (CH), 125.7 
(CH), 119.5 (C), 63.2 (CH2), 48.3 (C), 24.9 (CH3), 13.8 (CH3);  
IR (neat) ν = 2986 (w), 2942 (w), 2364 (w), 2246 (w), 1962 (w), 1741 (s), 1600 (w), 1991 
(w), 1494 (m), 1447 (s), 1380 (m), 1367 (w), 1297 (w), 1235 (s), 1150 (m), 1100 (s), 
1077 (m), 1013 (s), 934 (w), 914 (w), 894 (w), 855 (m), 810 (w), 767 (s), 729 (s), 696 
(s), 646 (m), 618 (w), 610 (w) cm−1;  
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LC-MS (MeCN), Rt. 3.05 min, m/z = 203.9 [M+H]+. HR-MS (ESI-TOF) calculated for 
C12H14NO2S 204.1025, found 204.1027 (Δ = 1.0 ppm). 
Ethyl 2-cyano-3-methylbutanoate, 399: 
 
Consistent with published data183 
A solution of ethyl 2-cyanocetate (1.996 g, 17.64 mmol) in dry THF (3 mL) was slowly 
added to a suspension of sodium hydride (0.235 g, 5.88 mmol, 60% in paraffin) and THF 
(5 mL) under a N2 at 0 °C. After 15 min, a solution of 2-iodopropane (1.00 g, 5.88 mmol) 
in THF (3 mL) was added dropwise and after stirring the suspension for 15 min at 0 °C, 
the reaction mixture was allowed to warm to room temperature and stirred for 8 h. The 
reaction was quenched with HCl (1 M, 10 mL) and extracted using EtOAc (2 × 25 mL). 
The organic layer was dried over sodium sulfate and the solvent was evaporated under 
reduced pressure to give the crude as an orange oil. The crude product was purified via 
silica column chromatography (1:4, EtOAc/hexanes) to give the desired product as a 
colourless oil.  
Isolated yield: 0.557 g (61%, 5.88 mmol scale);  
Colourless oil; Rf: 0.27 (1/9, EtOAc/hexane); 
1H NMR (400 MHz, CDCl3) δ/ppm 4.27 (qd, J = 7.1, 0.8 Hz, 2H), 3.39 (d, J = 5.3 Hz, 
1H), 2.42 (pd, J = 6.8, 5.3 Hz, 1H), 1.32 (t, J = 7.1 Hz, 3H), 1.14 (dd, J = 12.3, 6.8 Hz, 
6H);  
13C NMR (101 MHz, CDCl3) δ/ppm 166.1 (C), 115.6 (C), 62.8 (CH2), 45.5 (CH), 30.1 
(CH), 20.8 (CH3), 19.0 (CH3), 14.2 (CH3);  
IR (neat) ν = 2972 (m), 2936 (w), 2878 (w), 1743 (s), 1467 (w), 1394 (w), 1370 (w), 1304 
(w), 1253 (m), 1192 (m), 1133 (w), 1030 (m), 856 (w) cm-1;  
LC-MS (MeCN), Rt. 2.55 min, m/z = 156.1 [M+H]+. HR-MS (ESI-TOF) calculated for 




Isopropyl 2-phenyl-2-(thiazol-2-yl)acetate, 400: 
 
Prepared using general procedure A: Isolated yield; 28 mg (49%, 0.22 mmol scale);  
Colourless oil; Rf: 0.23 (1/4, EtOAc/hexane);   
1H NMR (400 MHz, CDCl3) δ/ppm 7.75 (d, J = 3.3 Hz, 1H), 7.47 – 7.30 (m, 5H), 7.29 
(d, J = 3.3 Hz, 1H), 5.38 (s, 1H), 5.11 (hept, J = 6.3 Hz, 1H), 1.27 (d, J = 6.3 Hz, 3H), 
1.19 (d, J = 6.2 Hz, 3H);  
13C NMR (101 MHz, CDCl3) δ/ppm 170.0 (C), 167.6 (C), 142.4 (CH), 136.8 (C), 128.9 
(CH), 128.4 (CH), 128.1 (CH), 120.0 (CH), 69.6 (CH), 55.7 (CH), 21.7 (CH3), 21.5 
(CH3);  
IR (neat) ν = 3111 (w), 3088 (w), 3063 (w), 2982 (w), 2936 (w), 1727 (s), 1646 (w), 1599 
(w), 1495 (w), 1449 (w), 1387 (w), 1243 (m), 1168 (m), 1100 (s), 1068 (m), 1003 (w), 
863 (w), 729 (m), 714 (m), 697 (s);  
LC-MS (MeCN), Rt. 3.07 min, m/z = 262.1 [M+H]+. HR-MS (ESI-TOF) calculated for 
C14H16NO2S 262.0902, found 262.0900 (Δ = 0.8 ppm). 
Ethyl 2-(4-methoxyphenyl)-2-(thiazol-2-yl)acetate, 401: 
 
Prepared using general procedure A: Isolated yield; 69 mg (57%, 0.44 mmol scale);  
Brown oil; Rf: 0.17 (2/4, EtOAc/hexane);  
1H NMR (700 MHz, CDCl3) δ/ppm 7.76 (d, J = 3.3 Hz, 1H), 7.37 – 7.40 (m, 2H), 7.30 (d, 
J = 3.3 Hz, 1H), 6.87 – 6.91 (m, 2H), 5.39 (s, 1H), 4.19 – 4.29 (m, 2H), 3.80 (s, 3H), 1.26 
(t, J = 7.1 Hz, 3H);  
13C NMR (176 MHz, CDCl3) δ/ppm 170.8, 168.5, 159.6, 142.1, 129.8, 128.7, 120.2, 
114.5, 62.1, 55.4, 54.6, 14.2;  
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IR (neat) ν = 3849 (w), 3735 (w), 3648 (w), 2982 (w), 2934 (w), 2900 (w), 2836 (w), 
2168 (w), 2154 (w), 2130 (w), 2047 (w), 2040 (w), 2024 (w), 1730 (s), 1608 (m), 1509 
(s), 1462 (m), 1442 (m), 1421 (w), 1391 (w), 1367 (w), 1302 (m), 1249 (s), 1177 (s), 
1156 (s), 1129 (m), 1093 (m), 1055 (w), 1023 (s), 867 (w), 835 (m), 796 (m), 777 (w), 
728 (m), 609 (w) cm−1;  
LC-MS (MeCN), Rt. 2.77 min, m/z = 278.5 [M+H]+. HR-MS (ESI-TOF) calculated for 
C14H16NO3S 278.0851, found 278.00853 (Δ = 0.7 ppm). 
Ethyl 2-(benzo[d][1,3]dioxol-5-yl)-2-(thiazol-2-yl)acetate, 402: 
 
Prepared using general procedure A: Isolated yield; 65 mg (51%, 0.44 mmol scale); 
Yellow oil; Rf: 0.07 (1/4, EtOAc/hexane); 
1H NMR (400 MHz, CDCl3) δ/ppm 7.75 (d, J = 3.3 Hz, 1H), 7.29 (d, J = 3.3 Hz, 1H), 
6.96 (d, J = 1.8 Hz, 1H), 6.90 (ddd, J = 8.0, 1.8, 0.5 Hz, 1H), 6.78 (d, J = 8.0 Hz, 1H), 
5.95 (s, 2H), 5.30 (s, 1H), 4.31 – 4.16 (m, 2H), 1.26 (t, J = 7.1 Hz, 3H);  
13C NMR (101 MHz, CDCl3) δ/ppm 170.5 (C), 167.7 (C), 148.0 (C), 147.6 (C), 142.5 
(CH), 130.2 (C), 122.1 (CH), 120.0 (CH), 109.0 (CH), 108.5 (CH), 101.3 (CH2), 62.0 
(CH2), 55.0 (CH), 14.01 (CH3);  
IR (neat) ν = 3125 (w), 3082 (w), 2986 (w), 2902 (w), 1732 (s), 1503 (m), 1488 9s), 1444 
(m), 1311 (w), 1244 (s), 1186 (s), 1162 (s), 1130 (w), 1099 (w), 1036 (s), 929 (m), 813 
(w), 772 (w), 731 (w) cm-1;  
LC-MS (MeCN), Rt. 2.67 min, m/z = 292.0 [M+H]+. HR-MS (ESI-TOF) calculated for 
C14H14NO4S 292.0644, found 292.0641 (Δ = 1.0 ppm). 
Methyl 2-(4-nitrophenyl)-2-(thiazol-2-yl)acetate, 403: 
 
Prepared using general procedure A: Isolated yield; 22 mg (36% 0.22 mmol scale);  
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Pale red oil; Rf: 0.35 (1/1, EtOAc/hexane);  
1H NMR (600 MHz, CDCl3) δ/ppm 8.21 – 8.25 (m, 2H), 7.78 (d, J = 3.3 Hz, 1H), 7.61 – 
7.65 (m, 2H), 7.36 (d, J = 3.3 Hz, 1H), 5.54 (s, 1H), 3.68 (s, 3H);  
13C NMR (151 MHz, CDCl3) δ/ppm 169.9 (C), 165.1 (C), 147.9 (C), 143.3 (C), 142.9 
(CH), 129.9 (CH), 124.2 (CH), 120.7 (CH), 54.8 (CH), 53.4 (CH3);  
LC-MS (MeCN), Rt. 2.77 min, m/z = 279.1 [M+H]+. HR-MS (ESI-TOF) calculated for 
C12H11N2O4S 279.0440, found 279.0439 (Δ = 0.4 ppm). 
Ethyl 2-(4-nitrophenyl)-2-(thiazol-2-yl)acetate, 404: 
 
Prepared using general procedure A: Isolated yield; 45 mg (35% 0.22 mmol scale);  
Pale red oil; Rf: 0.85 (9/1, DCM/MeOH);  
1H NMR (400 MHz, CDCl3) δ/ppm 8.27 – 8.20 (m, 2H), 7.80 (d, J = 3.3 Hz, 1H), 7.69 – 
7.62 (m, 2H), 7.38 (d, J = 3.3 Hz, 1H), 5.53 (s, 1H), 4.3 – 4.22 (m, 2H), 1.29 (t, J = 7.1 
Hz, 3H);  
13C NMR (101 MHz, CDCl3) δ/ppm 169.4 (C), 165.1 (C), 147.7 (C), 143.4 (C), 142.8 
(CH), 129.7 (CH), 124.1 (CH), 120.5 (CH), 62.5 (CH2), 54.9 (CH), 14.0 (CH3);  
IR (neat) ν = 3133 (w), 3079 (w), 2988 (w), 2944 (w), 2908 (w), 1733 (s), 1606 (m), 1597 
(m), 1519 (s), 1493 (m), 1346 (s), 1322 (m), 1302 (m), 1234 (m), 1185 (s), 1156 (s), 1016 
(m), 857 (m), 727 (m) 705 (m) cm-1;  
LC-MS (MeCN), Rt. 2.77 min, m/z = 291.9 [M-H]-. HR-MS (ESI-TOF) calculated for 





Prepared using general procedure A: Isolated yield; 64 mg (73% 0.44 mmol scale);  
Colourless oil; Rf: 0.20 (2/8, EtOAc/hexane);  
1H NMR (600 MHz, CDCl3) δ/ppm 7.79 (d, J = 3.3 Hz, 1H), 7.53–7.46 (m, 2H), 7.46 – 
7.37 (m, 3H), 7.34 (d, J = 3.3 Hz, 1H), 5.56 (s, 1H);  
13C NMR (151 MHz, CDCl3) δ/ppm 164.3 (C), 143.4 (CH), 133.5 (C), 129.6 (CH), 129.3 
(CH), 127.9 (CH), 121.2 (CH), 117.6 (C), 41.2 (CH);  
IR (neat) ν = 3119 (w), 3088 (w), 3033 (w), 2982 (w), 2901 (w), 2367 (w), 2250 (w), 
1494 (m), 1456 (m), 1129 (w), 1090 (w), 732 (s), 696 (s) cm-1;  
LC-MS (MeOH), Rt. 2.65 min, m/z = 201.0 [M+H]+. HR-MS (ESI-TOF) calculated for 
C11H8N2S 200.0486, found 200.0496 (Δ = 5.0 ppm). 
Methyl 3-phenyl-2-(thiazol-2-yl)propanoate, 406: 
 
Prepared using general procedure A: Isolated yield; 11 mg (16%, 0.22 mmol scale);  
Pale yellow oil; Rf: 0.07 (1/4, EtOAc/hexane);  
1H NMR (400 MHz, CDCl3) δ/ppm 7.75 (d, J = 3.3 Hz, 1H), 7.29 –7.12 (m, 6H), 4.44 
(dd, J = 8.5, 7.0 Hz, 1H), 3.67 (s, 3H), 3.47 (dd, J = 13.7, 8.5 Hz, 1H), 3.33 (dd, J = 13.7, 
7.0 Hz, 1H);  
13C NMR (101 MHz, CDCl3) δ/ppm 171.6 (C), 166.7 (C), 142.4 (CH), 137.7 (C), 129.0 
(CH), 128.7 (CH), 127.0 (CH), 119.8 (CH), 52.7 (CH3), 51.7 (CH), 39.7 (CH2);  
IR (neat) ν = 3031 (w), 2148 (w), 1983 (w), 1748 (s), 1604 (w), 1496 (w), 1455 (w), 1436 
(w), 1283 (m), 1163 (s), 1105 (m), 1082 (m), 1048 (m), 974 (m), 840 (w), 741 (m), 699 
(s), 666 (m), 652 (m), 624 (m) cm−1;  
LC-MS (MeCN), Rt. 0.28 min, m/z = 247.9 [M+H]+, HR-MS (ESI-TOF) calculated for 




Ethyl 3-phenyl-2-(thiazol-2-yl)propanoate, 407: 
 
Prepared using general procedure A: Isolated yield; 41 mg (36%, 0.44 mmol scale);  
Colorless oil; Rf: 0.12 (1/4, EtOAc/hexane); 
1H NMR (400 MHz, CDCl3) δ/ppm 7.83 (d, J = 3.2 Hz, 1H), 7.34 (d, J = 3.3 Hz, 1H), 
7.30 – 7.22 (m, 5H), 4.40 (s, 1H), 4.32 – 4.17 (m, 2H), 3.75 (d, J = 13.8 Hz, 1H), 3.42 (d, 
J = 13.8 Hz, 1H), 1.26 (t, J = 7.1 Hz, 3H);  
13C NMR (101 MHz, CDCl3) δ/ppm 171.91 (C), 171.88 (C), 143.1 (CH), 134.7 (C), 130.5 
(CH), 128.1 (CH), 127.2 (CH), 120.4 (CH), 79.2 (CH), 63.4 (CH2), 45.0 (CH2), 14.1 
(CH3);  
IR (neat) ν = 2978 (w), 2960 (w), 2181 (w), 2034 (w), 1686 (w), 1495 (w), 1453 (m), 
1397 (w), 1261 (m), 1179 (m), 1152 (m), 1101 (m), 1030 (m), 860 (w), 732 (m), 698 (m) 
cm−1;  
LC-MS (MeCN), Rt. 3.09 min, m/z = 262.1 [M+H]+, HR-MS (ESI-TOF) calculated for 
C14H16NO2S 262.0913, found 262.0902 (Δ = 4.2 ppm). 
3-Phenyl-2-(thiazol-2-yl)propanamide, 408: 
 
Prepared using general procedure A: Isolated yield; 35 mg (34%, 0.44 mmol scale);  
Amorphous white solid (recrystallised from EtOH); Rf: 0.21 (1/4, EtOAc/hexane); 
1H NMR (600 MHz, DMSO-d6) δ/ppm 7.67 (d, J = 3.0 Hz, 1H), 7.65 (br, 1H) 7.59 (d, J 
= 3.3 Hz, 1H), 7.27 – 7.19 (m, 2H), 7.16 (m, 3H), 7.06 (br, 1H), 4.30 (dd, J = 8.7, 6.7 Hz, 
1H), 3.26 (dd, J = 13.6, 8.7 Hz, 1H), 3.07 (dd, J = 13.6, 6.7 Hz, 1H);  
13C NMR (151 MHz, DMSO-d6) δ/ppm 172.3 (C), 168.7 (C), 142.0 (CH), 139.0 (C), 
129.3 (CH), 128.6 (CH), 126.7 (CH), 120.7 (CH), 51.9 (CH), 39.8 (CH2);  
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IR (neat) ν = 3291 (w, br), 3117 (w, br), 2918 (w), 1685 (s), 1680 (s), 1676 (s), 1497 (m), 
1452 (w), 1428 (w), 1405 (m), 1315 (w), 1286 (w), 1251 (w), 1128 (s), 1061 (m), 835 
(m), 745 (m), 728 (s), 695 (s);  
LC-MS (MeCN), Rt. 2.13 min, m/z = 233.4 [M+H]+. HR-MS (ESI-TOF) calculated for 
C12H13N2OS 233.0749, found 233.0752 (Δ = 1.3 ppm);  
Melting point: 145 °C (decomposed, EtOH). 
3-(4-Bromophenyl)-2-(thiazol-2-yl)propanamide, 409: 
 
Prepared using general procedure A: Isolated yield; 20 mg (37%, 0.176 mmol scale);  
White amorphous solid; (recrystallised from MeOH); Rf: 0.18 (1/4, EtOAc/hexane); 
1H NMR (600 MHz, DMSO-d6) δ/ppm 7.67 (d, J = 3.0 Hz, 1H), 7.65 (br, 1H), 7.59 (d, J 
= 3.3 Hz, 1H), 7.42 (d, J = 8.0 Hz, 2H), 7.12 (d, J = 8.0 Hz, 2H), 7.08 (s, 1H), 4.27 (dd, 
J = 8.9, 6.5 Hz, 1H), 3.22 (dd, J = 13.6, 8.7 Hz, 1H), 3.06 (dd, J = 13.6, 6.8 Hz, 1H);  
13C NMR (151 MHz, DMSO-d6) δ/ppm 172.1 (C), 168.4 (C), 142.1 (CH), 138.4 (C), 
131.6 (CH), 131.4 (CH), 120.8 (CH), 119.9 (C), 51.7 (CH), 39.1 (CH2);  
IR (neat) ν = 3303 (br), 3190 (br), 1681 (s), 1498 (m), 1486 (m), 1404 (m), 1284 (w), 
1253 (w), 1131 (m), 1065 (m), 1011 (s), 847 (s), 797 (m), 736 (s), 606 (m), 537 (s) cm-1;  
LC-MS (MeOH), Rt. 2.45 min, m/z = 310.9 [M+H]+. HR-MS (ESI-TOF) calculated for 
C12H12BrN2OS 310.9854, found 310.9857 (Δ = 1.0 ppm);  
Melting point: 144 °C (decomposed, MeOH).  
Ethyl-2-(thiazol-2-yl)propanoate, 410: 
 
Prepared using general procedure A: Isolated yield; 14 mg (35%, 0.22 mmol scale);  
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Pale yellow oil; Rf: 0.46 (1/1, EtOAc/hexane);  
1H NMR (700 MHz, CDCl3) δ/ppm 7.73 (d, J = 3.3 Hz, 1H), 7.29 (d, J = 3.3 Hz, 1H), 
4.24 – 4.17 (m, 3H), 1.67 (d, J = 7.3 Hz, 3H), 1.26 (t, J = 7.1 Hz, 3H);  
13C NMR (176 MHz, CDCl3) δ/ppm 172.3 (C), 168.8 (C), 142.3 (CH), 119.4 (CH), 61.6 
(CH2), 44.4 (CH), 18.5 (CH3), 14.2 (CH3); 
 IR (neat) ν = 3116 (w), 2983 (w), 2937 (w), 1732 (s), 1499 (w), 1446 (w), 1370 (w), 
1254 (m), 1173 (m), 1138 (m), 1096 (m), 1047 (m), 1017 (m), 939 (w), 859 (w), 730 (m), 
624 (w) cm-1;  
LC-MS (MeCN), Rt. 2.35 min, m/z = 186.9 [M+H]+. HR-MS (ESI-TOF) calculated for 
C8H12NO2S 186.0589, found 186.0588 (Δ = 0.5 ppm). 
Ethyl 2-(thiazol-2-yl)butanoate, 411: 
 
Prepared using general procedure A: Isolated yield; 15 mg (33%, 0.66 mmol scale);  
Colourless oil; Rf: 0.37 (1/1, EtOAc/hexane);  
1H NMR (400 MHz, CDCl3) δ/ppm: 7.73 (d, J = 3.3 Hz, 1H), 7.29 (dd, J = 3.3, 0.5 Hz, 
1H), 4.27–4.14 (m, 2H), 4.04 (t, J = 7.5 Hz, 1H), 2.25 – 1.97 (m, 2H), 1.26 (t, J = 7.1 Hz, 
3H), 0.97 (t, J = 7.4 Hz, 3H);  
13C NMR (101 MHz, CDCl3) δ/ppm: 171.9 (C), 167.7 (C), 142.3 (CH), 119.5 (CH), 61.5 
(CH2), 51.8 (CH), 27.5 (CH2), 14.3 (CH3), 11.9 (CH3);  
IR (neat) ν = 3116 (w), 3085 (w), 2972 (w), 2937 (w), 2828 (w), 1733 (s), 1498 (w), 1461 
(w), 1370 (w), 1253 (w), 1181 (s), 1138 (w), 1022 (m), 861 (w), 727 (w);  
LC-MS (MeCN), Rt. 2.48 min, m/z = 200.8 [M+H]+; HR-MS (ESI-TOF) calculated for 





Consistent with published data184 
Prepared using general procedure A: Isolated yield; 45 mg (quantitative, 0.22 mmol 
scale);  
Yellow crystalline product (recrystallised from EtOH);  
1H NMR (400 MHz, CDCl3) δ/ppm 7.70 (d, J = 7.2 Hz, 2H), 7.42-7.57 (m, 3H), 6.91 (d, 
J = 6.0 Hz, 1H), 6.16 (d, J = 6.0 Hz, 1H);  
13C NMR (101 MHz, CDCl3) δ/ppm 191.2 (C), 166.1 (C), 140.8 (C), 130.7 (CH), 128.1 
(CH), 127.8 (CH), 115.1 (C), 106.1 (CH);  
IR (neat) ν = 3359 (m), 3241 (br), 3128 (w), 1600 (m), 1570 (m), 1444 (s), 1420 (s), 1418 
(s), 1398 (m), 1325 (m), 1289 (m), 1213 (w), 1078 (w), 946 (w), 833 (s), 698 (s), 672 (s), 
664 (m), 654 (m), 587 (m), 494 (s) cm-1;  
HR-MS (ESI-TOF) calculated 204.0483, found 204.0475 (Δ = 3.9 ppm);  
Melting point: 151-153 °C (EtOH). (Literature: 152-153 °C, no solvent reported).184 
Ethyl 2-aminothiophene-3-carboxylate, 416: 
 
Consistent with published data185 
Prepared using general procedure A: Isolated yield; 30 mg (79%, 0.22 mmol scale);  
Colourless oil; Rf: 0.42 (1/9, EtOAc/hexane);  
1H NMR (400 MHz, CDCl3) δ/ppm 7.00 (d, J = 5.6 Hz, 1H), 6.20 (d, J = 5.6 Hz, 1H), 
5.93 (s, br, 2H), 4.30 (dd, J = 7.0, 14.2 Hz, 2H), 1.36 (t, J = 7.0 Hz, 3H);  
13C NMR (101 MHz, CDCl3) δ/ppm 165.4 (C), 162.6 (C), 125.9 (CH), 107.3 (C), 106.9 
(CH), 59.7 (CH2), 14.5 (CH3);  
IR (neat) ν = 3435 (w), 3326 (w), 1650 (m), 1582 (m), 1522 (m), 1485 (m), 1400 (m), 
1380 (m), 1305 (m), 1261 (m), 1169 (w), 1108 (m), 1070 (w), 1020 (m), 901 (w), 828 
(w), 783 (w), 679 (m) cm-1;  






Consistent with published data.127 
Prepared using general procedure A: Isolated yield; 37 mg (63%, 0.44 mmol scale);  
Pink amorphous solid; Rf: 0.35 (1/4, EtOAc/hexane); 
1H NMR (400 MHz, DMSO-d6) δ/ppm 7.46 – 7.10 (m, 3H), 7.04 (d, J = 5.8 Hz, 1H), 
6.80 (d, J = 50.6 Hz, 1H), 6.22 (d, J = 5.8 Hz, 1H);  
13C NMR (101 MHz, CDCl3) δ/ppm 168.0 (C), 162.1 (C), 125.3 (CH), 107.6 (C), 105.8 
(CH);  
IR (neat) ν = 3438 (w, br), 3409 (w, br), 3321 (w, br), 3261 (w, br), 3208 (w, br), 3119 
(w), 3083 (w), 1645 (m), 1594 (s), 1562 (s), 1559 (s), 1520 (s), 1417 (m), 1418 (s), 1348 
(m), 1284 (w), 1220 (w), 1101 (m), 895 (w), 872 (w), 785 (m), 690 (m), 664 (m) cm-1.  
LC-MS (MeOH), Rt. 1.47 min, m/z = 142.9 [M+H]+. HR-MS (ESI-TOF) calculated for 
C10H9N2O 142.0279, found 142.0278 (Δ = 0.7 ppm);  




Consistent with published data186 
Isolated as an oxidation product of 362 in 12 mg (4% yield).  
Pale yellow oil; Rf: 0.47 (1/4, EtOAc/hexane); 
1H NMR (700 MHz, CDCl3) δ/ppm 8.49 – 8.45 (m, 2H), 8.10 (d, J = 3.0 Hz, 1H), 7.73 
(d, J = 3.0 Hz, 1H), 7.68 – 7.61 (m, 1H), 7.56 – 7.50 (m, 2H). 
13C NMR (176 MHz, CDCl3) δ/ppm 184.3 (C), 168.1 (C), 145.0 (CH), 135.4 (C), 133.8 
(CH), 131.2 (CH), 128.6 (CH), 126.4 (CH). 
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LC-MS (MeCN), Rt. 2.35 min, m/z = 186.9 [M+H]+. HR-MS (ESI-TOF) calculated for 
C10H8NOS 190.0327, found 190.0323 (Δ = 2.1 ppm). 
(Ethyl 2-hydroxy-2-phenyl-2-(thiazol-2-yl)acetate), 441. 
 
Isolated as an oxidation product of 362 in 181 mg (60% yield).  
White, crystalline solid; Rf: 0.20 (1/4, EtOAc/hexane); 
1H NMR (700 MHz, CDCl3) δ/ppm 7.82 (d, J = 3.2 Hz, 1H), 7.73 – 7.70 (m, 2H), 7.40 – 
7.33 (m, 4H), 4.92 (s, 1H), 4.35 (q, J = 7.1 Hz, 2H), 1.28 (t, J = 7.2 Hz, 3H). 
13C NMR (176 MHz, CDCl3) δ/ppm 172.3 (C), 171.9 (C), 142.9 (CH), 139.6 (C), 128.8 
(CH), 128.3 (CH), 126.7 (CH), 120.7 (CH), 79.5 (C), 63.8 (CH2), 14.1 (CH3).  
IR (neat) ν = 3457 (w, br), 3118 (w), 2982 (w), 1730 (s), 1494 (w), 1449 (w), 1242 (s), 
1173 (m), 1097 (m), 1066 (m), 1012 (w), 733 (m), 699 (m) cm−1. 
LC-MS (MeCN), Rt. 2.56 min, m/z = 263.9 [M+H]+. HR-MS (ESI-TOF) calculated for 
C13H14NO3S 264.0694, found 264.0689 (Δ = 1.9 ppm).  
Elemental analysis: calculated for C13H13NO3S C: 59.30%, H: 4.98%, N: 5.32%; 
measured C: 58.96% (Δ = 0.34), H: 4.95% (Δ = 0.03), N: 5.24% (Δ = 0.08). 
Melting point:  95-97 °C (iPrOH). 
Crystal data for compound 441: C13H13NO3S, M = 263.30, monoclinic, space group P21/n 
(no. 14), a = 7.5217(2), b = 11.1445(3), c = 14.9519(4) Å, β = 91.003(3)°, V = 1253.16(6) 
Å3, Z = 4, T = 120.0 K, μ(MoKα) = 0.257 mm-1, Dcalc = 1.396 g/mm
3, 12888 reflections 
measured, 3654 unique (Rint = 0.0444) were used in all calculations. The final R1 was 
0.0419 (2878 refl. with I > 2σ(I)) and wR2 was 0.0975 (all data), GOOF = 1.052. CCDC-
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